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ABSTRACT 
DYSREGULATION OF SYSTEM XC- AND ITS IMPACT 
ON COCAINE SEEKING 
 
 
Aric Madayag 
 
Marquette University, 2012 
 
 
Abnormal glutamate signaling in the brain, particularly in the nucleus accumbens 
core, contributes to compulsive cocaine-seeking behavior. In the nucleus accumbens, two 
distinct pools of glutamate exist. The synaptic pool stimulates excitatory postsynaptic 
receptors, leading to cocaine seeking. Cystine-glutamate exchange by system xc- 
contributes to the extrasynaptic pool and regulates neurotransmission by activating 
extrasynaptic receptors including inhibitory Group II metabotropic glutamate receptors, 
positioning this as an important mechanism for regulating nucleus accumbens activity. 
We and others have found decreased levels of cystine-glutamate exchange in animals 
withdrawn from chronic cocaine administration. In chapter 1, we describe studies directly 
implicating diminished system xc- activity in abnormal glutamate signaling necessary for 
promoting drug seeking. Given that altered system xc- activity is essential to drug 
seeking, understanding the cellular basis of reduced cystine-glutamate exchange would 
advance our knowledge of the neural basis of addiction. Unfortunately, little is known 
about how the system is regulated. To address this, we sought to define conditions that 
permit the study of system xc- (chapter 2). In chapter 3, we examined potential regulation 
of xc- by dopamine, nonspecific dopamine agonists, D1-liked dopamine receptor 
agonists, and D2-like dopamine receptor agonists. While we found D1-like receptor 
regulation of cystine-glutamate exchange in mixed cortical culture, we did not observe 
this effect in tissue punches; thus, it is unlikely that abnormal regulation of system xc- by 
dopamine underlies reduced cystine-glutamate exchange in cocaine-withdrawn animals. 
In chapter 4, we examined pituitary adenylyl cyclase activating polypeptide (PACAP) 
because it has been recently shown to regulate extracellular glutamate homeostasis. We 
found acute and tonic regulation of cystine-glutamate exchange by PACAP-induced 
stimulation of Ca
2+
-dependent protein kinase (PKC) activity. More importantly, we also 
determined that PACAP regulation of system xc- is diminished in animals withdrawn 
from cocaine self-administration. These findings suggest dysregulated PACAP 
neurotransmission in cocaine-withdrawn animals contributes to the neural basis of 
addiction. By revealing novel mechanisms contributing to addiction, scientists can 
identify novel targets for therapeutic treatment. 
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INTRODUCTION 
Overview 
The development of cocaine addiction is a result of neuroplasticity that leads to 
compulsive use. The onset of cocaine use is due to a hedonic sensation when consumed 
in enough quantities leads to tolerance, elevated levels of consumption, and eventually 
addiction [for review, see (Hyman and Malenka, 2001)]. However, a compulsive pattern 
of drug taking emerges after chronic use that is thought to be the direct result of drug-
induced plasticity (Hyman and Malenka, 2001, Pierce and Vanderschuren, 2010). Even 
after extended withdrawal and abstinence from cocaine, people maintain a high 
vulnerability to relapse (O'Brien et al., 1992, O'Brien et al., 1998). To date, there exists a 
lack of effective clinical therapeutic treatments for cocaine addiction. To identify 
effective therapeutics for preventing relapse, scientists must first reveal cocaineinduced 
neuroplasticity that contributes to addiction and relapse susceptibility. 
Cocaine-induced neuroplasticity affects most of the brain, and can lead to 
compulsive drug seeking behavior (Hyman and Malenka, 2001, Pierce and 
Vanderschuren, 2010). In order to focus studies on brain regions relevant to cocaine 
seeking, the motive circuit is given serious attention. This is due to the fact that the 
nucleus accumbens core of the motive circuit is the primary output region for this 
circuitry. Investigators originally studied cocaine-induced long-term changes in 
dopamine signaling in the nucleus accumbens core, this given that cocaine is primarily 
viewed as a dopamine transporter blocker (Wise, 1984, Bradberry and Roth, 1989). 
However, previous studies have found that during the reinstatement phase of the self-
administration model of addiction, described in detail below, not dopamine but rather 
glutamate signaling in the nucleus accumbens core is necessary for reinstatement 
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(Cornish and Kalivas, 2000). Though glutamate is necessary for reinstatement, what is 
unknown are factors that determine different magnitudes of reinstatement, a potential 
correlate to relapse vulnerability. In this thesis, we will investigate the contribution of 
glutamate and dopamine signaling in the nucleus accumbens core to reinstatement 
magnitude. 
Glutamate neurotransmission is altered in animals withdrawn from repeated 
cocaine administration (Wolf et al., 2004, Kalivas et al., 2005), which likely contributes 
to addiction because abnormal activation of corticostriatal pathways correlates with 
craving in humans (Breiter et al., 1997, Volkow et al., 1999, Volkow et al., 2005) and is 
necessary for cocaine-seeking in rodents (Park et al., 2002, McFarland et al., 2003, 
Schmidt et al., 2005). Therefore, targeting glutamate neurotransmission therapeutically is 
likely to be an effective treatment for cocaine addiction. 
Two distinct pools of extracellular glutamate in the nucleus accumbens core exist, 
synaptic and extrasynaptic. Synaptic glutamate derives primarily from glutamatergic 
neurons originating in the dorsomedial prefrontal cortex. Extrasynaptic glutamate is 
contributed by astrocytic vesicular (Hepp et al., 1999, Araque et al., 2000, Jourdain et al., 
2007, Malarkey and Parpura, 2008) and non-vesicular sources (Baker et al., 2002, Moran 
et al., 2005). Non-vesicular glutamate provided primarily by system xc- regulates 
synaptic neurotransmission, and is decreased following withdrawal from cocaine self-
administration (Baker et al., 2002, Moran et al., 2005, Moussawi et al., 2011b). 
Investigators have been able to directly target cystine-glutamate exchange to reduce 
cocaine-seeking (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008). In addition, 
restoration of cystine-glutamate exchange expression decreases cocaine-seeking 
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(Knackstedt et al., 2010), but little is known about multiple aspects during withdrawal; 
for example the contribution of diminished cystine-glutamate exchange to basal 
extracellular glutamate and cocaine-evoked glutamate in animals withdrawn from 
cocaine. In addition, the source of cocaine-induced decreases in cystine-glutamate has not 
been studied thoroughly. 
The purpose of this thesis is to determine the contribution of diminished cystine-
glutamate exchange in cocaine-seeking and what contributes to decreased cystine-
glutamate following repeated cocaine. In order to address the former, we manipulate 
conditions that block cocaine-induced decreases in cystine-glutamate exchange. To 
address the latter, we will first determine neuronal signaling that regulates cystine-
glutamate exchange. Below, I will describe in detail: 
 Circuitry involved in cocaine-seeking: the motive circuit 
 Behavioral models of addiction 
 Cocaine-induced neuroplasticity relevant to cocaine-seeking 
 The cellular and molecular basis of glutamate homeostasis 
 Cystine-glutamate exchange by system xc- 
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The motive circuit 
In order to effectively 
identify pathological 
neuroplasticity in addiction, a 
detailed analysis of the circuitry 
contributing to addiction will be 
addressed. The motive circuit 
(figure i.1) is a combination of 
limbic circuit processing and 
motor control, and plays a central 
role in motivated behavior and 
addiction (Wise, 1984, Kalivas 
and McFarland, 2003, Kalivas et 
al., 2005, Schmidt et al., 2005). 
There exists two major divisions 
of the NAcc. The core division is the central part located mostly surrounding the anterior 
commissure. The shell division surrounds the core and occupies the ventral and medial 
portions of the NAcc. Though the core and shell share similar neuronal composition of 
medium spiny projection neurons (Meredith, 1999) in addition to cholinergic and 
parvalbumin interneurons (Kawaguchi et al., 1995), they differ in efferent and afferent 
pathways. Key among these distinct circuitry is the difference in excitatory input. For 
example, the nucleus accumbens core receives glutamatergic input primarily from the 
dorsomedial prefrontal cortex, whereas the nucleus accumbens shell receives input from 
Figure i.1. Multiple projections to the nucleus accumbens 
interact to determine behavioral output. Glutamatergic 
projections from the PFC, vSub, BLA, and thalamus are 
excitatory glutamate projections. Dopaminergic projections 
from the VTA are modulatory. There also GABAergic 
inhibitory inputs from the VP and VTA. PFC, prefrontal 
cortex; vSub, ventral subiculum of the hippocampus; BLA, 
basolateral amygdala; Mid, IL, midline and intralaminar 
thalamaic nuclei; NAcc, nucleus accumbens; VP, ventral 
pallidum; VTA, ventral tegmental area. 
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the ventromedial prefrontal cortex, the ventral subiculum of the hippocampus, and the 
amygdala (Kelley and Domesick, 1982, Kelley et al., 1982, Groenewegen et al., 1987, 
Groenewegen et al., 1990, Kita and Kitai, 1990, McDonald, 1991). In addition to the 
differential input to the core and shell of the nucleus accumbens, they also differ in their 
functional downstream effects. While the nucleus accumbens core is the central 
behavioral output region for the motive circuit (McFarland and Kalivas, 2001, Kalivas 
and McFarland, 2003), the nucleus accumbens shell receives excitatory input to regulate 
dopamine cell activity in the ventral tegmental area (Floresco et al., 2001, Floresco et al., 
2003, Goto and Grace, 2005). Investigators suggest that they also differ in their role in 
behavior and reward processing (Carlezon et al., 1995, Volkow and Fowler, 2000, Rodd-
Henricks et al., 2002, Kalivas and McFarland, 2003, Robbins et al., 2008). 
As portrayed in figure i.1, input to the nucleus accumbens can be divided into 
three major categories: excitatory (glutamatergic), inhibitory (GABAergic), and 
modulatory (dopamine and other neuromodulators). Excitatory input comes primarily 
from limbic areas such as the prefrontal cortex, entorhinal cortex, ventral subiculum of 
the hippocampus, and the basolateral amygdala (Kelley and Domesick, 1982, Kelley et 
al., 1982, Groenewegen et al., 1987, Kita and Kitai, 1990, McDonald, 1991, Berendse et 
al., 1992, Brog et al., 1993, Totterdell and Meredith, 1997, Reynolds and Zahm, 2005), as 
well as from the midline and intralaminar nuclei of the thalamus (Kelley and Stinus, 
1984, Berendse and Groenewegen, 1990). Major inhibitory inputs derive from the ventral 
tegmental area and the ventral pallidum (Brog et al., 1993, Groenewegen et al., 1993, 
Churchill and Kalivas, 1994, Van Bockstaele and Pickel, 1995, Wu et al., 1996). 
Dopamine input comes mainly from the midbrain ventral tegmental area (Voorn et al., 
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1986, Ikemoto, 2007). Understanding how these systems may be altered by chronic 
cocaine will be important to understanding the neural basis of addiction. 
Models of addiction: Conditioned Place Preference 
 Conditioned place preference (CPP) is widely used to test the rewarding 
properties of drugs. It is based on classical conditioning whereby spatial cue-associated 
chambers are paired to an injection of either drug (cocaine) or saline. During the 
acquisition phase of CPP, an animal is first assessed for its “preference” for a particular 
chamber in a drug naïve state. This allows the experimenter to follow a biased, unbiased, 
or balanced procedure for the acquisition phase. In the biased method, the experimenter 
gives an injection of a drug when animals in a group enter the same chamber throughout 
the experiment, while the other is paired with a vehicle (i.e. saline) injection. The 
experimenter generally pairs the drug injection with the chamber the animals did not 
prefer in the drug naïve state. In the unbiased method, the drug paired compartment is 
picked at random between animals. In the balanced method, each compartment is 
assigned the same number of drug pairs across all animals. To determine the presence or 
absence of CPP, an experimenter would compare the time spent in drug- and vehicle-
paired compartments (Parker and McDonald, 2000). Investigators appreciate this method 
based on the absence of contextual stimuli for which animals can acquire a secondary 
preference (i.e. light or noise) (Tzschentke, 2007). Whereas the development of place 
preference is a useful model for the rewarding properties of a drug, some experimenters 
prefer to utilize the extinction/reinstatement model of relapse. 
During extinction, the animal will either received a saline injection regardless of 
the chamber entered, or will be allowed to fully explore both chambers without any 
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injections. Animals will continue to be placed in the chamber until a preference is 
extinguished. This stage in the paradigm allows an investigator to evaluate the 
motivational properties of the drug administered during the acquisition phase, in the 
absence of drug treatment.  
Reinstatement of drug-paired behavior by a priming injection of the drug is a 
reliable model for drug craving and relapse (De Vries et al., 1998, Shalev et al., 2002). 
During the reinstatement phase of CPP, the animal receives an acute injection of drug or 
a stressor. Of particular interest is the ability of a variety of psychostimulants to cross-
react and reinstate CPP. For example, animals extinguished from cocaine CPP exhibit 
reinstatement in the presence of a priming injection of methamphetamine, morphine, 
nicotine, and ethanol (Itzhak and Martin, 2002, Romieu et al., 2004). An acute stressor is 
also capable of reinstating CPP for cocaine (Lu et al., 2002, Sanchez et al., 2003). 
There are advantages and disadvantages to the use of conditioned place 
preference as a model of addiction. Pharmacological treatment intended to reverse drug 
seeking during reinstatement may affect higher-level thought such as operant responding 
found in the self-administration model, which is less likely to alter cocaine-seeking in the 
CPP paradigm. In addition, the onset of “cocaine-seeking” by place preference is 
relatively quicker than the self-administration paradigm given that the animal is not 
required to learn operant responding. Disadvantages to this method include the lack of 
flexibility in the paradigm during particular phases of the experiment. For example, while 
the animal effectively prefers a chamber over the other, it is more difficult to determine 
magnitude of drug-seeking and its relation to compulsion. 
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Models of addiction: Self-administration 
The self-administration model of addiction is a more widely used addiction 
paradigm. In this model, an animal is surgically implanted with an intravenous catheter 
and trained to respond (e.g. lever press or nose poke) to receive an infusion of drug (i.e. 
cocaine) during the acquisition/maintenance phase (Clark et al., 1961, Weeks, 1962). As 
in the acquisition phase of CPP, certain conditions of this phase allow the experimenter to 
measure rewarding and reinforcing properties of the drug, supporting the abuse potential 
of the drug (Johanson, 1990, Balster and Bigelow, 2003, Panlilio and Goldberg, 2007). 
The experimenter may manipulate the responding required to receive an infusion of drug, 
the two most common variations are fixed and progressive ratio [for review see (Arnold 
and Roberts, 1997)]. Fixed ratio schedules, when a fixed number of responses are 
required to receive drug infusion, are commonly used to measure the reinforcing 
properties of a drug. On the other hand, progressive ratio schedules, when the number of 
responses required to receive drug infusion “progressively” increases with each response, 
are commonly used to measure the effectiveness of the reinforce; sometimes considered a 
measure of the amount of work an animal is willing to exert, or willing to “pay”, to 
receive the reinforcer. Some experimenters primarily utilize the acquisition/maintenance 
phase, this due to the fact that in the clinical setting a patient is not likely to remain 
abstinent unless under constant supervision. 
Most investigators make use of the extinction/reinstatement model of self-
administration. During extinction, drug-seeking is extinguished by replacing the infusion 
solution with saline or disconnection from the infusion pump. There are multiple variants 
of extinction/reinstatement such as between-session, within-session, and between-within-
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session. In the between-session paradigm, the drug self-administration, extinction, and 
reinstatement occur on consecutive days; for example an animal gains drug-seeking on 
day one (or over multiple days), extinguishes drug-seeking the following day, and 
undergoes reinstatement the day after that. In the within-session paradigm drug self-
administration, extinction, and reinstatement takes place sequentially within the same 
day. The between-within-session paradigm, by definition, involves drug self-
administration across multiple days, and the extinction/reinstatement take place on a later 
day, but within the same day of each other. A common variant of the between-within 
paradigm involves a protracted withdrawal period following the self-administration phase 
(Fuchs et al., 2006), extinction across multiple days until responding within each session 
is minimal, and then reinstatement. 
Following extinction, a stimulus such as drug, stress, or cue is provided to induce 
reinstatement of drug-seeking. Reinstatement of drug-seeking is defined as operant 
responding significantly higher than that observed on the last day of extinction. As in 
conditioned place preference, there exists cross sensitization of psychostimulants to 
induce reinstatement of drug seeking. Stress- (Erb et al., 1996, Shaham et al., 2000, Koob 
and Le Moal, 2001) and cue-induced (See, 2002) reinstatement are of interest due to their 
clinical relevance. 
A distinct advantage of the self-administration paradigm is the ability to 
manipulate conditions to allow for a measure of compulsive behavior. Previous studies 
have shown that the level of cocaine intake during the maintenance phase of self-
administration alters both the onset of compulsive drug seeking as measured by escalated 
intake during the maintenance phase, as well as elevated cocaine-induced reinstatement 
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after withdrawal (Ahmed and Koob, 1998), providing a preclinical basis for comparing 
recreational and addictive cocaine use. 
Drug-induced plasticity in the nucleus accumbens and reinstatement 
In the nucleus accumbens core, stimulation of glutamate (McFarland and Kalivas, 
2001, Di Ciano et al., 2008) and dopamine (Spealman et al., 1999, Cornish and Kalivas, 
2000, Park et al., 2002, Shalev et al., 2002) receptors is sufficient to produce drug-
seeking. However, blockade of glutamate (Cornish et al., 1999, Cornish and Kalivas, 
2000, McFarland et al., 2003) but not dopamine (McFarland and Kalivas, 2001, 
Anderson et al., 2003) receptors will abolish drug seeking. This suggests that long term 
changes in glutamate signaling in the nucleus accumbens core may underlie cocaine 
seeking behavior. This poses neuroplasticity involving glutamate in the nucleus 
accumbens core as a key mechanism that may be capable of producing compulsive drug 
seeking. In fact, studies have found long term changes in glutamate homeostasis and have 
linked these adaptations to cocaine-seeking (Pierce et al., 1996, Baker et al., 2003), as 
described below. 
Glutamate homeostasis in the nucleus accumbens 
 There exists two distinct pools of extracellular glutamate, synaptic and 
extrasynaptic. As it pertains to the nucleus accumbens core, synaptic glutamate derives 
from glutamate terminals originating in the prefrontal cortex (Groenewegen et al., 1990, 
Berendse et al., 1992, Brog et al., 1993). Propagation of an action potential leads to an 
increase in calcium in the presynaptic terminal, resulting in docking and vesicular release 
of glutamate into the synaptic cleft. 
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Synaptic glutamate then targets both ionotropic and metabotropic glutamate 
receptors. There are two primary ionotropic receptors, a low affinity a-amino-3-
hydroxy5-methyl-4-isoazole-proprionic acid (AMPA) and a high affinity N-methyl-D-
aspartic acid (NMDA), both named for selective exogenous ligands capable of activating 
the receptors. The high affinity NMDA receptors are under constant blockage by a 
voltage sensitive Mg
2+
-inhibitor. This magnesium blockade is removed when the cell is 
sufficiently depolarized, usually by activation of AMPA receptors. These conditions 
maintain a high signal/noise ration whereas sufficiently higher levels of glutamate are 
required to stimulate AMPA receptors, leading to relief of the Mg
2+
 blockade on NMDA 
receptors and further cellular depolarization. 
Metabotropic glutamate receptors are G-protein coupled receptors categorized 
into three families based on sequence homology [for review, see (Nakanishi, 1994)]: 
Group I mGluRs, consisting of mGluR 1 and 5, activate Gq; Group II mGluRs, consistend 
of mGluR 2 and 3, activate Gi; and Group III mGluRs, consisting of mGluRs 4, 6, 7, and 
8 activate Gi. Synaptic metabotropic glutamate receptors are primarily Group I. Group I 
receptors are primarily expressed on postsynaptic neurons and cholinergic neurons in the 
striatum (Kerner et al., 1997, Pisani et al., 2001a, Pisani et al., 2001b, Marino et al., 
2002). Activation of postsynaptic Group I receptors facilitates synaptic signaling by 
contributing to LTP and LTD (Gubellini et al., 2003). Group II and III receptors have 
been localized to presynaptic excitatory terminals (Testa et al., 1998, Bradley et al., 1999, 
Kosinski et al., 1999). Stimulation of these receptors leads to inhibition of glutamatergic 
synaptic release in the striatum (Lovinger and McCool, 1995, Manzoni et al., 1997). 
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Synaptic glutamate is cleared from the synaptic space primarily by an excitatory 
amino acid transporter (EAAT), of which there are five (EAAT 1-5). Glutamate transport 
by an EAAT is coupled to the influx of three Na
+
 molecules, one H
+
 molecule, and efflux 
of one K
+
 molecule (Zerangue and Kavanaugh, 1996, Levy et al., 1998, Owe et al., 
2006). Given that glutamate is a negatively charged amino acid, the electrical gradient 
created by cotrans/antiport of these ions makes glutamate transport energetically 
favorable. EAATs are located both at the synaptic cleft and in the extrasynaptic space. 
This allows for functional separation of synaptic and extrasynaptic glutamate 
compartments. 
As portrayed in figure i.2, 
extracellular glutamate derives from 
multiple sources and regulates synaptic 
activity. Glutamate release from 
astrocytes can occur through multiple 
mechanisms. Calcium-mediated glutamate 
release from astrocytes is dependent on 
storage of glutamate into vesicles and 
release by the SNARE complex (Parpura 
et al., 1995, Jeftinija et al., 1997, Hepp et 
al., 1999, Araque et al., 2000, Pasti et al., 
2001, Montana et al., 2004, Crippa et al., 
2006). Ca
2+
-dependent glutamate 
regulates synaptic activity by targeting 
Figure i.2. Extrasynaptic glutamate derived from 
astrocytes can regulate synaptic activity. (1) 
Nonvesicular glutamate from cystine-glutamate 
exchange stimulates presynaptic inhibitory Group 
II receptors, decreases synaptic release of 
neurotransmitter. (2) Ca
2+
-dependent vesicular 
release of glutamate activates extrasynaptic 
NMDA receptors, potentiating synaptic activity. 
CC, cystine; G, glutamate; II, group II 
metabotropic glutamate receptors; NMDA, 
NMDA receptor; AMPA, AMPA receptor; 
EAAT, excitatory amino acid transporter. 
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extrasynaptic NMDA receptors (D'Ascenzo et al., 2007, Jourdain et al., 2007). Other 
astrocytic sources of extrasynaptic glutamate include hemichannels (Ye et al., 2003), 
volume-sensitive organic ion channels (Strange et al., 1996, Basarsky et al., 1999, Ye et 
al., 2003), and cystine-glutamate exchange (Bannai, 1986, Murphy et al., 1990, Warr et 
al., 1999, Baker et al., 2002, Moran et al., 2005). 
Cystine-glutamate exchange by system xc- 
Cystine-glutamate exchange by 
system xc- contributes to extrasynaptic 
glutamate by stoichiometric exchange of 
an extracellular cystine molecule for an 
intracellular glutamate molecule 
(Bannai, 1986, Murphy et al., 1990, 
Warr et al., 1999, Baker et al., 2002, 
Moran et al., 2005). System xc- is 
comprised of two protein subunits. The 
heavy chain subunit, 4f2hc is 
nonspecific for amino acid transporter. 
The functional subunit, xCT is specific 
for system xc- and is necessary for 
cystine-glutamate exchange (Shih and 
Murphy, 2001). Cystine transport by 
cystine-glutamate exchange is chloride-
dependent and sodium-independent 
Figure i.3. Cystine-glutamate exchange regulates 
synaptic activity. Glutamate derived from cystine-
glutamate exchange stimulates presynaptic Group II 
receptors, which activates Gi signaling. Gi reduces 
adenylyl cyclase activity and eventually PKA 
activity, which under normal circumstances 
increases activity of Ca
2+
channels that are necessary 
for synaptic release of neurotransmitter. CC, cystine; 
G, glutamate; II, group II metabotropic glutamate 
receptors (mGluR2/3); AC, adenylyl cyclase, PKA, 
protein kinase A. 
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(Waniewski and Martin, 1984, Bannai, 1986), a key property that distinguishes it from 
other more common amino acid transporters such as EAATs. Figure i.3 illustrates how 
extrasynaptic glutamate from cystine-glutamate exchange stimulates presynaptic 
inhibitory group II metabotropic glutamate receptors (mGluR2/3) (Baker et al., 2002, 
Moran et al., 2005, Moussawi et al., 2011b), rendering it an essential mechanism for 
normal synaptic function. Cocaine-induced decreases in cystine-glutamate exchange have 
been found in animals withdrawn from chronic cocaine self-administration (Baker et al., 
2003, Moran et al., 2005, Kau et al., 2008, Moussawi et al., 2011b). As well, withdrawal 
from chronic cocaine results in a decrease in basal extracellular glutamate (Pierce et al., 
1996, Baker et al., 2003), though others have found this not to be the case (Reid and 
Berger, 1996). Decreases in basal extracellular glutamate likely contribute to the 
augmented cocaine-evoked glutamate in the nucleus accumbens of cocaine-withdrawn 
animals as extrasynaptic nonvesicular glutamate regulates synaptic transmission (Baker 
et al., 2002, Moran et al., 2005, Moussawi et al., 2011b). To overcome this deficit, we 
have targeted cystine-glutamate exchange both during reinstatement. Stimulating cystine-
glutamate exchange can reduce cocaine-primed reinstatement after protracted 
withdrawal. 
Given that altered system xc- activity is essential to elevated drug seeking, it is 
important to know why it is diminished. Cystine-glutamate exchange has been shown 
regulated in a tonic manner by interleukin-1(Jackman et al., 2010) and fibroblast 
growth factor 2 (FGF-2) (Liu et al., 2011), and acutely by Group II receptors (Xi et al., 
2002a), protein kinase A (Baker et al., 2003) and protein kinase C (Tang and Kalivas, 
2003). Further, evidence exists suggesting that dopamine regulates GLT-1 expression in 
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the striatum (Brito et al., 2009). In addition, a novel neuropeptide, pituitary adenylyl 
cyclase activating polypeptide (PACAP) has been shown to regulate glutamate 
homeostasis by regulating activity of glial glutamate transporters in the striatum (Figiel 
and Engele, 2000). In this dissertation, we will investigate regulation of cystine-glutamate 
exchange by dopamine and PACAP. 
Pituitary adenylyl cyclase activating polypeptide (PACAP) 
PACAP was originally discovered and cloned from ovine hypothalamus in 1989, 
and so named for its ability to stimulate adenylate cyclase and cAMP formation. Its first 
discovery in the rodent brain was in the anterior pituitary from the hypothalamus (Miyata 
et al., 1989). The first peptide discovered 
was 38 amino acids long (PACAP38), 
followed by discovery and cloning of 
PACAP27, comprising of the first 27 
amino acids of PACAP38 (Miyata et al., 
1990). 
As illustrated in figure i.4, 
PACAP is likely co-released with 
glutamate from glutamatergic neurons. 
This is based on studies showing that 
PACAP colocalizes with vesicular 
glutamate transporter 2 (VGLUT2) 
(Engelund et al., 2010). This concept is 
highly significant given that 
Figure i.4. PACAP is likely co-released with 
glutamate. An action potential leads to the Ca
2+
-
dependent release of PACAP from the nerve 
terminal. PACAP stimulates postsynaptic and 
astrocytic PAC1R in the nucleus accumbens core. 
At this point, not much is known on how PACAP is 
removed from the extracellular space or how it is 
metabolized. 
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glutamatergic signaling plays a major role in cocaine seeking. Unfortunately, not much 
more is known regarding the regulation of PACAP release and how it is affected 
following repeated consumption of cocaine.  
PACAP binds to three G-protein coupled receptors, PAC1, VPAC1, and VPAC2. 
PAC1 shows a higher affinity for PACAP over vasoactive intestinal peptide (VIP), 
whereas VPAC1 and VPAC2 have similar affinities to the two neuromodulators. PAC1 
receptor signaling is linked to both Gs or Gq mediated G-protein signaling. Three 
different isoforms of PAC1 exist, which help determine which G-protein signaling 
mechanism is activated. PAC1null and PAC1hop, of which there are hop1 or hop2, can 
activate both Gq and Gs signaling thereby either increasing adenylyl cyclase activity and 
increasing intracellular cAMP by Gs, as well as increasing intracellular calcium through 
Gq mediated events. On the other hand, the hip isoform is only capable of increasing 
adenylyl cyclase activity through Gs (Holighaus et al., 2011). There also exists a 
PAC1hiphop isoform that is not well known. While sparse, literature suggests that 
PAC1null and PAC1hop are the most abundant isoforms in the adult rat brain (Grimaldi 
and Cavallaro, 1999, Lutz et al., 2006, Mustafa et al., 2007). 
PACAP is distributed extensively throughout the central nervous system, 
including the hypothalamus, cerebral cortex, amygdala, nucleus accumbens, 
hippocampus, and cerebellum (Arimura et al., 1991, Hannibal, 2002); as well as the 
autonomic nervous system (Sundler et al., 1996). The distribution of PACAP-projecting 
neurons has been studied using in situ hybridization of PACAP mRNA as well as with 
intracellular immunohistochemical labeling of PACAP. The highest density of PACAP-
expressing fibers and cells bodes are found in the hypothalamus, particularly the 
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paraventricular nucleus, the supraoptic nucleus (Koves et al., 1991, Hannibal et al., 
1995a, Hannibal et al., 1995b), the arcuate nucleus (Hannibal et al., 1995b, Murase et al., 
1995, Das et al., 2007), and the ventromedial hypothalamic nucleus (Hannibal et al., 
1995a, Skoglosa et al., 1999). Further, there is evidence of PACAP mRNA as well as 
immunoreactive fibers in cortical regions, including the frontal cortex, neocortex, 
cingulate, and entorhinal cortex (Mikkelsen et al., 1994, Hannibal et al., 1995a). In the 
hippocampus, there is a moderate density of immunoreactive fibers and cell bodies 
containing PACAP in the CA1, CA2, CA3, and dentate gyrus (Koves et al., 1991, 
Skoglosa et al., 1999, Hannibal, 2002). 
The use of PACAP and PAC1R knockout mice has revealed some phenotypes in 
behavioral output. For example, investigators have shown that PACAP knockout mice 
exhibit elevation in locomotion in the presence of anxiolytic behavior (Hashimoto et al., 
2001). More relevant to this purpose of this dissertation, one study has shown a lack of 
difference in methamphetamine-induced behavioral sensitization when comparing wild-
type and PACAP-deficient mice (Fujii et al., 2007); in short, though both groups 
exhibited behavioral sensitization, neither group exhibited a significantly difference level 
of sensitization. 
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Summary 
The current state of cocaine addiction research posits cystine-glutamate exchange 
as a viable target for treatment (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008).  
Table 1 lists the current state of cocaine-seeking as it pertains to diminished cystine-
glutamate exchange. Animals receiving sufficiently high levels of cocaine during self-
administration exhibit an escalation in consumption during self-administration (Ahmed 
and Koob, 1998, Ahmed et al., 2003) and a decrease in cystine-glutamate exchange 
(Baker et al., 2003, Moran et al., 2005, Kau et al., 2008). 
  
 
Table 1. Known and unknown contributions of diminished cystine-glutamate 
exchange to cocaine-seeking. 
 
Known 
 Cystine-glutamate exchange regulates neurotransmission by stimulating 
presynaptic inhibitor Group II receptors 
 Repeated cocaine by self-administration leads to a decrease in cystine-glutamate 
exchange by system xc- 
 Animals with cocaine-induced decreases in cystine-glutamate exchange also 
exhibit diminished basal extracellular glutamate in the nucleus accumbens 
 Animals withdrawn from repeated cocaine, and thus diminished cystine-glutamate 
exchange, exhibit cocaine-evoked glutamate after withdrawal 
 Acute restoration of cystine-glutamate exchange reduces cocaine-seeking 
Unknown 
 Does diminished cystine-glutamate exchange a consequence of repeated cocaine, 
does it contribute to basal extracellular glutamate, cocaine-evoked glutamate, and 
reinstatement 
 What contributes to the magnitude of cocaine seeking (i.e. reinstatement) 
 What contributes to decreased cystine-glutamate exchange in cocaine-withdrawn 
animals 
 What regulates cystine-glutamate exchange 
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The aim of this dissertation will be to further advance the field by revealing 
mechanisms that contribute to relapse vulnerability. As shown in Table 2, we will further 
characterize neuroplasticity contributing to compulsive drug seeking and relapse 
vulnerability. As well, we attempt to distinguish differential neurotransmitter signaling in 
animals exhibiting elevated reinstatement. Though much is known regarding regulation 
of glutamate homeostasis through glutamate transporters, little is known regarding the 
regulation of cystine-glutamate exchange. We attempt to determine neuronal signaling 
that may regulate system xc- and how it is effected following withdrawal from cocaine 
self-administration. Altogether, findings in this dissertation should further the field of 
cocaine addiction research, and reveal potential novel therapeutic targets. 
Table 2. Aims and experimental approaches in this dissertation. 
AIM EXPERIMENT 
Determine the contribution of cocaine 
induced diminished cystine-glutamate 
exchange to basal extracellular glutamate, 
cocaine-evoked glutamate, and 
reinstatement. 
Block cocaine-induced neuroplasticity by 
repeated stimulation of cystine-glutamate 
exchange during the maintenance phase of 
self-administration 
Determine what contributes to the 
magnitude of reinstatement to help 
understand relapse vulnerability 
Alter cocaine intake during the 
maintenance phase of self-administration 
and determine differences in cocaine-
evoked neurochemistry, neuronal 
signaling, and cystine-glutamate exchange 
Determine the source of diminished 
cystine-glutamate exchange in cocaine-
withdrawn animals 
Measure regulation of cystine-glutamate 
exchange by neuronal signaling, then 
determine if this is altered in cocaine-
withdrawn animals 
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CHAPTER 1 
 
 
 
 
 
 
 
 
 
 
Contribution of diminished system xc- to cocaine-evoked neurochemistry 
and cocaine-seeking
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Introduction 
Repeated cocaine alters glutamate neurotransmission even following protracted 
withdrawal (Wolf et al., 2004, Kalivas et al., 2005), and this likely contributes to 
addiction since abnormal activation of corticostriatal pathways correlates with craving in 
humans (Breiter et al., 1997, Volkow et al., 1999, Volkow et al., 2005) and is necessary 
for cocaine seeking in rodents (Park et al., 2002, McFarland et al., 2003, Schmidt et al., 
2005). Revealing cellular mechanisms underlying altered corticostriatal activation should 
advance our understanding of the neurobiological basis of addiction and identify novel 
therapeutic targets (Volkow and Fowler, 2000, Dackis, 2004). 
Models of pathological glutamate signaling proposed to underlie addiction need to 
account for the existence of multiple pools of extracellular glutamate. Aside from 
synaptic glutamate maintained by vesicular release, extrasynaptic glutamate is sustained 
primarily by nonvesicular release (Herrera-Marschitz et al., 1996, Timmerman and 
Westerink, 1997). In support, basal extrasynaptic glutamate sampled using microdialysis 
are largely independent of vesicular glutamate (Westerink, 1995). Glutamate transporters 
may partition the two pools by limiting glutamate overflow from the synapse into 
extrasynaptic compartments (Danbolt, 2001), and restricting entry of nonvesicular 
glutamate into synapses (Jabaudon et al., 1999). Although confined to the extrasynaptic 
compartment, nonvesicular glutamate regulates neurotransmission by stimulating group 
II metabotropic glutamate receptors (mGluRs) (Baker et al., 2002, Xi et al., 2002a) which 
are extrasynaptic receptors capable of inhibiting vesicular release (Baskys and Malenka, 
1991, Cochilla and Alford, 1998, Schoepp, 2001). Thus, extrasynaptic receptors permit 
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crosstalk between the two pools and indicate that altered nonvesicular glutamate release 
may contribute to pathological glutamate signaling linked to addiction. 
Cystine-glutamate exchange via system xc- may be critical in the capacity of 
extrasynaptic glutamate to regulate corticostriatal signaling in the normal and 
pathological states. First, nonvesicular release from cystine-glutamate exchange 
maintains basal extracellular glutamate in the nucleus accumbens (Baker et al., 2002, Xi 
et al., 2002a), and thereby regulates the extent of endogenous group II mGluR stimulation 
(Baker et al., 2002, Melendez et al., 2005, Moran et al., 2005). Repeated cocaine blunts 
system xc- activity which leads to reduced basal and likely increased cocaine-evoked 
glutamate in the nucleus accumbens that persists for at least three weeks after the last 
cocaine treatment (Baker et al., 2003). These changes are relevant for drug seeking since 
N-acetylcysteine, a cysteine prodrug used to drive system xc- (Williamson and Meister, 
1981, Meister, 1985, Pileblad and Magnusson, 1992), blocks cocaine-evoked glutamate 
in the nucleus accumbens and subsequent cocaine-induced reinstatement (Baker et al., 
2003). What is lacking is a clear demonstration that the changes in glutamate and 
cocaine-seeking require reduced cystine-glutamate exchange. 
In these studies, we test the hypothesis that diminished system xc- activity is part 
of the neuroplasticity contributing to compulsive drug seeking. As shown in the 
introduction, stimulating cystine-glutamate exchange during self-administration prevents 
escalation of cocaine-seeking. We hypothesize that preventing escalation of cocaine-
seeking alters cocaine-induced neuroplasticity associated with reinstatement after 
protracted withdrawal. Further, we also hypothesize that escalation of cocaine-seeking 
results in long-term changes in cystine-glutamate exchange. 
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Materials and Methods 
Animals 
These experiments utilized male Sprague Dawley rats (Harlan, Indianapolis, IN) 
weighing 275–325 grams upon arrival. Rats were individually housed in a temperature-
controlled colony room with a 12-h reversed light/dark cycle. Housing conditions and 
experimental protocols were approved by the Marquette University Institutional Animal 
Care and Use Committee and carried out according to the NIH Guide for the Care and 
Use of Laboratory Animals (revised 1996). 
Surgeries 
Rats were implanted with indwelling catheters under ketamine HCl (100 mg/kg, 
IP, Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, IP, Lloyd 
Laboratories, Shenandoah, IA, USA) anesthesia. A silicon tubing catheter (Dow Corning 
Co., Midland, MI; 0.64 mm ID; 1.19 mm OD) was implanted such that it entered the 
jugular vein through the right posterior facial vein and terminated at the right atrium. The 
catheter was sutured to the vein at the entry point. The distal aspect of the catheter, which 
consisted of a 22-gauge guide cannula (Plastics One Inc., Roanoke, VA) attached with 
dental acrylic to a piece of polypropylene monofilament surgical mesh (Atrium Medical, 
Co., Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the experiment, 
catheters were filled daily with a heparin solution (83 i.u./ml; Elkins-Sinn, Inc., Cherry 
Hill, NJ) and capped when disconnected from the leash/delivery line assembly. Rats were 
also implanted with indwelling bilateral guide cannulae (20 gauge, 14 mm; Plastics One, 
Roanoke VA) using the following coordinates derived from Paxinos and Watson (1986): 
+ 0.9 mm anterior, ± 2.5 mm mediolateral to Bregma, and −4.4 mm from the surface of 
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the skull at a 6° angle from vertical. The placement of the active region of the 
microdialysis probe, which began 1 mm beyond the ventral tip of the guide cannulae, was 
primarily in the NAcc although regions immediately dorsal and ventral to this were also 
likely sampled. Following surgery, rats were given at least five days to recover prior to 
testing. During this time, rats were provided acetaminophen (480 mg/L) in their drinking 
water and injected daily with a sterile cefazolin antibiotic solution (15 mg, IV; West-
Ward Pharmaceutical Co., Eatontown, NJ). 
Cocaine Self-Administration Training 
Self-administration occurred in operant conditioning chambers (ENV-008CT, 
MED-Associates Inc., St Albans, VT, USA) housed in sound attenuating cubicles (ENV-
016M, MED-Associates Inc.) and equipped with two retractable levers, two stimulus 
lights, and a water bottle. At least five days after surgery, rats were food restricted with 
water available ad libitum; food restriction continued for the duration of the experiment 
(e.g., through reinstatement testing) and involved daily administration of 15 grams of rat 
chow in the late afternoon or immediately following an operant session. Rats were then 
placed into the operant conditioning chambers overnight and responses on the lever 
designated as active resulted in the delivery of food pellets under a fixed ratio 1 schedule 
of reinforcement. Daily food training continued until subjects received at least 150 food 
rewards in a session, which typically occurred following the first session. During the 
acquisition phase of the experiment, all rats underwent drug self-administration training 
during daily 2-hr sessions in which operant responses on the active lever were reinforced 
with an infusion of cocaine (0.5 mg/kg/200μl infusion, IV, National Institute on Drug 
Abuse, Bethesda, MD, USA) under a fixed ratio 1 schedule of reinforcement. Each 
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reinforced lever response resulted in the illumination of the stimulus light located above 
the active lever and was followed by a 25-s time-out period. Responding on a second, 
inactive lever located on the back wall was recorded but had no programmed 
consequences. Acquisition of cocaine self-administration was operationally defined as < 
10% variation in daily responding over at least three consecutive sessions. During the 
maintenance phase of the experiment, rats were assigned to self-administer cocaine under 
low- (0.5 mg/kg/200μl infusion, IV, 2 hrs/day) or high-intake conditions (1.0 
mg/kg/200μl, IV, 6 hrs/day) for 11 days. 
Extinction/Reinstatement testing 
After completing eleven maintenance self-administration sessions, rats remained 
in their home cages for seven days prior to extinction training. The seven day delay was 
used to ensure an adequate drug-free period prior to reinstatement, even in rats that 
quickly extinguished responding. Extinction training involved placing rats into the 
operant conditioning chambers for 2-hr/day as described above except each active lever 
press now resulted in an infusion of saline. This continued until the mean number of lever 
presses was ≤ 10 responses across at least three sessions, at which point rats were tested 
for drug-primed reinstatement. The reinstatement test day was identical to each extinction 
session except rats were injected with cocaine (10 mg/kg, IP). Because the mean number 
of extinction sessions needed to meet criteria (± SEM) was 12.2 ± 1.2, reinstatement 
testing occurred approximately 19 days after the last self-administration session. 
In vivo Microdialysis Testing 
On the night before testing, microdialysis probes, constructed as previously 
described (Baker et al., 2003), were inserted into indwelling guide cannula. Rats were 
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then housed overnight in the self-administration chambers. The next day, dialysis buffer 
(5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM MgCl2, and 0.15% phosphate 
buffer saline, pH 7.4) was pumped through the probes at a rate of 1 μl/min for at least 3 
hr to permit an adequate period of time for neurotransmitter levels to stabilize. 
Afterwards, twenty min samples were collected as described below for each experiment. 
Quantification of Glutamate 
The concentration of glutamate in dialysis samples was quantified by comparing 
peak heights from samples and external standards using HPLC coupled to fluorescence 
detection. Precolumn derivatization of glutamate with opthaldehyde was performed using 
a Shimadzu LC10AD VP autosampler. The mobile phase consisted of 13% acetonitrile, 
100 mM Na2HPO4, and 0.1 mM EDTA, pH 5.90. Glutamate was separated using a 
reversed-phase column (4 μm; 140 × 6.0 mm; Phenomenex, Torrance, CA), and detected 
using a Shimadzu 10RF-AXL fluorescence detector with excitation and emission 
wavelengths of 320 and 400 nm, respectively. 
Quantification of Dopamine 
Dopamine concentrations were quantified by comparing peak heights from 
samples and external standards using HPLC coupled to electrochemical detection. The 
mobile phase consisted of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM 
citric acid, 3 mM SDS, and 50 μM EDTA, pH 5.6. Dopamine was separated using a 
reversed-phase column (3 μm; 80 × 3.2 mm; ESA Inc., Bedford, MA) and detected using 
an ESA Coulochem II detector coupled to two electrodes set at −0.075 V and +0.25 V, 
respectively. 
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[
35
S] Cystine uptake ex vivo 
Rats were decapitated and the brains were rapidly extracted and cut into 2 mm 
coronal slices using a brain matrix. Tissue punches (1.25 mm diameter; Stoelting, Wood 
Dale, IL) were collected from the nucleus accumbens core and incubated at 37°C for ∼30 
min on a nylon bolting cloth platform, submerged beneath 2 mm of standard buffer 
(Lobner and Lipton, 1993); the standard buffer contained 124 mM NaCl, 3.0 mM KCl, 
1.4 mM KH2PO4, 1.3 mM MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4 mM glucose, 
equilibrated with 95% O2, 5% CO2, pH 7.4. After a 30 min wash, the tissue was 
incubated for 30 min in standard buffer containing [
35S]cystine (4 μCi/ml; GE Healthcare, 
Piscataway, NJ). D-Aspartate (1 mM) was also added to the incubation buffer to prevent 
uptake via XAG. After 30 min incubation, the tissue punches were washed four times in 
ice-cold standard buffer and dissolved in 250 μl of 1% SDS. One aliquot (100 μl) was 
used to measure [
35
S]cystine uptake by scintillation counting; a second aliquot (100 μl) 
was used to assess protein content by the BCA method. Additional punches from each 
subject were processed as described above with the exception that unlabeled CPG [(S)-4-
carboxyphenylglycine] (1 mM) was added 10 min before and for the duration of the 30 
min incubation with [
35S]cystine (4 μCi/ml). These values reflect labeling independent of 
system xc− and were subtracted from the total labeling obtained from each subject to get 
a measure that solely reflected uptake through cystine–glutamate exchange. 
Experiment 1: Impact of repeated N-acetylcysteine on cystine-glutamate exchange in 
cocaine-withdrawn animals 
 N-acetylcysteine (Sigma, St. Louis, MO) is a cysteine prodrug that stimulates 
cystine-glutamate exchange (Moldeus et al., 1981, Meister, 1985). Animals underwent 
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self-administration training and during the maintenance phase were pretreated with saline 
or N-acetylcysteine (60mg/kg, IP) one hour prior to daily saline or cocaine self-
administration (1.0mg/kg/200L infusion, IV 6 hrs/day) for 11 days. This produced four 
treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc. After protracted withdrawal 
of at least 7 days, animals were rapidly decapitated and measure for ex vivo cystine 
uptake in the nucleus accumbens core as described above. 
Experiment 2: Impact of repeated N-acetylcysteine on basal extracellular glutamate 
 Animals underwent self-administration training and during the maintenance 
phase were pretreated with saline or N-acetylcysteine (60mg/kg, IP) one hour prior to 
daily saline or cocaine self-administration (0.5mg/kg/200L infusion, IV 2hrs/day) for 11 
days. This produced four treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc. 
Animals then underwent 7 days of withdrawal and extinction training. After the last day 
of extinction training, animals were placed into the self-administration chambers and 
underwent microdialysis as described above. To determine the level of basal extracellular 
glutamate, the first 3 samples were quantified for glutamate and area under the curve 
(AUC) was calculated. 
Experiment 3: Impact of repeated N-acetylcysteine on cocaine-evoked glutamate 
 Animals underwent self-administration training and during the maintenance 
phase were pretreated with saline or N-acetylcysteine (60mg/kg, IP) one hour prior to 
daily saline or cocaine self-administration (0.5mg/kg/200L infusion, IV 2hrs/day) for 11 
days. This produced four treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc. 
Animals then underwent 7 days of withdrawal and extinction training. After the last day 
of extinction training, animals were placed into the self-administration chambers and 
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underwent microdialysis as described above. To determine the magnitude of cocaine-
evoked glutamate, after the baseline was established all animals received an injection of 
cocaine (10mg/kg, IP) and the self-administration chamber was activated. Glutamate 
levels were normalized to the mean of the 3 baseline samples. 
Experiment 4: Impact of repeated N-acetylcysteine on cocaine-primed reinstatement 
Animals underwent self-administration training and during the maintenance 
phase were pretreated with saline or N-acetylcysteine (60mg/kg, IP) one hour prior to 
daily saline or cocaine self-administration (0.5mg/kg/200L infusion, IV 2hrs/day) for 11 
days. This produced four treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc. 
Animals then underwent 7 days of withdrawal and extinction training. After the last day 
of extinction training, animals were placed into the self-administration chambers and 
underwent reinstatement as described above.  
Histology 
Rats included in the microdialysis studies were given an overdose of pentobarbital 
(60 mg/kg, IP), and the brains were fixed by intracardiac infusion of 0.9% saline 
followed by 2.5% formalin solution. Brains were removed and stored in 2.5 % formalin 
for at least seven days prior to sectioning. The tissue was then blocked and coronal 
sections (100 μM) were cut and stained with cresyl violet to verify probe placements. 
Statistical analyses 
SPSS software (version 16) was used to perform the statistical analyses. Data were 
analyzed using analysis of variance (ANOVA) with self-administration access conditions 
and N-acetylcysteine dose as potential between-subject factors and time (20-min interval) 
as a repeated factor. Post hoc comparisons were conducted using t-tests when only two 
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data points were compared. Other post hoc comparisons are as noted. Note, the p value 
required for significance in the post hoc tests are adjusted downward by the total number 
of comparisons conducted to control for alpha inflation. 
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Results 
Experiment 1: Impact of repeated N-acetylcysteine on cystine-glutamate exchange in 
cocaine-withdrawn animals 
Figure 1.1 illustrates the impact of daily 
N-acetylcysteine pretreatment on 
cocaine-induced plasticity involving 
system xc-. A comparison of [
35
S]cystine 
transport produced an interaction 
between N-acetylcysteine and cocaine 
treatment conditions (F1,31= 7.53; 
p=0.01). Post hoc analyses revealed that 
rats pretreated with saline before cocaine 
self-administration exhibited reduced 
[
35
S]cystine transport relative to saline 
controls (Dunnett's t, p<0.05). Furthermore, rats pretreated with N-acetylcysteine before 
cocaine self-administration failed to exhibit diminished cystine–glutamate exchange, 
although cystine uptake was measured 23–34 d after the last treatment of either cocaine 
or N-acetylcysteine (Dunnett's t, p<0.05). 
Experiment 2: Impact of repeated N-acetylcysteine on basal extracellular glutamate 
Cystine-glutamate exchange is diminished in the nucleus accumbens of animals 
withdrawn from cocaine self-administration (Baker et al., 2003). As well, cystine-
glutamate exchange regulates synaptic neurotransmission (Baker et al., 2002, Moran et 
al., 2005, Moussawi et al., 2011b). We wanted to determine if chronic stimulation of 
Figure 1.1. Daily N-acetylcysteine prevents long-
term deficits in cystine-glutamate exchange in the 
nucleus accumbens produced by repeated cocaine. 
Cystine transport was measured in tissue punches 
from the nucleus accumbens after withdrawal from 
self-administration. *Significant difference from 
Sal-Sal controls. 
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cystine-glutamate exchange and 
therefore constant regulation of synaptic 
signaling, during cocaine self-
administration will reverse deficits 
found in basal and cocaine-evoked 
glutamate. Figure 1.2 illustrates that 
chronic treatment with the cysteine 
prodrug N-acetylcysteine restores basal 
glutamate during withdrawal. A 
comparison of basal glutamate (before 
cocaine primer) as measured by area under the curve yielded a significant interaction 
between N-acetylcysteine and cocaine treatments (ANOVA: F1,37=4.05, p<0.05). Post 
hoc analyses revealed that a reduction in basal glutamate relative to saline controls was 
found in rats pretreated with daily saline before cocaine self-administration sessions 
(Dunnet’s t, p<0.05), a significant difference was also found when comparing with rats 
that had been treated with N-acetylcysteine during self-administration training (Dunnet’s 
t, p<0.05). 
Experiment 3: Impact of repeated N-acetylcysteine on cocaine-evoked glutamate 
Increased glutamate signaling in the nucleus accumbens is necessary for cocaine-
seeking during reinstatement. As well, others have shown that only animals withdrawn 
from repeated cocaine exhibit cocaine-evoked glutamate. We wanted to determine if 
cocaine-evoked (10 mg/kg, IP) glutamate is absent in animals that underwent self-
administration but exhibit normal levels of cystine-glutamate exchange and basal 
Figure 1.2. Daily N-acetylcysteine prevents long-
term changes in extracellular basal glutamate levels 
in the nucleus accumbens produced by repeated 
cocaine. Basal glutamate levels are depicted as area 
under the curve calculated using samples collected 
before the cocaine injection. *Significant difference 
from Sal-Sal controls. 
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glutamate. An ANOVA comparing 
cocaine-evoked glutamate during 
reinstatement (Figure 1.3) with N-
acetylcysteine and cocaine treatment as 
between-subjects measures and time (20 
min samples) as a repeated measure 
yielded a significant three-way 
interaction (F8,296=2.05, p<0.05). Post 
hoc analyses revealed that animals 
pretreated with saline prior to daily 
cocaine self-administration session 
exhibited significantly higher levels of 
cocaine-evoked glutamate during 
reinstatement (Figure 1.3a; Dunnet’s t, 
p<0.05), though there was no significant 
difference found in animals treated with 
N-acetylcysteine prior to daily cocaine self-administration. When measuring area under 
the curve (AUC), a significant interaction between N-acetylcysteine and cocaine 
treatment was observed (Figure 1.3b; F1,37=4.05, p<0.05). Post hoc analyses yielded a 
significant increase in glutamate in rats pretreated with saline before cocaine self-
administration when compared to animals pretreated with N-acetylcysteine (Dunnet’s t, 
p<0.05). 
 
Figure 1.3. Daily N-acetylcysteine prevents changes 
in cocaine-evoked extracellular glutamate levels in 
the nucleus accumbens produced by repeated 
cocaine. Cocaine-evoked glutamate is presented as 
percent change from baseline (a) or area under the 
curve calculated using samples collected after the 
cocaine injection (b). *Significant difference from 
Sal-Sal controls; +Significant difference from the 
last baseline sample; #Significant difference from 
NAC-Coc rats. 
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Experiment 4: Impact of repeated N-acetylcysteine on cocaine-primed reinstatement 
The above findings show that diminished cystine-glutamate exchange contributes 
to altered basal and cocaine-evoked glutamate. We wanted to determine if it also 
contributes to cocaine-primed reinstatement. Figure 1.4 illustrates the impact of repeated 
N-acetylcysteine on the last three extinction sessions and cocaine-primed (10mg/kg, IP) 
reinstatement in animals withdrawn 
from short-access cocaine-self 
administration conditions 
(0.5mg/kg/200L infusion, IV, 2 
hrs/day). N-acetylcysteine administered 
during self-administration did not alter 
the number of extinction session 
required to meet criteria when compared 
to cocaine animals pretreated with saline 
(Mean ± SEM: NAC, 11 ± 2; Sal, 13.6 ± 
1.7; Student’s t, p>0.05). In contrast a comparison of lever pressing during the 
reinstatement test day and the last three extinction sessions produced a three-way 
interaction between test day, N-acetylcysteine treatment, and cocaine treatment 
(ANOVA: F3,111=3.06, p<0.05). Post hoc analyses revealed that a cocaine primer 
reinstated extinguished drug seeking, evident as a significant increase in lever pressing on 
the reinstatement test relative to the last extinction session, but only in rats that had been 
treated with saline and cocaine during self-administration (Dunnet’s t, p<0.05); this group 
of rats also exhibited significantly higher levels of responding on the reinstatement test 
Figure 1.4. Daily N-acetylcysteine prevents 
cocaine-induced reinstatement. Data depict mean ± 
SEM behavior during the last three extinction 
sessions and following a cocaine-primer (10mg/kg, 
IP) for groups treated as designated during self-
administration. *Significant difference from the last 
extinction session; Dunnet’s t, p<0.05. #Significant 
difference from all other groups; Dunnet’s t, p<0.05. 
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day compared to all other groups (Dunnet’s t, p<0.05). In contrast, cocaine rats pretreated 
with N-acetylcysteine failed to reinstate cocaine-seeking despite testing 2-3 weeks after 
the last N-acetylcysteine treatment. 
------------------------------------------------------------------------------------------------------------ 
The above findings suggest that diminished cystine-glutamate exchange by cocaine-self-
administration contributes to the following: 
 Diminished basal extracellular glutamate in the nucleus accumbens 
 Cocaine-evoked glutamate in the nucleus accumbens 
 Cocaine-primed reinstatement 
These findings reveal diminished cystine-glutamate exchange by system xc- as a 
necessary event for decreased basal glutamate, increased cocaine-evoked glutamate, and 
cocaine-primed reinstatement. Thus reduced system xc- activity may be critical to the 
transition of drug-seeking from casual to compulsive. To further test this, we examined 
the status of cystine-glutamate exchange under conditions that have been shown to 
produce elevated levels of cocaine intake and heightened cocaine-primed reinstatement. 
Previous studies have suggested that animals consuming elevated levels of cocaine 
during self-administration exhibit elevated reinstatement (Ahmed and Koob, 1998, 
Ahmed et al., 2003).  In the next section, we test the hypothesis that high-intake rats 
(1.0mg/kg/200L infusion, IV, 6 hrs/day) exhibiting heightened reinstatement of 
cocaine-seeking display a more robust cocaine-induced increase in extracellular 
glutamate in the nucleus accumbens compared to low-intake rats (0.5mg/kg/200L 
infusion, IV, 2 hrs/day) given that glutamate is necessary for cocaine-seeking (Park et al., 
2002, McFarland et al., 2003, Schmidt et al., 2005). Given that diminished cystine-
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glutamate exchange is essential to cocaine-evoked neurotransmission and reinstatement, 
as shown in the previous section, we hypothesize that animals receiving high-intake 
cocaine during self-administration exhibit diminished cystine-glutamate exchange 
compared to low-intake animals. 
------------------------------------------------------------------------------------------------------------ 
Cocaine-evoked extracellular glutamate is not affected by cocaine self-administration 
intake conditions 
Glutamate neurotransmission in the nucleus accumbens following cocaine self-
administration is altered and is necessary for cocaine-seeking as shown above and in 
previous findings (Pierce et al., 1996, Torregrossa et al., 2008, Suto et al., 2009). We 
hypothesized that animals consuming higher levels of cocaine show augmented glutamate 
neurotransmission during reinstatement. In animals that received either high- or low-
intake conditions, we measured cocaine-evoked glutamate by microdialysis during the 
reinstatement phase. Figure 1.5a illustrates that there was no significant difference in 
cocaine-evoked glutamate release between low- and high-intake animals. An ANOVA 
with time (20 minute samples) as a repeated measure and intake conditions as a between 
subjects factor yieled a significant main effect of time (F10,350=4.32, p<0.001), no 
significant main effect of intake (F1,35=0.101, p=0.752), nor an interaction between the 
variables (F10,350=0.773, p=0.655). Post hoc analyses revealed significant increases in 
cocaine-evoked glutamate for both low- and high-intake animals in 4 of the samples 
collected after the cocaine injection regardless of intake condition (Fisher LSD, p<0.008). 
To verify the lack of a difference in cocaine-evoked glutamate between low- and high-
intake animals, we measured area under the curve (AUC) for samples collected after the 
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cocaine injection. Figure 1.5b illustrates no significant difference in cocaine-evoked 
glutamate as measured by AUC (t35=0.5, p=0.691). Figure 1.5c illustrates that low-intake 
animals exhibited lower cocaine-primed reinstatement when compared to high intake 
animals despite no difference in extracellular glutamate (t33=4.476, p<0.001). 
 
Figure 1.5. Cocaine-evoked extracellular glutamate 
in the nucleus accumbens is not different between 
low- and high-intake animals. A cocaine primer (10 
mg/kg, i.p.) was given to low- and high-intake 
animals, and extracellular glutamate was measured 
(a, b). There there was no significant effect after 
cocaine injection (a, F10,350=0.773, p=0.655) or 
when comparing cocaine-evoked glutamate as 
measured by area under the curve (b, t35=0.5, 
p=0.691) despite the fact that the high-intake 
animals exhibited a significant increase in cocaine-
induced reinstatement (t33=4.476, p<0.001). 
*Significant difference from the last baseline 
sample.  #Significant difference from low-intake 
animals. 
 
 
High-intake cocaine self-administration conditions augment cocaine-evoked extracellular 
dopamine 
Glutamate is necessary for cocaine-seeking and cocaine-evoked glutamate is 
exhibited only in animals withdrawn from repeated cocaine. However, glutamate is not 
essential for heightened reinstatement as shown above. Dopamine is not necessary for 
cocaine-primed reinstatement as by blocking dopamine signaling in the nucleus 
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accumbens does not abolish reinstatement. Conversely, elevating dopamine signaling in 
the nucleus accumbens either by microinjection of dopamine or activating dopamine 
receptors is sufficient to induce reinstatement. Therefore, we hypothesized that while 
dopamine is not necessary for reinstatement, it determines the magnitude of 
reinstatement. Figure 1.6a illustrates extracellular dopamine levels in the NAcc before 
and after a cocaine injection (10 mg/kg, i.p.) in high- and low-intake rats when tested 
after withdrawal and extinction from cocaine self-administration. An ANOVA with 
intake conditions as a between-subjects factor and time (20 min samples) as a repeated 
measure yielded a significant interaction (F10,230=4.14, p<0.001). An augmented cocaine-
induced increase in extracellular dopamine was evident in high-intake rats when areas 
under the curve were calculated using all of the postinjection samples and compared 
across low- and high-intake conditions (Fig 1.6b; t23=2.143, p=0.043). As expected, the 
high-intake group in this microdialysis study exhibited augmented reinstatement relative 
to low-intake rats (Fig. 1.6c; t32=5.689, p<0.001). 
39 
 
 
Figure 1.6. High-intake cocaine self-administration 
augments both cocaine-evoked extracellular 
dopamine levels in the nucleus accumbens core 
presented as femtomoles/L as well as 
reinstatement. A cocaine primer (10 mg/kg, i.p.) was 
given to low- and high-intake animals, and 
extracellular dopamine was measured (a, b). Post 
hoc analyses reveal a significant effect of intake 
condition as measured by areas under the curve (b, 
t23=2.143, p=0.043), as well as reinstatement (c, 
t32=5.689, p<0.001). *Significant difference from 
last baseline sample (Fisher LSD, p<0.05). 
#Significant difference from low-intake animals. 
 
Impact of D1 receptor blockade on cocaine-induced reinstatement by low- and high-
intake rats  
As shown above, cocaine-evoked dopamine levels in the nucleus accumbens are 
altered based on cocaine intake conditions. We want to determine if this effect is 
behaviorally relevant. We hypothesized that elevated dopamine stimulates D1-like 
dopamine receptors leading to augmented reinstatement. Therefore, we reverse dialyzed 
the D1-like dopamine receptor antagonist, SCH-23390 (0 or 10M) and determined if 
receptor blockade alters cocaine-primed reinstatement. This concentration of SCH-23390 
was determine based on previous published usage (Anderson et al., 2003, Schmidt et al., 
2006, Schmidt and Pierce, 2006). Figure 1.7 depicts responding during extinction and 
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reinstatement testing in rats when 
conducted in the absence (Fig. 1.7a) or 
presence of SCH-23390 (Fig. 1.7b) 
infused into the NAcc via reverse 
dialysis. An ANOVA with intake 
conditions and SCH-23390 
concentration (0 or 10μM) as between-
subjects factors and experimental test 
phase (extinction, reinstatement) as a 
repeated measure yielded a three-way 
interaction (F1,31=16.99, p<0.001). 
Two separate ANOVAs (in the 
presence or absence of SCH-23390 
infusion) were then conducted to 
deconstruct the three-way interaction 
with intake conditions as a between-
subjects variable and experimental 
phase as a repeated measure. In the 
absence of SCH-23390, a two-way interaction (F1,17=25.93, p<0.001) was obtained. 
Subsequent post hoc comparisons indicated that both intake groups exhibited significant 
reinstatement, and that the high-intake group exhibited higher levels of responding during 
the test for reinstatement relative to low-intake rats (t test, p < 0.0125). In the presence of 
SCH-23390, there was a main effect of experimental phase (F1,14=14.28, p<0.05), without 
Figure 1.7. Augmented cocaine-primed reinstatement 
in high-intake animals is due to stimulation of D1-like 
dopamine receptoirs. Data depict responding during 
extinction and cocaine-primed reinstatement testing in 
the absence (a) or presence (b) of SCH-23390. SCH-
23390 (0 and 10 μM) was infused into the nucleus 
accumbens core via reverse dialysis beginning 1 hour 
before the cocaine primer (10mg/kg, IP) and for the 
duration of the experiment. 
+
Significant difference 
from low-intake rats (t test, p < 0.001). *Significant 
difference from extinction responding (a, t test, p < 
0.001; b, ANOVA main effect, p < 0.05). 
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a significant main effect of intake conditions (F1,14=0.002, p=0.965) or an interaction 
between the variables (F1,14=0.028, p=0.870). 
N-Acetylcysteine blocks augmented cocaine-evoked dopamine in high-intake cocaine self-
administration animals 
 Restoring or preventing reduced 
cystine-glutamate exchange by system 
xc- in cocaine-withdrawn animals 
lowers reinstatement and eliminates 
cocaine-evoked glutamate after 
withdrawal. We wanted to determine if 
augmented cocaine-evoked dopamine 
found in high-intake animals during 
reinstatement is affected by cystine-
glutamate exchange. We pretreated 
high-intake animals with the cysteine 
prodrug N-acetylcysteine just prior to a 
cocaine primer and measured 
extracellular dopamine. Figure 1.8a 
illustrates the effectiveness of N-
acetylcysteine (NAC) in reducing 
cocaine-evoked extracellular dopamine 
in high-intake cocaine self-
administration animals. An ANOVA 
Figure 1.8. Stimulating cystine-glutamate exchange 
diminishes elevated cocaine-evoked dopamine in 
animals withdrawn from high-intake cocaine self-
administration. Extracellular dopamine in the 
nucleus accumbens core presented as 
femtomoles/mL (a) or area under the curve (b) 
calculated from the samples collected following the 
cocaine injection. Microdialysis was used to sample 
extracellular dopamine in the nucleus accumbens 
core before and after injection of N-acetylcysteine 
(NAC, 0 or 60 mg/kg, i.p., N = 10-11/group) and 
cocaine (10 mg/kg, i.p.). *Significant difference 
from baseline. #Significant difference from 0 N-
acetylcysteine group. 
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with NAC (0 or 60 mg/kg i.p.) as a between-subjects variable and time (20 min samples) 
as a repeated measure yielded a significant interaction (F13,247=14.9850, p<0.001). 
Pretreatment with NAC diminished cocaine-induced increases in extracellular dopamine 
when areas under the curve were calculated using all of the post-injection samples and 
compared across pretreatment (Fig 1.8b;  
t19=2.148, p=0.045). 
When combining all animals from figure 1.5 and figure 1.6, we found a 
significant correlation between reinstatement and cocaine-evoked dopamine as measured 
by areas under the curve (Pearson Correlation; r
2
 = 0.313, p<0.05), suggesting a link 
between the cocaine-evoked neurochemical and behavioral responses. 
Self-administration intake conditions result in differential altered system xc- activity 
 Figure 1.9 illustrates that animals 
withdrawn from high-intake cocaine self-
administration exhibit diminished cystine-
glutamate exchange in the nucleus 
accumbens core when compared to low-
intake animals as measured by [
14
C]cystine 
transport ex vivo (t7=2.36, p<0.05). 
 
 
 
 
 
Figure 1.9. High-intake conditions decrease 
cystine-glutamate exchange. Ex vivo tissue 
punches from the nucleus accumbens core are 
measured for [
14
C]cystine transport and 
normalized to drug naïve animals following 
withdrawal from cocaine self-administration. 
*Significant difference from low-intake animals 
(t7=2.36, p<0.05). 
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Discussion 
The aim of this chapter was to show that diminished cystine-glutamate exchange 
contributes to cocaine-seeking behavior. Stimulating cystine-glutamate exchange with the 
cysteine prodrug N-acetylcysteine (NAC) just prior to daily cocaine self-administration 
blocked cocaine-induced deficits in cysteine-glutamate exchange. Animals with 
functional cystine-glutamate exchange exhibited normal basal extracellular glutamate and 
a lack of cocaine-evoked extracellular glutamate in the nucleus accumbens during 
reinstatement. These findings suggest that diminished cystine-glutamate exchange by 
system xc- and basal extracellular glutamate are essential to cocaine-evoked glutamate 
and reinstatement, likely due to the fact that extracellular glutamate from cystine-
glutamate exchange regulates neurotransmission (Baker et al., 2002, Moran et al., 2005, 
Moussawi et al., 2011b). 
Though we were able to block cocaine-induced deficits in cystine-glutamate 
exchange by repeated treatment with N-acetylcysteine during the maintenance phase of 
self-administration, it is unclear how this takes place. We show that drug naïve animals 
do not exhibit cocaine-evoked glutamate in the nucleus accumbens (figure 1.2), however 
others have shown that an acute intraperitoneal injection leads to a significant increase in 
glutamate (Smith et al., 1995). Therefore, it is possible that repeated stimulation of 
cystine-glutamate exchange reduces levels of cocaine-evoked glutamate from the first 
day of self-administration. It is unlikely that cystine-glutamate exchange stimulation 
prevents cocaine-induced neuroplasticity by its actions at dopamine terminals. This is 
based on previous findings that suggest blocking D2 (Caine et al., 2002) or D1 dopamine 
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(Koob et al., 1987) receptors during self-administration either is ineffective or 
exacerbates cocaine-seeking during the maintenance phase. 
Cocaine-induced neuroplasticity may occur in the absence of diminished cystine-
glutamate exchange. By chronic stimulation of cystine-glutamate exchange during the 
maintenance phase of self-administration we deduce that preventing diminished cystine-
glutamate exchange was the primary contributor to blocking cocaine-induced 
neuroplasticity in the form of cocaine-evoked glutamate, diminished basal glutamate, and 
reinstatement behavior. Most data supports that cystine-glutamate exchange regulates 
synaptic glutamate (Baker et al., 2003, Moran et al., 2003, Moussawi et al., 2011a) and 
dopamine as shown in this chapter. However, cocaine can alter levels of other 
neurotransmitters [for review see (Torregrossa and Kalivas, 2008)]. Therefore, it is 
possible that diminished cystine-glutamate exchange may be coincidental in cocaine-
induced neuroplasticity. To address this, a future experiment may involve blocking 
cystine-glutamate exchange during reinstatement in animals that received repeated N-
acetylcysteine. If diminished cystine-glutamate exchange is central to cocaine-evoked 
glutamate and reinstatement, CPG should restore levels of reinstatement to what is 
observed in rats not receiving NAC during self-administration. 
An alternate mechanism that may contribute to altered glutamate signaling in the 
nucleus accumbens core is glutamate transport. As mentioned previously, glutamate 
transporters regulate the levels of glutamate both in the extrasynaptic pool and at the 
synaptic cleft (Danbolt, 2001). Interestingly, glutamate transporters are highly coupled to 
cystine-glutamate exchange. For example, GLT-1 and system xc- can be expressed by the 
same transcription factor, Nrf2 (Shih et al., 2003), and pharmacological agents, such as 
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the -lactam antibiotic ceftriaxone, that restores expression of cystine-glutamate 
exchange also restores expression of GLT-1 (Knackstedt et al., 2010). Diminished 
glutamate transport by GLT-1 would also contribute to elevated cocaine-evoked 
glutamate. In order to address this, an experimenter may need to determine if repeated N-
acetylcysteine prevents cocaine-induced decreased GLT-1 expression. 
We are particularly interested in neuroplasticity contributing to relapse 
vulnerability. We hypothesized that animals exhibiting elevated cocaine-primed 
reinstatement due to high-intake cocaine during the maintenance phase of self-
administration also exhibit elevated cocaine-evoked glutamate neurotransmission during 
reinstatement. This approach was used because it has been previously shown that the 
magnitude of behavioral output during reinstatement correlates with the amount of 
cocaine intake during self-administration (Sutton et al., 2000), which is consistent with 
findings presented in this chapter. Surprisingly, animals consuming elevated levels of 
cocaine showed no changes in cocaine-evoked glutamate during reinstatement when 
compared to low-intake animals, despite an increase in cocaine-primed reinstatement. 
Increasing levels of dopamine specifically in the nucleus accumbens core is 
sufficient to induce reinstatement (Spealman et al., 1999, Cornish and Kalivas, 2000, 
Park et al., 2002, Shalev et al., 2002). However, blocking dopamine receptors does not 
abolish cocaine-primed reinstatement (McFarland and Kalivas, 2001, Anderson et al., 
2003). Given this, we did not expect to find differences in cocaine-evoked dopamine in 
animals withdrawn from low- versus high-intake self-administration conditions. 
Interestingly, the cocaine-evoked extracellular dopamine response in the nucleus 
accumbens was elevated in high- compared to low-intake animals. More importantly, we 
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were able to reduce this augmented dopamine response by pretreatment with N-
acetylcysteine, suggesting that diminished cystine-glutamate exchange may play a role in 
augmented dopamine release and reinstatement in high-intake animals. Animals 
withdrawn from high-intake cocaine self-administration exhibited diminished cystine-
glutamate exchange compared to low-intake animals. These findings suggest that 
decreased system xc- activity may contribute to augmented dopamine and reinstatement 
in animals with heightened relapse susceptibility. 
N-acetylcysteine blunts cocaine-induced reinstatement 
 Stimulating cystine-glutamate exchange with the cysteine prodrug N-
acetylcysteine (NAC) reduces cocaine-primed reinstatement as shown in this chapter and 
previously (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008). Further, increased 
glutamate neurotransmission is necessary for cocaine craving in humans (Breiter et al., 
1997, Volkow et al., 2005) and essential for reinstatement of cocaine-seeking in rodents 
(Park et al., 2002, McFarland et al., 2003, Schmidt et al., 2005), therefore it may seem 
counterintuitive that stimulating glutamate release through cystine-glutamate exchange is 
effective in reducing cocaine-seeking as seen in this chapter. However, it is important to 
be mindful of the purpose of multiple pools of extracellular glutamate. System xc- 
releases glutamate into the extrasynaptic compartment, activating presynaptic group II 
metabotropic glutamate receptors (Baker et al., 2002, Moran et al., 2005), then reducing 
the release of synaptic vesicular glutamate (Moran et al., 2003, Moran et al., 2005, 
Moussawi et al., 2011b) and dopamine as shown in this chapter. 
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Contribution of system xc- and dopamine in the NAcc to heightened relapse vulnerability 
Animals that received high levels of cocaine during self-administration (1.0 
mg/kg/200L infusion, IV, 6 h/d) showed elevated levels of cocaine-evoked dopamine 
when compared to animals that received lower levels (0.5 mg/kg/200L infusion, IV, 2 
h/d), contrary to findings by others (Ahmed et al., 2003, Lack et al., 2008). However, in 
the mentioned studies, animals underwent microdialysis within 24 hours of the final self-
administration session and in chambers that were not associated with cocaine self-
administration. This is important as it has been shown previously that drug-paired cues 
contribute to cocaine-evoked dopamine (Ito et al., 2000). Therefore, it is likely that 
microdialysis taken place in the self-administration chambers, such as described in this 
chapter, provides a more accurate assessment of cocaine-evoked dopamine. The addiction 
field would benefit by investigating the contribution of drug-associated cues to cocaine-
evoked drug seeking and dopamine. Interestingly, previous findings have shown that 
inhibiting the ventral subiculum of the hippocampus can block cocaine-primed 
reinstatement (Sun and Rebec, 2003). This is significant because the hippocampus is 
highly associated with spatial cues (Baylis and Moore, 1994, 1996), making it a likely 
region contributing to the differential release of dopamine in cocaine-withdrawn rats.  
Animals withdrawn from high-intake conditions exhibited diminished cystine-
glutamate exchange compared to low-intake animals. Further, when stimulating cystine-
glutamate exchange in high-intake animals just prior to cocaine-primed reinstatement, the 
augmented extracellular dopamine response was diminished. This suggests that 
diminished system xc- activity contributes to augmented dopamine signaling in the 
nucleus accumbens, as illustrated in figure 1.10, leading to elevated cocaine-seeking. 
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One possible link between augmented reinstatement and elevated cocaine-evoked 
dopamine are the receptor affinities for dopamine. For example, D2-like dopamine 
receptors, which are considered inhibitory because they are Gi-linked, have a higher 
affinity for dopamine. This means that lower levels of dopamine stimulate primarily D2-
like dopamine receptors. Conversely, D1-like dopamine receptors are considered 
excitatory because they are Gs-linked, and have a lower affinity for dopamine. Therefore, 
it is likely that augmented extracellular dopamine is required for activation of D1-like 
dopamine receptors. This is in line with findings that inactivation of D1-like or D2-like 
receptors in the core individually can block cocaine-primed reinstatement [for review see 
(Anderson et al., 2003, Schmidt et al., 2005, Schmidt et al., 2006)]. 
 Cocaine-evoked dopamine 
in High-intake animals 
Cocaine-evoked dopamine 
in High-intake animals 
pretreated with NAC 
   
Figure 1.10. Representative schematic depicting changes in cystine-glutamate exchange, dopamine 
neurotransmission, and how treatment with N-acetylcysteine reduces augmented dopamine release. 
(a) Under normal drug naïve conditions, dopamine release is tightly regulated by cystine-glutamate 
exchange and group II receptors. (b) Animals withdrawn from cocaine self-administration have 
diminished cystine-glutamate exchange and therefore less tone on group II receptors, disinhibiting 
synaptic release of dopamine. (c) Treating cocaine-withdrawn animals with N-acetylcysteine 
increases extrasynaptic glutamate and tone on group II receptors, returning dopamine release to 
almost normal levels. 
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By manipulating conditions that altered reinstatement behavior and cocaine-
induced plasticity, we were able to support the predictive validity of self-administration 
as a preclinical model for addictive behavior. The findings in this chapter suggest that 
high levels of drug intake results in the emergence of drug-induced adaptations that 
contribute to heightened relapse vulnerability. High-intake rats exhibit a more robust 
increase in extracellular levels of nucleus accumbens dopamine, but not glutamate, 
following a cocaine injection and this likely contributes to augmented reinstatement. The 
results are surprising because increased extracellular glutamate, but not dopamine, in the 
nucleus accumbens is necessary for cocaine-primed reinstatement (Cornish et al., 1999, 
Cornish and Kalivas, 2000, Park et al., 2002, Anderson et al., 2003, McFarland et al., 
2003, Bachtell et al., 2005, Schmidt et al., 2005). In addition, diminished cystine-
glutamate exchange was exhibited in high-intake animals when compared to low-intake 
animals. These findings also suggest that dysregulation of system xc- in high-intake 
animals may be due to altered dopamine signaling. We will investigate the regulation of 
cystine-glutamate exchange by dopamine receptors. But first, in chapter 2 we establish a 
model for measuring regulation of system xc-. 
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CHAPTER 2 
 
 
 
 
 
 
 
 
 
Development of assays for measurement of cystine-glutamate exchange
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Introduction 
Cystine-glutamate exchange by system xc- is an important regulator of synaptic 
activity that is altered in neuronal disorders such as schizophrenia (Baker et al., 2008, 
Lavoie et al., 2008) and cocaine addiction (Baker et al., 2003, Moran et al., 2005, Amen 
et al., 2011). In order to determine how cystine-glutamate exchange is altered in diseased 
states, we must first investigate how it is regulated. The aim of this chapter is to establish 
in vitro and in vivo assays that allow us to efficiently measure regulation of system xc-. 
Cystine-glutamate exchange stoichiometrically exchanges extracellular cystine for an 
intracellular glutamate at a 1:1 ratio. We will compare the use of glutamate release and 
cystine uptake as a reliable measure of cystine-glutamate exchange. We will also look to 
determine the cell type from which cystine-glutamate exchange takes place in vitro. In 
order to determine if we can regulate cystine-glutamate exchange in vitro, we will 
attempt to modulate cystine transport by cAMP-dependent protein kinase (PKA). 
Cystine-glutamate exchange contributes to neuronal dopamine signaling in the nucleus 
accumbens core. In order to use mixed cultures from the cortex, we attempt to show that 
there is similar regulation of neuronal signaling in the cortex as is found in the 
accumbens. 
Others have used glutamate transport to measure cystine-glutamate exchange 
activity (Knackstedt et al., 2010); the advantage to this method is the availability and 
stability of [
3
H]glutamate when compared to cystine. This requires that the experimenter 
distinguish between Na
+
-dependent and Na
+
-independent uptake. While cystine is 
primarily transported by system xc- (Murphy et al., 1989), glutamate can be transported 
both through system xc- and system XAG. In order to distinguish system xc- from system 
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XAG transport, the experimenter must utilize Na
+
-free media, an unacceptable condition 
when attempting to regulate cystine-glutamate exchange through receptor stimulation and 
kinase activity. This chapter will show that the use of [
14
C]cystine transport in vitro is a 
preferable model for measuring cystine-glutamate exchange activity. 
System xc- is composed of two proteins, the nonspecific 4f2hc heavy chain 
subunit, and the functional xCT subunit. xCT has consensus phosphorylation sites and 
has previously been shown regulated by PKA and PKC (Baker et al., 2003, Tang and 
Kalivas, 2003). In this chapter, we support these findings using in vitro methods utilized 
in chapters 3 and 4. 
Cystine-glutamate exchange regulates synaptic activity in vivo (Baker et al., 2002) 
and in slice preparation from the nucleus accumbens (Moran et al., 2005, Moussawi et 
al., 2011b). In vitro studies in this dissertation are performed in cortical cultures. In this 
chapter, we present data suggesting cystine-glutamate exchange regulates 
neurotransmission in the cortex as well, supporting the use of cortical cultures in future 
studies.  
 
Materials and Methods 
Animals 
Animal housing conditions and experimental protocols were approved by the 
Marquette University Institutional Animal Care and Use Committee and carried out 
according to the NIH Guide for the Care and Use of Laboratory Animals (revised 1996). 
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Mouse cortical cultures 
Mixed cortical cell cultures containing glial and neuronal cells were prepared 
from fetal (15–16 day gestation) mice as previously described (Lobner, 2000). 
Dissociated cortical cells were plated on 24-well plates coated with poly-D-lysine and 
laminin in Eagles’ Minimal Essential Medium (MEM, Earle’s salts, supplied glutamine-
free) supplemented with 5% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM 
glutamine and glucose (total 21 mM).  Astrocyte enriched glial cultures were prepared as 
described for mixed cultures except they are from cortical tissue taken from post-natal 
day 1–3 mice (Choi et al., 1987, Schwartz and Wilson, 1992). Neuronal cultures were 
prepared as described for mixed cultures with cytosine arabinoside (10 μM) added to the 
cultures 48 h after plating to inhibit glial replication. Less than 1% of cells in these 
cultures stain for glial fibrillary acidic protein (GFAP) (Dugan et al., 1995). Cultures 
were maintained in humidified 5% CO2 incubators at 37 °C. Mice were handled in 
accordance with a protocol approved by our institutional animal care committee and in 
compliance with the Public Health Service Policy on Humane Care and Use of 
Laboratory Animals. All efforts were made to minimize animal suffering and reduce the 
number of animals used. 
C6 glioma cell cultures 
 C6 glioma cells (ATCC, Manassas, VA) were grown and propagated in F-12K 
medium supplemented with 10% heat inactivated fetal bovine serum in 25cm
2
 tissue 
flasks.  For in vitro cystine uptake experiments, cells were lifted with trypsin (0.25% 
trypsin/0.53mM EDTA in HBSS), and plated in poly-lysine coated 24-well tissue culture 
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plates at a density of ~2 to 3x10
5
 cells/well.  Cells were allowed to grow to confluence 
(~3 DIV) prior to testing for cystine uptake. 
Acute regulation of cystine uptake in vitro 
 All experiments were performed in a 37ºC bath.  As illustrated below, cells were 
washed 3x with 1mL warm HEPES buffered saline solution, vacuumed to 150 L, and 
250L of the drug was added to bring to the indicated concentration.  Cells incubated for 
20 minutes with the drug, then a small aliquot, 10 L, of HEPES buffered saline solution 
was added that brought the concentration of [
14
C]cystine (Perkin Elmer, Waltham, MA) 
and TBOA to 1 M and 10 M, respectively.  Cells incubated for another 20 minutes.  
The uptake experiment was rapidly terminated by wash 3x with 1mL of ice-cold PBS, 
vacuumed dry, and 500 L 0.1% SDS added to solubilize the cells.  Resultant lysate was 
analyzed by scintillation counter and counts were normalized to the mean of the control 
group. 
 
 
 
Time Dependent Glutamate Release in vitro 
 C6 glioma cells cultured as mentioned above were washed 3x with 1mL HEPES 
buffered saline solution. 10L aliquots were collected at 0, 2.5, 5, 10, 20, 40, 80, and 160 
minute increments. Each aliquot was measured for glutamate content by HPLC. 
Time Dependent Cystine Uptake in vitro 
 C6 glioma cells cultured as mentioned above were wash 3x with 1mL HEPES 
buffered saline solution and [
14
C]cystine (1M) was added to the media. Cells were 
3x wash and drug 
application Cystine application 
3x ice-cold PBS wash, and 
solubilize 
20 minutes 20 minutes 
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washed 3x with 1mL ice-cold PBS, solubilized with 500L 0.1% SDS, and measured for 
cystine by scintillation counter at 0, 2.5, 5, 10, 20, 40, 80, or 160 minutes. 
Quantification of Glutamate 
The concentration of glutamate in culture was quantified by comparing peak 
heights from samples and external standards using HPLC coupled to fluorescence 
detection. Precolumn derivatization of glutamate with opthaldehyde was performed using 
a Shimadzu LC10AD VP autosampler. The mobile phase consisted of 13% acetonitrile, 
100 mM Na2HPO4, and 0.1 mM EDTA, pH 5.90. Glutamate was separated using a 
reversed-phase column (4 μm; 140 × 6.0 mm; Phenomenex, Torrance, CA), and detected 
using a Shimadzu 10RF-AXL fluorescence detector with excitation and emission 
wavelengths of 320 and 400 nm, respectively. 
Quantification of Dopamine 
Dopamine concentrations were quantified by comparing peak heights from 
samples and external standards using HPLC coupled to electrochemical detection. The 
mobile phase consisted of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM 
citric acid, 3 mM SDS, and 50 μM EDTA, pH 5.6. Dopamine was separated using a 
reversed-phase column (3 μm; 80 × 3.2 mm; ESA Inc., Bedford, MA) and detected using 
an ESA Coulochem II detector coupled to two electrodes set at −0.075 V and +0.25 V, 
respectively. 
Prefrontal cortical surgery 
Male Sprague–Dawley rats (Harlan, Indianapolis, IN) weighing 300–350 g were 
individually housed in a temperature-controlled colony room with a 12-h light/dark cycle 
with food and water available ad libitum. The housing conditions and care of the rats was 
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in accordance with the Animal Welfare Act, and all procedures were approved by the 
Marquette University IACU Committee. Rats included in the microdialysis studies were 
anesthetized using pentobarbital (50 mg/kg, IP) with atropine sulfate (1 mg/kg, IP) 
pretreatment to limit tracheobronchial secretions. Bilateral guide cannula (20 gauge, 
14 mm; Plastics One, Roanoke, VA) were implanted using coordinates (+3.1 mm anterior 
and ±1.0 mm mediolateral to Bregma, and −0.75 mm ventral from the surface of the skull 
at a 6° angle from vertical) derived from (Paxinos and Watson, 1986). Rats were then 
given at least 5 days to recover from surgery prior to testing. 
In Vivo Microdialysis 
Microdialysis experiments were conducted as described previously (Baker et al., 
2008). Briefly, removable probes were inserted through the guide cannulae into the 
prefrontal cortex. The next day, dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM 
CaCl2, 1.2 mM MgCl2, and 0.15% phosphate-buffered saline, pH 7.4) was pumped 
through the probes at 1 μl/min for at least 3 h; afterwards 20 min samples were collected 
before and after treatment with N-acetylcysteine (90mg/kg, IP). Dopamine concentrations 
were quantified by comparing peak heights from samples and external standards using 
HPLC coupled to electrochemical detection. The mobile phase consisted of 15% 
acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM citric acid, 3 mM SDS, and 50 
μM EDTA, pH 5.6. Dopamine was separated using a reversed-phase column (3 μm; 80 × 
3.2 mm; ESA) and detected using an ESA Coulochem II detector coupled to two 
electrodes set at −0.075 V and +0.25 V, respectively. 
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Histology 
Rats included in the microdialysis studies were given an overdose of pentobarbital 
(60 mg/kg, IP), and the brains were fixed by intracardiac infusion of 0.9% saline 
followed by 2.5% formalin solution. Brains were removed and stored in 2.5 % formalin 
for at least seven days prior to sectioning. The tissue was then blocked and coronal 
sections (100 μm) were cut and stained with cresyl violet to verify probe placements. 
Statistical analyses 
SPSS software (version 16) was used to perform the statistical analyses. When 
comparing between two treatments, a Student’s t test was performed. Two way analysis 
of variance (ANOVA) was used with more than one between subject factors. Data 
collected over time were analyzed using analysis of variance (ANOVA) with 
sulfasalazine as a between subjects measure and time (20-min interval) as a repeated 
factor. Post hoc comparisons were conducted using t-tests when only two data points 
were compared, or with Tukey HSD with multiple data points. 
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Results 
Differential cystine uptake in neurons and glia in culture 
 Figure 2.1 illustrates the differential uptake of cystine in primary mouse cortical 
culture. Pure neurons or pure glia were cultured and [
14
C]cystine transport was measured. 
A two-way ANOVA with cell type and treatment as between subjects factors revealed a 
significant main effect of cell type 
(F1,63=139.045, p<0.001), treatment 
(F3,63=79.043, p<0.001), and a 
significant interaction between the two 
(F3,63=43.311, p<0.001). The cystine 
glutamate exchange inhibitor (S)-4-
carboxyphenylglycine was used to 
determine the system xc- specific portion 
of uptake, and D-aspartate was used to 
determine the system XAG-specific 
portion of uptake. Post hoc analyses 
with treatment as a variable in neuronal 
culture yielded significant contributions 
of CPG-dependent uptake (ANOVA: F3,31=20.193, p<0.001; Tukey HSD p<0.001) and 
D-aspartate-dependent uptake (Tukey HSD, p<0.001). Interestingly, post hoc analyses 
with treatment as a variable in glial culture revealed significant contributions of CPG-
dependent uptake (ANOVA: F3,31=69.105, p<0.001; Tukey HSD, p<0.001), but not for 
D-aspartate-dependent uptake (Tukey HSD, p=0.120). 
Figure 2.1. System xc- is expressed primarily on 
astrocytes. Primary mouse cortical cells were 
cultured for two weeks and measured for cystine 
uptake in the presence or absence of the cystine-
glutamate exchange inhibitor (S)-4-
carboxyphenylglycine (CPG) or the system XAG 
inhibitor D-aspartate. A two-way ANOVA with cell 
and treatment as between subjects factors reveal a 
significant main effect of cell culture (F1,63=139.045, 
p<0.001), treatment (F3,63=79.043, p<0.001), and a 
significant interaction between the two 
(F3,63=43.311, p<0.001). *Significant difference 
from control. 
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Cystine transport as a valid model for measuring cystine-glutamate exchange 
 The above experiments indicate that glia, likely astrocytes, is the primary cell type 
expressing cystine-glutamate exchange. Further, neurons express multiple sources of 
cystine transport in addition to system xc-. C6 glioma cells were utilized in the following 
experiments because they express high levels of cystine-glutamate exchange with 
diminished system XAG (Ye et al., 1999). 
These cells were used to determine if 
glutamate release or cystine transport is 
the optimal measure of system xc- activity. 
Figure 2.2 illustrates that glutamate 
accumulates in the media over time even 
in the absence of exogenous cystine. A 
two-way ANOVA with time (0 – 160 min) 
as a repeated measure and SSZ as between 
subjects factors yielded significant main 
effects of time (F7,47=144.808, p<0.001), 
SSZ (F1,47=27.483, p<0.001), as well as a 
significant interaction (F7,47=6.416, p<0.001). Post hoc analyses reveal that there was a 
significant increase in glutamate release in the absence of cystine at multiple time points 
(Tukey HSD, p<0.05).  This was not significantly altered by the inhibition of system xc- 
(i.e., SSZ) (Tukey HSD, p<0.001) indicating that most of the glutamate accumulating in 
the media is not due to cystine-glutamate exchange. These data demonstrate that one 
issue with measuring glutamate to reflect system xc- is that this approach is influenced by 
Figure 2.2. Cystine-glutamate exchange as 
assessed by the measurement of extracellular 
glutamate. C6 glioma cells were cultured, washed 
with HEPES buffered saline solution, and either 
measured for extracellular glutamate. In the 
presence of the cystine-glutamate exchange 
inhibitor sulfasalazine (0 or 500M), glutamate 
release was significantly different for the 10, 80, 
and 160 minute time points. *Significant 
difference from SSZ treated (t test, p<0.05). 
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other mechanisms contributing to 
glutamate homeostasis, and this may 
present signal-noise concerns. 
Figure 2.3 illustrates that 
[
14
C]cystine (1M) transport significantly 
increased over time. A two way ANOVA 
with time and SSZ as between subject 
factors yielded significant main effects of 
time (F7,44=625.350, p<0.001), SSZ 
(F1,44=1841.993, p<0.001), as well as a 
significant interaction (F7,44=401.081, 
p<0.001). Further, at 20 minutes, there 
was a significant difference, when compared to 0 minutes, in cystine uptake in the 
absence (Tukey HSD, p<0.05) but not the presence (Tukey HSD, p=0.846) of SSZ, as 
well as a significant difference between the two at 20 minutes (t4=11.145, p<0.001). 
Given that cystine transport was significantly diminished in the absence of cystine-
glutamate exchange (i.e. in the presence of SSZ), these findings suggest that cystine 
transport is a more reliable measure of cystine-glutamate exchange in culture. 
Cystine-glutamate exchange in vitro is regulated by protein kinase A (PKA) 
Previous studies have shown that cystine-glutamate exchange can be regulated by 
PKA in tissue punches (Baker et al., 2003) and in vitro (Tang and Kalivas, 2003). Our 
next goal was to determine whether a similar regulation occurs in C6 cells, in part to 
evaluate the suitability of using these cells to study the regulation of system xc- activity. 
Figure 2.3. Cystine-glutamate exchange as 
assessed by the measurement of uptake of 
radiolabeled cystine. C6 glioma cells were 
cultured, washed with HEPES buffered saline 
solution, and measured for [
14
C] cystine uptake. 
In the presence of the cystine-glutamate exchange 
inhibitor sulfasalazine (0 or 500M), cystine 
transport was significantly different at most of the 
time points. *Significant difference from SSZ 
treated (t test, p<0.05). 
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Figure 2.4 illustrates regulation of 
cystine-glutamate exchange in vitro as 
measured by [
14
C]cystine uptake in C6 
glioma cells. Cystine transport was 
unaffected by stimulating protein kinase 
A (PKA) activity with the cAMP analog 
Sp-cAMPS (0 or 100 M; t29=0.8100, 
p=0.425). Interestingly, inhibiting PKA 
with H89 (0 or 10M) showed a 
significant decrease in cystine uptake 
(10M; t6=0.2.4050, p=0.05). We also 
examined the effect of KT5720, a more potent and selective allosteric inhibitor of PKA. 
KT5720 significantly decreased cystine transport (0 or 100nM; t6=3.0200, p<0.05). The 
drug concentrations used were based on previous publications for their use in vitro: SP-
cAMPS (Song et al., 2006, Zhang et al., 2009, Zhang et al., 2010), H89 (Park et al., 
2009), and KT572 (Russo et al., 2009). The lack of an effect of Sp-cAMPs creates 
concerns regarding the utility of using C6 cells to study the regulation of system xc-.   
Cystine-glutamate exchange regulates dopamine signaling in the cortex 
An alternative to using C6 cells is to use cortical cultures (Liu et al., 2009, Liu et 
al., 2011, Rush et al., 2012). Interestingly, similar to ex vivo punches (Baker et al., 2003), 
system xc- activity in these cells are also regulated by PKA (Tang and Kalivas, 2003), 
thereby supporting the use of these cells for the study of system xc-. Because these cells 
are harvested from a region other than the nucleus accumbens, we sought to determine 
Figure 2.4. PKA regulates cystine-glutamate 
exchange in culture. C6 glioma cells were grown in 
culture and pretreated for 20 minutes with drugs 
that regulate PKA activity. Stimulating PKA with 
Sp-cAMPS had no significant effect on cystine 
transport (100M; t29=0.8100, p=0.425). Inhibiting 
PKA with H89 decreased cystine transport (10M; 
t6=0.2.4050, p=0.05), as well as with the more 
specific PKA inhibitor KT 5720 (100nM; 
t6=3.0200, p<0.05). *Significant difference from 
control (t test, p<0.05). 
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whether system xc- in the cortex regulates neurotransmission in this region in a manner 
that is similar to the nucleus accumbens. To do this, we examined the impact of the 
cysteine prodrug N-acetylcysteine on dopamine signaling. The reason for sampling 
dopamine rather than glutamate is that 
extracellular dopamine levels are known 
to be entirely neuronal in nature, thereby 
providing a more clear assessment of the 
synaptic activity. Figure 2.5 illustrates 
that stimulating cystine-glutamate 
exchange with N-acetylcysteine (NAC; 
90 mg/kg, IP) decreased extracellular 
dopamine levels in the prefrontal cortex 
in vivo; a finding that is similar to what 
we have observed in the nucleus accumbens. A repeated measures ANOVA yielded a 
significant effect of time (F8,24=6.609, p<0.001), suggesting cystine-glutamate exchange 
regulates neurotransmission in the cortex. 
 
Discussion 
The aim of this chapter was to determine the cell type and substrate for measuring 
cystine-glutamate exchange in vitro. Primary mouse cortical cultures, both pure neuronal 
and pure glial, were measured for [
14
C]cystine uptake. The majority of cystine transport 
occurred in astrocytes as opposed to neurons. In addition, neurons expressed transport by 
system XAG and system xc-, whereas astrocytes only expressed transport by system xc-. 
Figure 2.5. Stimulating cystine-glutamate 
exchange decreases dopamine in the prefrontal 
cortex. Acute treatment with N-acetylcysteine 
(90mg/kg, IP) decreases extracellular dopamine 
in the prefrontal cortex. A repeated measures 
ANOVA yielded a significant effect of time 
(F8,24=6.609, p<0.001). *Significant difference 
from last baseline sample (Tukey HSD, p<0.05). 
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These findings suggest that cystine-glutamate exchange is expressed primarily on 
astrocytes, and that these cells maintain a cleaner measure of system xc- activity per 
measure of protein in culture. 
The C6 glioma cell line was utilized due to the fact that these cells express 
cystine-glutamate exchange but have decreased glutamate transporter function (Ye et al., 
1999). We chose to measure glutamate release in the absence of exogenous cystine and 
found that extracellular glutamate increased both in the presence and absence of cystine-
glutamate exchange despite application of exogenous cystine, suggesting that an alternate 
mechanism contributes to the accumulation of glutamate. One possible contribution to 
extracellular glutamate is glutathione cycling. When glutathione is released, it is 
metabolized into its amino acid components, among them glutamate and cysteine, which 
can be auto-oxidized into cystine. However, the primary source of intracellular cystine, 
the rate limiting step to glutathione synthesis, is cystine-glutamate exchange (Kranich et 
al., 1998). Therefore, blockade of cystine-glutamate exchange by sulfasalazine should 
inhibit increases in glutamate by glutathione cycling. Future experiments should 
investigate the source of extracellular glutamate. 
We found that [
14
C]cystine uptake significantly increase over time in a cystine-
glutamate dependent manner. Important to note is that glutathione cycling may also 
contribute to confounds in cystine transport experiments. For example, as mentioned 
previously, cystine that is transported into the cell is utilized to form glutathione. This 
glutathione is then released via MRP-1, which could result in an underestimate of the 
total amount of cystine-glutamate exchange Therefore, it is important to utilize the 
shortest time possible to isolate the functional assay to cystine-glutamate exchange. 
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An important question regarding the utility of using C6 cells to learn about the 
regulation of system xc- in vivo is the degree to which we can replicate in C6 cells what 
is known about in vivo system xc- regulation.  To do this, we examined the impact of 
increasing PKA activity since this has been shown to regulate cystine-glutamate 
exchange in ex vivo punches as well as mixed cortical cultures (Baker et al., 2003, Tang 
and Kalivas, 2003). Stimulating protein kinase A (PKA) activity was unable to alter 
cystine transport. There are at least two interpretations of this data set.  The first is that 
these cells exhibit tonic PKA activity at a level that is not observed in vivo or in primary 
cultured cells.  Alternatively, this could indicate that PKA does not modulate system xc- 
activity in C6 cells.  Interestingly, our results indicate that system xc- activity was 
increased in C6 cells following the activation of PKA, which supports the former 
interpretation.  Regardless, either interpretation would indicate differential regulation of 
system xc- in C6 cells relative to either primary cultures or ex vivo tissue punches.  This 
greatly detracts from the utility of these cells for the experiments in this thesis. Therefore, 
for future studies we utilized primary cultures. 
Mixed cortical cultures are a common model for measuring regulation of cystine-
glutamate exchange (Jackman et al., 2010, Liu et al., 2011, Rush et al., 2012). However, 
we are particularly interested in system xc- in the nucleus accumbens core, given deficits 
in cystine-glutamate exchange in the nucleus accumbens core contribute to cocaine-
seeking (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008, Knackstedt et al., 2010, 
Moussawi et al., 2011b). Therefore, we wanted to determine if cystine-glutamate 
exchange regulates neurotransmission in the cortex as it does in the nucleus accumbens. 
Figure 2.4 illustrates that stimulating cystine-glutamate exchange decreases extracellular 
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dopamine in the prefrontal cortex. This finding, coupled with previous demonstration that 
cystine-glutamate exchange by system xc- is maintained by PKA and PKC in mixed 
cortical culture (Tang and Kalivas, 2003), suggests that we should be able to measure 
regulation by neurotransmitter signaling in this culture. Cystine-glutamate exchange by 
system xc- has previously been shown tonically regulated by a number of growth factors 
including interleukin-1 (Jackman et al., 2010) and fibroblast growth factor-2 (Liu et al., 
2011) in addition to acute regulation by protein kinase A (Baker et al., 2003) and protein 
kinase C (Tang and Kalivas, 2003). This reveals potential regulation by neurotransmitters 
that are linked to PKA or PKC, such as dopamine. Because we are interested specifically 
in changes that may account for reduced activity following repeated cocaine, in the 
following chapter we investigate regulation of cystine-glutamate by dopamine signaling.  
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CHAPTER 3 
 
 
 
 
Regulation of system xc- by dopamine
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Introduction 
Extrasynaptic glutamate is a pool of extracellular glutamate contributed to by 
astrocytic mechanisms such as cystine-glutamate exchange by system xc- that regulates 
neurotransmission (Baker et al., 2002). Cystine-glutamate exchange is altered in multiple 
disorders including schizophrenia (Baker et al., 2008, Lavoie et al., 2008, Dean et al., 
2009, Dean et al., 2010, Dean et al., 2011) and addiction (Baker et al., 2003, Moran et al., 
2005, Kau et al., 2008, Moussawi et al., 2011b). Interestingly, both disorders are 
considered hyperdopaminergic disorders based on their association with dopamine 
neurotransmission and altered behavior. This raises the possibility that system xc- is 
regulated by dopamine. 
Previous findings suggest that cystine-glutamate exchange is regulated by PKA 
and PKC (Baker et al., 2003, Tang and Kalivas, 2003). Interestingly, dopamine receptors 
are G-protein coupled (Beaulieu and Gainetdinov, 2011). Particularly, D2-like dopamine 
receptors are Gi- and D1-like dopamine receptors are Gs-coupled, which means 
stimulating leads to respective inactivation and activation of PKA. The aim of this 
chapter is to determine if dopamine receptor signaling regulates cystine-glutamate 
exchange. We examine the regulation of system xc- by dopamine, nonspecific dopamine 
agonists, D1-like, and D2-like dopamine receptor agonists. We hypothesize that D1-like 
dopamine receptors increase, and D2-like dopamine receptors decrease cystine-glutamate 
exchange activity based on their respective activation and inactivation of PKA activity. 
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Materials and Methods 
Animals 
These experiments utilized male and female Sprague Dawley rats (Harlan, 
Indianapolis, IN). Female rats arrived at 14 days gestation. Rats were individually housed 
in a temperature-controlled colony room with a 12-h reversed light/dark cycle. Housing 
conditions and experimental protocols were approved by the Marquette University 
Institutional Animal Care and Use Committee and carried out according to the NIH 
Guide for the Care and Use of Laboratory Animals (revised 1996). 
Rat mixed cortical cultures 
Mixed cortical cell cultures containing glial and neuronal cells from rats were 
prepared from fetal (15–16 day gestation) rats as previously described (Lobner, 2000), 
with some exceptions. Dissociated cortical cells were plated on 24-well plates coated 
with poly-D-lysine and laminin at a density of ~6x10
5
 cells/well in Neurobasal medium 
supplemented with 10% fetal bovine serum and 1% Glutamax-I (Life Technologies). 
Cultures were maintained in humidified 5% CO2 incubators at 37 °C. All efforts were 
made to minimize animal suffering and reduce the number of animals used. 
Acute regulation of cystine-glutamate exchange in vitro 
All experiments were performed in a 37ºC bath. As illustrated below, cells were 
washed 3x with 1mL warm HEPES buffered saline solution, vacuumed to 150 L, and 
250L of the drug was added to bring to the indicated drug concentration. Cells 
incubated for 20 minutes with the drug, then a small aliquot, 10 L, of HEPES buffered 
saline solution was added that brought the concentration of [
14
C]cystine (Perkin Elmer, 
Waltham, MA) and TBOA to 1 M and 10 M, respectively. Cells incubated for another 
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20 minutes. The uptake experiment was rapidly terminated by wash 3x with 1mL of ice-
cold PBS, vacuumed dry, and 500 L 0.1% SDS added to solubilize the cells. Resultant 
lysate was analyzed by scintillation counter and counts were normalized to the mean of 
the control group. 
 
 
 
Regulation of cystine-glutamate exchange ex vivo 
As illustrated below, tissue punches (1.25 mm diameter; Stoelting, Wood Dale, 
IL) were collected from the nucleus accumbens core (figure 1.4) and incubated at 37°C 
for ∼30 min on a nylon mesh platform, submerged beneath 2 mm of standard buffer 
(Lobner and Lipton, 1993); the standard buffer contained 124 mM NaCl, 3.0 mM KCl, 
1.4 mM KH2PO4, 1.3 mM MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4 mM glucose, 
equilibrated with 95% O2, 5% CO2, pH 7.4. After a 20 min wash, the tissue was 
incubated for 20 min in standard buffer containing dopamine, SKF38393, or 
apomorphine and the cystine-glutamate exchange blocker sulfasalazine (0 or 500 M). 
The tissue was transferred to standard buffer containing the drug treatment, [
14
C]cystine 
(1 M), and DL-TBOA (10 M) to prevent uptake via XAG. After 20 min incubation, the 
tissue punches were washed four times in ice-cold PBS and dissolved in 250 μl of 1% 
SDS. One aliquot (175 μl) was used to measure [14C]cystine uptake by scintillation 
counting; a second aliquot (50 μl) was used to assess protein content by the BCA method. 
 
 
3x Wash and drug 
application Cystine application 
3x ice-cold PBS wash, and 
solubilize 
20 minutes 20 minutes 
Tissue extraction Drug application 
Wash and 
solubilize 
20 minute 
equilibration 20 minutes 20 minutes 
Drug and Cystine 
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Statistical analyses 
SPSS software (version 16) was used to perform the statistical analyses. When 
comparing between two treatments, a Student’s t test was performed. Two way analysis 
of variance (ANOVA) was used with more than one between subject factors (such as 
SCH23390 and intake condition). Experiments with multiple concentrations of one 
treatment utilized ANOVA. Post hoc comparisons were conducted using t-tests when 
only two data points were compared, or with Tukey HSD with multiple data points. 
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Results 
D2-like dopamine receptors do not regulate cystine-glutamate exchange in vitro 
 PKA regulates cystine-glutamate exchange ex vivo (Baker et al., 2003) and in 
vitro (Tang and Kalivas, 2003). In chapter 2, we showed that inhibiting PKA activity in 
vitro decreased system xc- activity. D2-like dopamine receptors are Gi-coupled and 
therefore decrease adenylyl cyclase and 
PKA activity (Beaulieu and Gainetdinov, 
2011). We examined the ability of D2-like 
receptors to decrease cystine-glutamate 
exchange. Figure 3.1 illustrates that the 
selective D2 receptor agonist quinpirole (0 
– 100M) was unable to alter [14C]cystine 
transport in rat mixed cortical cultures 
(ANOVA: F5,47=0.500, p=0.774). Drug 
concentrations were selected based on 
previous findings (Li et al., 2006, Guo et al., 2010). Quinpirole was selected due to its 
affinity for D2-like versus D1-like dopamine receptors (Km = 4.8nM for D2 and 1.9M 
for D1) over other available agonists such as bromocriptine (Km = 8nM for D2 and 
440nM for D1). 
Figure 3.1. D2 receptor stimulation did not 
regulate cystine-glutamate exchange in vitro. 
Primary rat mixed cortical cultures were made 
from embryonic dissection (E15-E17) and 
cultured for 14 days. Pretreatment with the 
selective D2 agonist quinpirole (0 – 100M) 
yielded no significant change in [
14
C]cystine 
uptake (F5,47=0.500, p=0.774). 
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Regulation of cystine-glutamate exchange by D1-like dopamine receptors 
 We also examined the ability of 
Gs-coupled D1-like dopamine receptors 
to regulate cystine-glutamate exchange. 
Figure 3.2 illustrates regulation of 
cystine-glutamate exchange by D1-
dopamine receptors in vitro. Acute 
application of SKF38393 (0 – 1M) 
increased [
14
C]cystine transport in mixed 
cortical cultures from rat (ANOVA: 
F3,39=3.587, p<0.05). Post hoc analyses 
show a significant effect of SKF38393 at 
the 0.1 M concentration (Tukey HSD, p<0.05). The concentration of SKF38393 was 
selected based on previous findings 
(Dumont et al., 2004, Gomes et al., 2004). 
Cystine-glutamate exchange by 
system xc- is diminished in the nucleus 
accumbens core of animals withdrawn 
from chronic cocaine. Therefore, we 
wanted to determine of D1-like dopamine 
receptors regulate cystine-glutamate 
exchange in ex vivo tissue punches from 
the nucleus accumbens core. Figure 3.3 
Figure 3.2. D1 dopamine receptor stimulation 
increased cystine-glutamate exchange in vitro. 
Primary rat mixed cortical cultures were made from 
embryonic dissection (E15-E17) and cultured for 
14 days. Pretreatment with the D1 agonist 
SKF38393 (0 – 1M) significantly increased 
[
14
C]cystine uptake (F3,39=3.587, p<0.05). 
*Significant difference from control (Tukey HSD, 
p<0.05). 
Figure 3.3. The D1 agonist SKF38393 does not 
increase cystine transport in the nucleus 
accumbens core ex vivo. 1mm x 1mm tissue 
punches from the nucleus accumbens core were 
extracted from drug naïve animals and incubated 
in slice buffer, pretreated with SKF38393 (0 or 
100nM), then treated with SKF38393 and 
[
14
C]cystine (1M). A t-test yielded no 
significant effect of drug (t9=0.450, p=0.664). 
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illustrates lack of regulation by SKF3839 (0 
or 100nM) ex vivo (t  test, t9=0.450, 
p=0.664). One explanation for this finding 
is that there may be differences in 
dopamine receptor-dependent regulation of 
system xc- between primary cultures and ex 
vivo punches.  The nature of the difference 
may be in terms of drug potency indicating 
that either higher or lower concentrations of 
SKF38393are needed to fully evaluate the 
effect of D1-like receptors on system xc- 
activity in ex vivo punches.  Alternatively, 
the differences may be more substantive 
indicating differential regulation at the 
level of the receptor, which could complicate the interpretation of even the D2 data.  
Given that the rational for these experiments stems from the hypothesis that dopamine 
may regulate system xc-, additional characterization involved ex vivo punches and 
dopamine.Figure 3.4a illustrates that dopamine was not capable of altering cystine-
glutamate exchange in ex vivo tissue punches from the nucleus accumbens core. We did 
observe a non-significant trend, suggesting that we were not able to fully stimulate 
dopamine receptors. There are two interpretations of this data set.  First, dopamine may 
exert mild, insignificant effects on system xc- activity.  Alternatively, the modest effect 
may be due to the elimination of dopamine since dopamine can be cleared by organic 
Figure 3.4. Nonspecific dopamine receptor 
stimulation did not regulate cystine-glutamate 
exchange in the nucleus accumbens core ex vivo. 
Tissue punches from the rat nucleus accumbens 
core were pretreated with (a) dopamine (0 – 
300nM), (b) apomorphine (0 – 10M), None of 
which had a significant effect on [
14
C]cystine 
transport. 
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cation transporters (OCT-3) and dopamine transporters (DAT) or inactivated by oxidation 
and metabolism by monoamine oxidase. Therefore, we looked at nonspecific stimulation 
of dopamine receptors by apomorphine, which would not be cleared or eliminated in a 
manner that may complicate the interpretation of the dopamine experiment. Figure 3.4b 
illustrates that apomorphine was not capable of altering cystine-glutamate exchange. The 
concentration of apomorphine used was based on previous findings eliciting effects in 
astrocytes (Li et al., 2006). ANOVAs run for [
14
C]cystine transport  yielded no 
significant effect of dopamine (3.4a; 0 – 300nM; F3,33=2.014, p=0.131) or apomorphine 
(3.4b; 0 – 10M; F3,28=0.734, p=0.542). 
 
Discussion 
 The aim of this chapter was to determine if diminished cystine-glutamate 
exchange during withdrawal from cocaine self-administration can be attributed to altered 
dopamine signaling (Bradberry and Roth, 1989, Xia et al., 1992, Cerruti et al., 1994, De 
Vries et al., 1999, Alleweireldt et al., 2002, Bachtell et al., 2005, Ben-Shahar et al., 
2007). Cystine-glutamate exchange has previously been shown regulated by protein 
kinase A (Baker et al., 2003, Tang and Kalivas, 2003). D2-like dopamine receptors are 
linked to Gi signaling, decreased adenylyl cyclase activity, and cAMP production [for 
review see (Missale et al., 1998)]. Therefore, we hypothesized that D2 dopamine receptor 
stimulation would decrease cystine-glutamate exchange activity. Contrary to our 
expectations, the selective D2-like dopamine receptor agonist quinpirole was 
unsuccessful at altering cystine transport in vitro. This finding was surprising giving that 
others have shown regulation of cystine-glutamate exchange by receptors also linked to 
Gi, such as Group II metabotropic glutamate receptors (Xi et al., 2002a). In the 
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mentioned publication, stimulating and inhibiting Group II receptors decreased and 
increased, respectively, extracellular glutamate in the nucleus accumbens in a cystine-
glutamate exchange dependent manner. Aside from targeting D2 receptors, our 
experiment differs in that it was performed in mixed cortical culture. A likely explanation 
for the lack of regulation of cystine-glutamate exchange by D2-like receptors is the level 
of expression of these receptors in the developing central nervous system. In particular, 
previous studies have suggested that in the developing rat cerebral cortex, D2 receptor 
expression does not reach maximal levels until postnatal day 35 (Tarazi and Baldessarini, 
2000). In this study, they showed that postnatal day 14, similar to the age of the mixed 
cortical culture, rat showed no significant increase in D2 receptor expression than day 7.  
We examined regulation of cystine-glutamate exchange by D1-dopamine 
receptors. D1-like dopamine receptors are coupled to Gs, and therefore activate 
PKA,leading us to hypothesize that targeting D1-like dopamine receptors would regulate 
system xc- activity. Stimulating D1-like dopamine receptors in vitro significantly 
increased cystine transport, suggesting that D1-like dopamine receptors regulate cystine-
glutamate exchange. Cystine-glutamate exchange by system xc- is diminished in the 
nucleus accumbens core of animals withdrawn from chronic cocaine. Therefore, we 
wanted to determine of D1-like dopamine receptors regulate cystine-glutamate exchange 
in ex vivo tissue punches from the nucleus accumbens core. The D1 dopamine receptor 
agonist, SKF38393 did not alter cystine transport in the nucleus accumbens core ex 
vivo.The fact that D1-like receptor stimulation regulated cystine-glutamate exchange in 
vitro but not in tissue punches from the nucleus accumbens core is likely attributed to a 
number of differences between the systems. In vitro cultures were acquired from the 
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cortex, whereas the tissue punches are from the nucleus accumbens. Further, in vivo 
tissue punches were acquired from adult males, whereas the culture system originally 
derives from embryonic day 16, and are utilized 14 days later. Receptor expression and 
signaling develops over time in the rat. For example, GABA receptors act in a more 
stimulatory manner in early development due to elevated internal chloride concentrations 
in immature neurons (Pfeffer et al., 2009) and NMDA receptor subunit expression 
changes through early development (Wenzel et al., 1997). As with D2 receptors in the 
developing rat cortex, D1 receptor expression does not reach its maximum until at least 
postnatal day 60, which postnatal day 14 at significantly lower levels (Tarazi and 
Baldessarini, 2000). However, though there was no direct comparison between D1 and 
D2 receptors, the data presented in this publication suggest a higher expression of D1 
receptors over D2 receptors; a potential reason for regulation of cystine-glutamate 
exchange by D1, but not D2 receptors in mixed cortical culture. 
In tissue punches, afferent fibers are dissected out, leaving only cell bodies from 
the region from which the tissue was taken and removing synaptic signaling. Conversely, 
in mixed cortical culture neuronal signaling remains intact, revealing the possibility that 
D1-like receptor activation occurred on the cortical neurons, leading to release of 
neuronal signaling that may act on astrocytes. Cortical neurons, such as glutamatergic, 
project to the nucleus accumbens. Therefore it is possible that cortical activation, perhaps 
by D1-like dopamine receptor stimulation, may lead to downstream regulation of cystine-
glutamate exchange in the nucleus accumbens. In support of this, previous investigators 
have found that a single activation of the prefrontal cortex can restore basal glutamate by 
cystine-glutamate exchange in the nucleus accumbens of cocaine-withdrawn animals 
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(Berglind et al., 2009). While we can report that stimulation of D1-like receptors in the 
nucleus accumbens core was unable to regulate cystine-glutamate exchange, it is possible 
that dopamine in the prefrontal cortex regulates cystine-glutamate exchange in the 
nucleus accumbens core. To address this, similar to previous experiments (Berglind et al., 
2009), future studies should attempt to stimulate D1-like receptors in the prefrontal 
cortex and measure cystine-glutamate exchange in vivo. Predicted findings are likely that 
stimulation would lead to an increase in basal glutamate. Alternatively, it is possible that 
basal cystine-glutamate exchange is difficult to elevate in vivo. In that instance, one may 
consider attempting to restore cocaine-induced diminished cystine-glutamate exchange 
by stimulation of D1-like receptors in the prefrontal cortex. 
Our assumption is that regulation by dopamine is dependent on dopamine 
receptor activation, yet in this system, it may result from non-receptor mediated actions. 
For example, cystine-glutamate exchange can be upregulated in the presence of oxidative 
stress (Allen et al., 2002, Dun et al., 2006, Lewerenz et al., 2006). Further, dopamine can 
induce oxidative stress either by auto-oxidation into dopamine quinones (LaVoie and 
Hastings, 1999) or by eventual formation of cysteinyl-dopamine (Rabinovic and 
Hastings, 1998). Thus, there may be alternate possibilities for dopamine to regulate 
cystine-glutamate exchange that are not specific to receptor stimulation. However, 
dopamine alone lacked an effect on cystine transport ex vivo. There are multiple sources 
of inactivation of dopamine signaling. Dopamine can be transported by organic cation 
transporter (OCT-3) (Wu et al., 1998) and dopamine transporters (DAT), and is 
metabolized by monoamine oxidase. Therefore, we tested a nonspecific dopamine 
receptor agonist that is not susceptible to normal metabolism. However, we were also 
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unable to alter cystine-glutamate exchange with the nonspecific dopamine agonist 
apomorphine. To this end, it may prove valuable to investigate a potential interaction of 
long-term increases in dopamine and altered cystine-glutamate exchange. Shih et al. have 
previously shown that excessive dopamine signaling in vitro can lead to activation of the 
Nrf2 transcription factor and eventual increase in expression of cystine glutamate 
exchange (Shih et al., 2007). Assuming this is the case, then one would assume that 
animals exhibiting elevated dopamine levels due to cocaine-withdrawal would also 
exhibit elevated levels of cystine-glutamate exchange by system xc-. Therefore, future 
experiments may investigate this proposed pathway, DA > Nrf2 > system xc-, in cocaine-
withdrawn animals. 
Our inability to regulate cystine-glutamate exchange by dopamine receptors in the 
nucleus accumbens core suggests that dopamine does not contribute to diminished 
cystine-glutamate exchange during withdrawal from chronic cocaine. In the following 
chapter we investigate the ability of a novel neuropeptide, pituitary adenylyl cyclase 
activating polypeptide (PACAP) to regulate cystine-glutamate exchange because it has 
previously been shown to regulate glutamate homeostasis in the striatum (Figiel and 
Engele, 2000). 
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CHAPTER 4 
 
 
 
 
Regulation of system xc- by pituitary adenylyl cyclase activating polypeptide
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Introduction 
Glutamate homeostasis is altered following withdrawal from cocaine self-
administration due to reduced cystine-glutamate exchange by system xc- (Pierce et al., 
1996, Baker et al., 2003); which can be attributed in part to reduced expression of xCT, 
the functional subunit of system xc- (Knackstedt et al., 2010). We are interested in 
determining if neurotransmitters and peptides play a role in regulating cystine-glutamate 
exchange. Interestingly, a novel neuropeptide, pituitary adenylyl cyclase activating 
polypeptide (PACAP) is likely co-released with synaptic glutamate based on findings that 
it is produced in the cortex (Mikkelsen et al., 1994, Figiel and Engele, 2000) and is 
colocalized with vesicular glutamate transporter 2 (Engelund et al., 2010). PACAP has 
also been shown to regulate glutamate homeostasis through glutamate transporters such 
as GLT-1 (Figiel and Engele, 2000). Others have found that some treatments leading to 
an increase in GLT-1 expression have also increased expression of cystine-glutamate 
exchange (Knackstedt et al., 2010) 
The aim of this chapter is to determine if PACAP signaling regulates cystine-
glutamate exchange. We examine PACAP regulation of cystine transport in vitro and ex 
vivo. In chapter 3, we were unable to alter cystine-glutamate exchange with receptors 
known to couple to Gi and Gs. However, PAC1 receptors are coupled to Gs or Gq. Gq 
signaling stimulates Ca
2+
-dependent protein kinase (PKC), also previously shown to 
regulate cystine-glutamate exchange (Tang and Kalivas, 2003). Three G-protein coupled 
receptors have relevant affinity for PACAP: PAC1, VPAC1, and VPAC2; with PAC1 
having the highest affinity and selectivity for PACAP (Lam et al., 1990). PAC1 receptor 
signaling is linked to both Gs or Gq mediated signaling (Holighaus et al., 2011). Further, 
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xCT has consensus phosphorylation sites and is regulated by PKA and PKC as shown in 
chapter 2 and previously (Baker et al., 2003, Tang and Kalivas, 2003). Therefore, we 
hypothesize that PAC1R activation increases cystine-glutamate exchange based on its 
ability to stimulate both PKA and PKC activity (Holighaus et al., 2011). 
 
Materials and Methods 
Animals 
All experimental protocols were approved by the Marquette University 
Institutional Animal Care and Use Committee and carried out according to the NIH 
Guide for the Care and Use of Laboratory Animals (revised 1996). 
Rat mixed cortical cultures 
 Mixed cortical cell cultures containing glial and neuronal cells were prepared 
from fetal (15–16 day gestation) rat as previously described (Lobner, 2000), with some 
exceptions.  Dissociated cortical cells were plated on 24-well plates coated with poly-D-
lysine and laminin at a density of ~6x10
5
 cells/well in Neurobasal medium supplemented 
with 10% fetal bovine serum and 1% Glutamax-I (Life Technologies).  Cultures were 
maintained in humidified 5% CO2 incubators at 37 °C. Rats were handled in accordance 
with a protocol approved by our institutional animal care committee and in compliance 
with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. 
All efforts were made to minimize animal suffering and reduce the number of animals 
used. 
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Mouse cortical cultures 
Mixed cortical cell cultures containing glial and neuronal cells were prepared 
from fetal (15–16 day gestation) mice as previously described (Lobner, 2000). 
Dissociated cortical cells were plated on 24-well plates coated with poly-D-lysine and 
laminin in Eagles’ Minimal Essential Medium (MEM, Earle’s salts, supplied glutamine-
free) supplemented with 5% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM 
glutamine and glucose (total 21 mM).  Astrocyte enriched glial cultures were prepared as 
described for mixed cultures except they are from cortical tissue taken from post-natal 
day 1–3 mice (Choi et al., 1987, Schwartz and Wilson, 1992). Cultures were maintained 
in humidified 5% CO2 incubators at 37 °C. Mice were handled in accordance with a 
protocol approved by our institutional animal care committee and in compliance with the 
Public Health Service Policy on Humane Care and Use of Laboratory Animals. All 
efforts were made to minimize animal suffering and reduce the number of animals used. 
Acute regulation of cystine uptake in vitro 
 All experiments were performed in a 37ºC bath.  As illustrated below, rat mixed 
cortical or differentiated striatal astrocyte cultures were washed 3x with 1mL warm 
HEPES buffered saline solution, vacuumed to 150 L, then 250 L of the drug was 
added to bring to the indicated concentration.  Cells incubated for 20 minutes with the 
drug, then a small aliquot, 10 L, of HEPES buffered saline solution was added that 
brought the concentration of [
14
C]cystine (Perkin Elmer, Waltham, MA) and TBOA to 1 
M and 10 M, respectively.  Cells incubated for another 20 minutes.  The uptake 
experiment was rapidly terminated by wash 3x with 1mL of ice-cold PBS, vacuumed dry, 
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and 500 L 0.1% SDS added to solubilize the cells.  Resultant lysate was analyzed by 
scintillation counter and counts were normalized to the mean of the control group. 
 
 
 
 
Long-term regulation of cystine uptake in vitro 
 As illustrated below, mouse cortical cultures cells were treated with indicated 
drugs (; or 0 or 100 nM PACAP) for ~48 hours in growth culture media. For the PACAP 
antagonist (0 or 10 M PACAP6-38) experiment, mixed cortical culture was used. For 
the PACAP38 experiment (0 or 100nM), pure glia were used.  On test days, cells were 
washed 3x with 1mL HEPES buffered saline solution and vacuumed to 150 mL.  Then, 
250 L of HEPES buffered saline solution containing cystine to bring the culture media 
to one of the following concentrations (CC denotes “cold” cystine, CC* denotes 
[
14
C]cystine):  0.1 M (0.1 M CC*), 0.3 M (0.3 M CC*), 1 M (1 M CC*), 3 M 
(1 M CC + 2 M CC*), 10 M (1 M CC + 9 M CC*), or 30 M (3 M CC + 27 M 
CC*) as previously described (Fogal et al., 2007).  Five minutes later, uptake was rapidly 
terminated by washing 3x with 1mL of ice-cold PBS, 250 L of 0.1% SDS was added 
and allowed to solubilize the cells.  175 L was used for scintillation counting and 50 L 
was used for measuring protein by the BCA method. 
 
 
 
3x Wash and drug 
application Cystine application 
3x ice-cold PBS wash, and 
solubilize 
20 minutes 20 minutes 
Drug Application 
3x wash and cystine 
application 
3x ice-cold PBS wash, and 
solubilize 
~48 hours 5 minutes 
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Aliquots of radiolabeled cystine at 0, 1, 3, and 10 pmoles were measured by scintillation 
counter, divided by the cystine content and averaged to determine the specific activity.  
Amount of cystine transport was then determined using the following equation: 
 
([S] = concentration of cold cystine, [S*] = concentration of hot cystine) 
Cystine transport was normalized to protein to yield transport/g protein. 
 In order to measure changes in Km or Vmax, uptake data was converted to a 
Hanes-Woolf plot by plotting velocity/[CC] against [CC].  For Hanes-Woolf plot, 
Vmax=1/slope, and Km= - x-intercept. 
Surgeries 
Rats were implanted with indwelling catheters under ketamine HCl (100 mg/kg, 
IP, Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, IP, Lloyd 
Laboratories, Shenandoah, IA, USA) anesthesia. A silicon tubing catheter (Dow Corning 
Co., Midland, MI; 0.64 mm ID; 1.19 mm OD) was implanted such that it entered the 
jugular vein through the right posterior facial vein and terminated at the right atrium. The 
catheter was sutured to the vein at the entry point. The distal aspect of the catheter, which 
consisted of a 22-gauge guide cannula (Plastics One Inc., Roanoke, VA) attached with 
dental acrylic to a piece of polypropylene monofilament surgical mesh (Atrium Medical, 
Co., Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the experiment, 
catheters were filled daily with a heparin solution (83 i.u./ml; Elkins-Sinn, Inc., Cherry 
Hill, NJ) and capped when disconnected from the leash/delivery line assembly. 
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Cocaine Self-Administration Training 
Self-administration occurred in operant conditioning chambers (ENV-008CT, 
MED-Associates Inc., St Albans, VT, USA) housed in sound attenuating cubicles (ENV-
016M, MED-Associates Inc.) and equipped with two retractable levers, two stimulus 
lights, and a water bottle. At least five days after surgery, rats were food restricted with 
water available ad libitum; food restriction continued for the duration of the experiment 
(e.g., through reinstatement testing) and involved daily administration of 15 grams of rat 
chow in the late afternoon or immediately following an operant session. Rats were then 
placed into the operant conditioning chambers overnight and responses on the lever 
designated as active resulted in the delivery of food pellets under a fixed ratio 1 schedule 
of reinforcement. Daily food training continued until subjects received at least 150 food 
rewards in a session, which typically occurred following the first session. During the 
acquisition phase of the experiment, all rats underwent drug self-administration training 
during daily 2-hr sessions in which operant responses on the active lever were reinforced 
with an infusion of cocaine (0.5 mg/kg/200 μl IV, National Institute on Drug Abuse, 
Bethesda, MD, USA) under a fixed ratio 1 schedule of reinforcement. Each reinforced 
lever response resulted in the illumination of the stimulus light located above the active 
lever and was followed by a 25-s time-out period. Responding on a second, inactive lever 
located on the back wall was recorded but had no programmed consequences. 
Acquisition of cocaine self-administration was operationally defined as < 10% variation 
in daily responding over at least three consecutive sessions. During the maintenance 
phase of the experiment, rats were assigned to self-administer cocaine under high-intake 
conditions (1.0 mg/kg/200 μl IV; 6-hr/day for 11 days). 
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Regulation of cystine-glutamate exchange ex vivo 
 Rats withdrawn from saline or high-intake (1.0 mg/kg/200 mL infusion, i.v., 6 
h/d) cocaine self-administration were decapitated and the brains were rapidly extracted 
and cut into 1 mm coronal slices using a brain matrix. As illustrated below, tissue 
punches (1.25 mm diameter; Stoelting, Wood Dale, IL) were collected from the nucleus 
accumbens core (figure 1-4) and incubated at 37°C for ∼30 min on a nylon bolting cloth 
platform, submerged beneath 2 mm of standard buffer (Lobner and Lipton, 1993); the 
standard buffer contained 124 mM NaCl, 3.0 mM KCl, 1.4 mM KH2PO4, 1.3 mM 
MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4 mM glucose, equilibrated with 95% O2, 
5% CO2, pH 7.4. After a 20 min wash, the tissue was incubated for 20 min in standard 
buffer containing PACAP (0 – 1 nM), or PACAP (0 or 1 nM) and the cystine-glutamate 
exchange blocker sulfasalazine (0 or 500 M).  The tissue was transferred to standard 
buffer containing [
14
C]cystine (1 M). DL-TBOA (10 M) was also added to the 
incubation buffer to prevent uptake via XAG. After 20 min incubation, the tissue punches 
were washed four times in ice-cold PBS and dissolved in 250 μl of 1% SDS. One aliquot 
(175 μl) was used to measure [14C]cystine uptake by scintillation counting; a second 
aliquot (50 μl) was used to assess protein content by the BCA method. 
 
 
 
Statistical analyses 
SPSS software (version 16) was used to perform the statistical analyses. When 
comparing between two treatments, a Student’s t test was performed. Two way analysis 
Tissue extraction Drug application 
Wash and 
solubilize 
20 minute 
equilibration 20 minutes 20 minutes 
Drug and Cystine 
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of variance (ANOVA) was used with more than one between subject factors (such as 
PACAP6-38 and sulfasalazine). Experiments with multiple concentrations of one 
treatment utilized ANOVA. Post hoc comparisons were conducted using t-tests when 
only two data points were compared, or with Tukey HSD with multiple data points. 
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Results 
Regulation of xc- by pituitary adenylyl cyclase activating polypeptide 
We examined the regulation of cystine-glutamate exchange by PACAP. Figure 
4.1 illustrates that exogenous PACAP was not capable of altering [
14
C]cystine uptake in 
mixed cortical cultures from rat 
(ANOVA: F4,39=0.830, p=0.515). 
Because cortical cultures produce 
PACAP endogenously (Figiel and Engele, 
2000), we looked to determine if blocking 
PACAP signaling in vitro would alter 
[
14
C]cystine uptake.  
Figure 4.2a illustrates that acute 
blockade of PAC1Rs with the specific 
antagonist PACAP6-38 reduced cystine-
glutamate exchange (ANOVA: F3,55=14.551, p<0.001). Post hoc analyses reveal a 
significant effect of 10M PACAP6-38 (Tukey HSD, p<0.001). We then looked to 
determine if this decrease in [
14
C]cystine uptake was specific to cystine-glutamate 
exchange. Figure 4.2b illustrates that PACAP signaling regulates [
14
C]cystine uptake by 
system xc-. A two-way ANOVA with PACAP6-38 (0 or 10M) and sulfasalazine (0 or 
500M) as between subjects factors yielded significant main effects of PACAP6-38 
(F1,12=8.190, p<0.05) and SSZ (F1,12=233.707, p<0.001), as well as an interaction 
between the two (F1,12=8.190, p<0.05). Post hoc analyses confirmed a significant effect 
of PACAP6-38 in the absence (t6=2.898, p<0.05), but not the presence of SSZ (t6<0.001, 
Figure 4.1. Acute treatment of PACAP in rat 
mixed cortical cultures does not affect cystine-
glutamate exchange. Primary rat mixed cortical 
cultures were pretreated with PACAP (0 – 100nM) 
and tested for cystine uptake. An ANOVA 
revealed no significant change from control 
(ANOVA: F4,39=0.830, p=0.515). 
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p=1.000). The concentration of PACAP6-38 that induced the significant effect on 
cystine-glutamate exchange is the same as used in a previous publication (Figiel and 
Engele, 2000). 
 
  
Figure 4.2. PACAP Regulates cystine-glutamate exchange. (a) Acute treatment with the PAC1R 
antagonist, PACAP6-38, showed a significant regulation of cystine uptake in rat primary mixed cortical 
cultures (ANOVA: F3,55=14.551, p<0.001; 10M, Tukey HSD, p<0.001). (b) Addition of sulfasalazine (0 
or 500 M) shows PACAP6-38 regulation of cystine-glutamate exchange in ex vivo tissue punches 
(t6=2.898, p<0.05). 
 
Protein Kinase C signaling is necessary for PACAP regulation of cystine-glutamate 
exchange 
Because PAC1 receptors can stimulate PKA and PKC (Holighaus et al., 2011), 
we examined the role of PKA and PKC signaling in PACAP regulation of cystine-
glutamate exchange. Figure 4.3a illustrates that PACAP regulation of cystine-glutamate 
exchange is not dependent on PKA activity. We treated primary culture with PACAP6-38 
(0 or 10M) and the PKA activator dBcAMP (0 or 100M). An ANOVA yielded a 
significant effect of treatment (F3,41=9.749, p<0.001). Post hoc analyses revealed a 
significant effect of PACAP6-38 (Tukey HSD, p<0.001). However, there was no 
significant difference of PACAP6-38 in the presence and absence of dBcAMP (Tukey 
HSD, p=0.084). 
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We also examined the role of PKC on PACAP regulation of cystine-glutamate 
exchange. Figure 4.3b illustrates that PACAP regulation of system xc- activity is 
dependent on protein kinase C (PKC) signaling. We treated primary culture with 
PACAP6-38 (0 or 10M) and the PKC 
activator phorbol 12-myristate 13-acetate 
(PMA; 0 or 1M). An ANOVA yielded a 
significant effect of treatment 
(F3,41=11.573, p<0.001). Post hoc analyses 
revealed a significant decrease with 
PACAP6-38 (Tukey HSD, p<0.05). In 
addition, we measured a significant 
difference in cells treated with PACAP6-
38 in the presence or absence of PMA  
(Tukey HSD, p<0.001). These findings 
suggest that PKC activity is necessary for 
PACAP regulation of system xc-. 
 
 
 
 
 
 
 
Figure 4.3. PACAP regulates cystine-glutamate 
exchange in a PKC-dependent manner. Primary 
rat mixed cortical cultures were pretreated with 
the noted compounds. Pretreatment with the 
PACAP receptor antagonist PACAP6-38 (10M) 
significantly decreased cystine transport. This 
decrease was reversed with the PKC activator 
phorbol 12-myristate 13-acetate (PMA, 100nM), 
but not with the PKA activator dibutyryl cAMP 
(dBcAMP, 100M). *Significant effect from 
control. +Significant effect from PACAP6-38 
alone. 
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PACAP regulation of system xc- activity is altered in cocaine-withdrawn animals 
Acute treatment with PACAP was 
unable to regulate cystine-glutamate 
exchange in culture because of endogenous 
PACAP release. If this is the case, then we 
should be able to appropriately stimulate 
PAC1R in ex vivo tissue punches given that 
afferent corticostriatal pathways are 
denervated. Therefore, we looked to 
determine if PACAP signaling regulates 
system xc- activity in the nucleus 
accumbens core as it does in vitro by acute application of PACAP. Figure 4.4 illustrates 
that PACAP regulates cystine-glutamate exchange in nucleus accumbens core tissue 
punches. A two way ANOVA with PACAP (0 or 1nM) and the cystine-glutamate 
exchange inhibitor sulfasalazine (SSZ, 0 or 500M) as between subjects factors yielded a 
significant main effect of SSZ (F1,19=69.431, p<0.001) as well as an interaction between 
PACAP and SSZ (F1,19=6.874, p<0.05), but no main effect of PACAP (F1,19=1.032, 
p=0.325). When splitting the groups based on SSZ, a t test comparing the PACAP groups 
(0 or 1nM) revealed a significant effect of PACAP in the absence of SSZ (t10=2.563, 
p<0.05), but not in the presence of SSZ (t6=1.374, p=0.218). 
Figure 4.4. PACAP regulates cystine-glutamate 
exchange in the nucleus accumbens core. 
Pretreatment with PACAP (0 or 1nM) and SSZ 
(0 or 500M) showed a significant effect of 
PACAP on [
14
C]cystine transport by system xc- 
in ex vivo tissue punches. *Significant difference 
from control. 
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We then examined the ability of 
PACAP to regulate cystine-glutamate 
exchange in animals withdrawn from 
cocaine self-administration. Pretreatment 
with PACAP resulted in a significant 
effect on [
14
C]cystine transport for drug 
naïve animals (Figure 4.5a; ANOVA: 
F3,42=2.876, p<0.05), but not for cocaine-
withdrawn animals (Figure 4.5b; 
ANOVA: F3,18=1.670, p=0.216). Post hoc 
analyses reveal a significant effect at the 
0.1nM concentration for drug naïve 
animals (Tukey HSD, p<0.05). 
 
 
 
 
 
Tonic PACAP signaling regulates the capacity of cystine-glutamate exchange 
The previous findings show that acute PACAP signaling regulates cystine-
glutamate exchange. However, there is a tonic decrease in cystine-glutamate exchange 
during withdrawal from cocaine self-administration. We are interested in what leads to 
this long-term diminished system xc- activity. In order to determine if a long-term 
Figure 4.5. PACAP regulation of cystine-
glutamate exchange in the nucleus accumbens 
core is diminished in cocaine-withdrawn animals. 
Rats withdrawn from saline (a) or cocaine (b) 
self-administration are represented. Drug naïve 
animals showed increases in cystine transport 
with acute treatment of PACAP (F3,42=2.876, 
p<0.05). Animals withdrawn from cocaine self-
administration did not respond to PACAP 
(F3,18=1.670, p=0.216). *Significant difference 
from control (Tukey HSD, p<0.05). 
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decrease in PACAP signaling leads to 
diminished cystine-glutamate exchange, 
mixed cortical cultures were treated with the 
PAC1R antagonist PACAP6-38 for 48 hours. 
Figure 4.6 illustrates that long-term blockade 
of PACAP signaling results in a decrease in 
cystine-glutamate exchange. A t test yielded a 
significant difference between controls and 
PACAP6-38 (t30=3.287, p<0.001). These 
findings suggest that a decrease in PACAP 
signaling may contribute to diminished basal 
cystine-glutamate exchange in cocaine-
withdrawn animals. 
 We wanted to determine if long-term 
regulation of xc- by PACAP changes the Km 
or Vmax of cystine transport. In order to do 
this, we treated pure glial cultures with 
PACAP for 48 hours and measured the 
kinetic activity of [
14
C]cystine transport. An 
ANOVA with concentration of cystine as a 
repeated measure and PACAP (0 or 100 nM) 
as a between subjects measure yielded a 
significant interaction (figure 4.7a; 
Figure 4.6. Tonic PACAP signaling regulates 
cystine-glutamate exchange. Blocking PAC1R 
receptors for 48 hours in mixed cortical 
culture decreases overall cystine uptake 
(t30=3.287, p<0.001). 
Figure 4.7. Tonic PACAP signaling regulates 
the capacity (Vmax) of cystine-glutamate 
exchange on glia. (a) Plotting [CC] against the 
velocity portrays the raw transport data. (b) 
The Hanes-Woolf plot allows for 
interpretation of the data. 48 hour incubation 
of pure glia by PACAP increases the capacity, 
or Vmax, of the transporter (ANOVA: 
F1,44=4.259, p<0.05). 
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F5,50=2.966, p<0.05). Converting to and analyzing as a Hanes-Woolf plot revealed a 
significant increase in the Vmax (figure 4.7b; ANOVA: F1,44=4.259, p<0.05) with PACAP. 
 
Discussion 
The aim of this chapter was to determine if PACAP signaling regulates cystine-
glutamate exchange. PACAP has been previously shown to regulate glutamate 
homeostasis by stimulating receptors on astrocytes (Figiel and Engele, 2000). In this 
chapter, data is presented suggesting that PACAP also regulates glutamate homeostasis 
by stimulating cystine-glutamate exchange. 
We first found that acute treatment with PACAP in mixed cortical culture was 
unable to alter cystine transport. Interestingly, cortical neurons produce and release 
PACAP in vitro (Figiel and Engele, 2000). Therefore, we hypothesized that blocking 
endogenous PACAP signaling would be able to decrease cystine-glutamate exchange. To 
test this, we treated mixed cortical culture with the selective PAC1R antagonist, 
PACAP6-38 and found this was capable of decreasing cystine transport in mixed cortical 
culture. There is concern that the concentration of PACAP6-38 required (10M) to 
significantly decrease cystine-glutamate exchange is orders of magnitude higher than the 
effective concentrations of PACAP (Holighaus et al., 2011). However, the concentration 
of PACAP6-38 used was identical to that used by others (Figiel and Engele, 2000). In 
addition, our ability to regulate cystine-glutamate exchange in tissue punches from the 
nucleus accumbens core by PACAP further supports our findings. 
Cystine-glutamate exchange is diminished in the nucleus accumbens core of 
cocaine-withdrawn animals (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008), 
contributing to cocaine-seeking. In order to determine if PACAP regulation of system xc- 
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is altered in cocaine-withdrawn animals, we examined the capacity of PACAP to regulate 
cystine-glutamate exchange in tissue punches from the nucleus accumbens core of drug 
naïve and cocaine-withdrawn animals. 
We found that cystine-glutamate exchange in animals withdrawn from high-
intake cocaine self-administration is not regulated by PACAP, whereas it was regulated 
in drug naïve animals. Lack of phasic (acute) regulation does not fully explain the 
decrease in cystine-glutamate exchange we find in ex vivo tissue punches of cocaine-
withdrawn animals, as seen in chapter 1. Therefore, it is likely that diminished tonic 
regulation by PACAP contributes to diminished cystine-glutamate exchange. This 
scenario is highly possible given that animals withdrawn from cocaine self-administration 
exhibit a form of hyprofrontality (Sun and Rebec, 2006), and PACAP is likely co-
released with glutamate from the prefrontal cortex (Mikkelsen et al., 1994, Engelund et 
al., 2010) and possibly explains decreased GLT-1 expression in cocaine-withdrawn 
animals (Knackstedt et al., 2010) given that PACAP regulates GLT-1 expression (Figiel 
and Engele, 2000). Future studies should attempt to restore PACAP signaling in the 
nucleus accumbens core of cocaine-withdrawn animals in an effort to reverse the 
cocaine-induced decrease in cystine-glutamate exchange. In addition, future studies will 
examine the capacity of exogenous stimulation of PAC1R to alter cocaine-primed 
reinstatement in animals that exhibit augmented reinstatement. 
Previous findings suggest that tonic PACAP signaling regulates glutamate 
homeostasis through glutamate transporters (Figiel and Engele, 2000). We found that 
long-term PACAP signaling regulates the maximal capacity of cystine transport in vitro, 
suggesting that basal PACAP contributes to the expression of system xc-. What is 
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unknown is the mechanism by which long-term PACAP signaling regulates cystine-
glutamate exchange. Previous studies have shown that PACAP can be considered a 
neuroprotectant (Onoue et al., 2002, Deguil et al., 2007, Deguil et al., 2010, Botia et al., 
2011, Endo et al., 2011). The aforementioned studies fall short in determining the 
mechanism by which it acts as a neurprotectant. As mentioned previously, it is possible 
that neuronal signaling may contribute to cystine-glutamate exchange, a mechanism by 
which PACAP as a neuroprotectant can maintain system xc-. PACAP regulates cystine-
glutamate exchange, also a neuroprotectant through its eventual formation of the 
antioxidant glutathione (Kranich et al., 1998), therefore it is possible that PACAP-
induced expression of cystine-glutamate is the mechanism by which the neuroprotectant 
is working, though future investigation is warranted. 
Altogether, these findings suggest that PACAP regulates both short- and long-
term activity of cystine-glutamate exchange, and reveals PACAP signaling as a novel 
target for cocaine addiction research. 
PACAP regulation of cystine-glutamate exchange in vitro 
 PACAP has been shown to regulate glutamate homeostasis by increasing glial-
glutamate transport (GLT-1) in vitro (Figiel and Engele, 2000). Interestingly, stimulation 
of PAC1R can lead to downstream effects including increases in cAMP and Ca
2+
 (Tanaka 
et al., 1996, Grimaldi and Cavallaro, 1999, Aoyagi and Takahashi, 2001, Mustafa et al., 
2007), however the PACAP-mediated increases in GLT-1 were found to be protein 
kinase C (PKC) mediated (Figiel and Engele, 2000). PKC is activated by diacyl glycerol 
(DAG) and Ca
2+
 as a result of activation of Gq coupled receptors. This suggests that the 
PACAP-induced increases in GLT-1 expression were calcium mediated. Conversely, 
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others have found that PACAP 
only increases cAMP and not 
Ca
2+
 in astrocytes (Grimaldi and 
Cavallaro, 1999). 
In rat mixed cortical 
culture, we found that PACAP 
was unable to affect cystine 
transport. At first this was 
surprising giving the existing 
presence of PACAP signaling in 
basal mixed cortical cultures 
(Figiel and Engele, 2000). There 
could be two explanations for the inability of PACAP to stimulate cystine transport in 
vitro. First, there is enough basal signaling from neurons in these cultures that the 
concentration of PACAP added was not sufficient to overcome the endogenous signaling; 
though increasing the concentration of PACAP over that used in these experiments would 
lose specificity for the PAC1 receptor. Second, there may be intrinsic activity of the 
PAC1R that could not be overcome by adding more PACAP but could only be affected 
by the antagonist. 
Pretreatment with the selective PAC1R antagonist, PACAP6-38 significantly 
decreased cystine transport in these cultures by affecting PKC signaling (figure 4.3b). At 
this point, we do not know if PACAP-induced activation of PKC acts directly on system 
xc- or through an intermediary. Future studies in our lab will look to determine if xCT, 
Figure 4.8. PACAP regulates system xc- through PKC. 
PAC1Rs activates Gq signaling, stimulating phospholipase 
C (PLC). PLC produces inositol trisphosphate (IP3) and 
diacylglycerol (DAG) membrane lipids. IP3 induces release 
of Ca
2+
 from intracellular stores such as the endoplasmic 
reticulum (ER). Ca
2+
 and DAG activate protein kinase C 
(PKC). PKC increases activity of cystine-glutamate 
exchange. PLC, phospholipase C; IP3, inositol 
trisphosphate; ER, endoplasmic reituculum; DAG, diacyl 
glycerol; PKC, protein kinase C; AC, adenylyl cyclase; 
PKA, protein kinase A. 
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the functional subunit of system xc- is directly phosphorylated. To do this, point 
mutations at putative phosphorylation sites for xCT will be developed. The Mutated 
cDNA can then be transfected into a cell line that lacks significant levels of xCT such as 
neurons or HEK293 cells (Shih and Murphy, 2001). This method will allow the 
investigator to determine changes in both trafficking and kinetics, potentially revealing 
more novel and therapeutic targets for the treatment of cocaine addiction. 
Altered Regulation of xc- by PACAP in Cocaine-withdrawn Animals 
Cystine-glutamate exchange is diminished in the nucleus accumbens core of 
animals withdrawn from cocaine self-administration (Baker et al., 2003, Moran et al., 
2005, Moussawi et al., 2011b). We looked to determine if cystine-glutamate exchange is 
regulated by PACAP in drug naïve and cocaine-withdrawn animals. In ex vivo tissue 
punches, synaptic signaling is absent due to denervation of the efferent pathways; 
therefore, applying PACAP should have an effect on the PAC1R without the concern of 
overcoming endogenous PACAP signaling. We found that acute application of PACAP 
to ex vivo tissue punches from the nucleus accumbens core was able to significantly 
increase cystine-glutamate exchange in drug naïve but not cocaine-withdrawn animals. 
It is possible that diminished PACAP regulation of cystine-glutamate exchange in 
cocaine-withdrawn animals may be due to diminished PACAP release. However, 
currently technology does not allow for accurate measurement of extracellular PACAP in 
the brain. In this experimental model, however, the neurons that project PACAP to the 
nucleus accumbens core are denervated, effectively eliminating endogenous PACAP 
signaling. Therefore, altered receptor signaling, either through receptor expression or 
signaling pathways, likely contributes to this effect. Further, PAC1 receptors are 
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expressed both on neurons and astrocytes (Grimaldi and Cavallaro, 1999), making it 
difficult to identify the source of PACAP regulation of cystine-glutamate exchange. As 
mentioned in chapter 3, it is possible that receptor activation on neurons could lead to 
regulation of cystine-glutamate exchange. Further studies may reveal the ability to 
differentially measure the expression of the receptor on neurons and astrocytes, which 
could allow an experimenter to further investigate the contribution of cocaine to altered 
PACAP signaling. 
 Pituitary adenylyl cyclase activating polypeptide (PACAP) regulates glutamate 
homeostasis by maintaining glial glutamate transport (Figiel and Engele, 2000) and 
cystine-glutamate exchange, as shown in this chapter. Animals withdrawn from cocaine 
self-administration show diminished cystine-glutamate exchange and basal extracellular 
glutamate in the nucleus accumbens (Baker et al., 2003, Moran et al., 2005, Kau et al., 
2008, Moussawi et al., 2011b). Though PACAP regulated cystine-glutamate exchange in 
the nucleus accumbens core of drug naïve animals, cocaine-withdrawn animals did not 
exhibit that effect. This suggests that basal extracellular glutamate is regulated in an acute 
manner by PACAP. Our findings are novel in that acute regulation of cystine-glutamate 
exchange is rarely investigated, PACAP regulation of cystine-glutamate exchange has 
never been reported, and certainly the deficit found in PACAP signaling in cocaine-
withdrawn animals has never been discovered. 
Figiel and Engele (2000) increased glial glutamate transport by long-term 
application of PACAP. We wanted to determine if system xc- responds in the same 
manner. Just as with glial glutamate transport, we found that 48 hour treatment of the 
PAC1R antagonist, PACAP6-38 led to a decrease in cystine transport in mixed culture. 
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To investigate further, we applied PACAP to pure glial cultures for 48 hours. Though 
there was no change in the binding affinity, Km, we did find a significant increase in the 
full efficacy, or Vmax. These findings suggest that PACAP signaling plays an extremely 
important role in glutamate homeostasis due to the fact that it regulates both the source of 
extrasynaptic, nonvesicular glutamate as well as the mechanism for clearance (Figiel and 
Engele, 2000). This likely effects the regulation of synaptic transmission as cystine-
glutamate exchange regulates synaptic release (Baker et al., 2002), and that glutamate 
transport is necessary for synaptic clearance and maintaining the distinct pools of 
extracellular glutamate (Danbolt, 2001). 
 Chapter 1 showed that amount of cocaine-intake leads to differing levels of 
neuroplasticity. For example, animals withdrawn from high-intake cocaine self-
administration exhibited augmented extracellular dopamine in the nucleus accumbens 
after a cocaine injection when compared to animals withdrawn from low-intake cocaine. 
It was mentioned earlier that these conditions reveal a more accurate assessment of 
neuroplasticity following chronic cocaine. The current studies compared drug naïve and 
animals withdrawn from high-intake cocaine self-administration, therefore it may prove 
valuable to repeat the current study to include animals withdrawn from low-intake 
cocaine self-administration conditions. 
Historically, investigators have suggested that corticostriatal pathways regulate 
extracellular dopamine by targeting presynaptic terminals of midbrain dopaminergic 
neurons directly (Stewart, 2000, Schmidt et al., 2005, Thomas et al., 2008). Our findings 
suggest that a novel method of regulating dopamine release may converge at cystine-
glutamate exchange. Not much is known as to the contribution of hypofrontality to the 
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neuropathology of addiction. We find that PACAP regulates cystine-glutamate exchange 
both tonic and acutely. As well, cystine-glutamate exchange regulates dopamine release, 
which contributes to elevated reinstatement. Therefore, diminished corticostriatal, and 
therefore PACAP signaling may contribute to augmented dopamine and relapse 
vulnerability. 
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CHAPTER 5 
DISCUSSION 
Compulsive cocaine seeking emerges after chronic use that is thought to be the 
direct result of drug-induced plasticity (Hyman and Malenka, 2001, Pierce and 
Vanderschuren, 2010). Cystine-glutamate exchange has been previously identified as a 
mechanism effected by chronic cocaine and contributes to multiple aspects of addiction 
(Baker et al., 2003, Moran et al., 2005, Kau et al., 2008, Moussawi et al., 2011b). 
Interestingly, previous studies have found that targeting cystine-glutamate exchange an 
effective treatment for drug craving in humans (Baker et al., 2003, Moran et al., 2005, 
Kau et al., 2008, Moussawi et al., 2011b). The purpose of the experiments in this 
dissertation was to better understand cystine-glutamate exchange by system xc- in terms 
of the impact that diminished cystine-glutamate exchange has on behaviors used to model 
cocaine addiction, and its regulation at the cellular level to begin to understand how it 
may be reduced following repeated cocaine. Our primary findings were the following: 
 Decreased basal extracellular glutamate due to diminished cystine-
glutamate exchange contributes to augmented cocaine-evoked dopamine 
and heightened relapse vulnerability 
 D1-like dopamine receptors regulate system xc- activity in mixed cortical 
culture, but not tissue punches from the nucleus accumbens core 
 PACAP acutely regulates cystine-glutamate exchange both in mixed 
cortical culture and in tissue punches from the nucleus accumbens core 
 In animals withdrawn from cocaine self-administration, PACAP does not 
regulate system xc- activity 
 Long-term PACAP signaling regulates the maximal capacity of system xc- 
suggesting a source of diminished cystine-glutamate exchange in cocaine 
withdrawn animals 
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Diminished system xc- contributes to relapse vulnerability 
We found that diminished cystine-glutamate exchange led to neuroplasticity and 
cocaine-seeking following withdrawal from cocaine self-administration. By manipulating 
conditions that restore basal glutamate and functional cystine-glutamate exchange, we 
were able to determine the contribution of altered extracellular glutamate in cocaine-
primed reinstatement. Our findings show that diminished basal glutamate due to 
diminished cystine-glutamate exchange is essential to cocaine-primed reinstatement and 
cocaine-evoked extracellular glutamate. 
Glutamate release into the nucleus accumbens core is necessary for cocaine-
primed reinstatement (McFarland et al., 2003), therefore we hypothesized that animals 
exhibiting augmented cocaine-primed reinstatement would also show elevated cocaine-
evoked extracellular glutamate. However, we did not detect a difference in cocaine-
evoked glutamate despite the fact that animals receiving high-intake cocaine had 
diminished cystine-glutamate exchange. A possible explanation for this is findings by 
others that suggest uncoupling of presynaptic inhibitory Group II autorceptors in the 
nucleus accumbens core (Xi et al., 2002b). Conversely, we did find elevated cocaine-
evoked dopamine in animals that consumed higher levels of cocaine. This was surprising 
as glutamate (McFarland et al., 2003) but not dopamine (McFarland and Kalivas, 2001, 
Anderson et al., 2003) is necessary for cocaine-primed reinstatement. Further, acute 
stimulation of cystine-glutamate exchange with N-acetylcysteine reversed the augmented 
cocaine-evoked dopamine response as well as decreased reinstatement. This suggests that 
diminished cystine-glutamate exchange contributes to augmented cocaine-evoked 
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dopamine. While glutamate signaling is necessary for cocaine-primed reinstatement, 
these findings reveal dopamine as a likely contributor to heightened relapse vulnerability. 
Diminished cystine-glutamate exchange in cocaine-withdrawn animals: contribution of 
dysregulation by neurotransmission 
 In chapter 3, we examined the ability of dopamine to regulate cystine-glutamate 
exchange given that animals exhibiting augmented dopamine signaling also show 
heightened reinstatement. We did find a significant increase in [
14
C]cystine transport in 
mixed cortical cultures treated with a D1-like receptor agonist. However, we found no 
regulation of cystine-glutamate exchange in nucleus accumbens core tissue punches by a 
D1-like dopamine receptor agonist. The differential regulation of system xc- by D1 
receptors was not expected. However, in tissue punches corticostriatal projections are 
eliminated, whereas in mixed cortical cultures cortical neuronal signaling remains intact. 
Therefore, it is possible that there is a contribution of dopamine regulation of 
corticostriatal signaling that regulates cystine-glutamate exchange. In support of this, 
findings by others suggest that acute stimulation of the prefrontal cortex by BDNF both 
restores basal glutamate in the nucleus accumbens and reduces cocaine seeking in 
cocaine-withdrawn animals (Berglind et al., 2007, Berglind et al., 2009). Our findings 
suggests the scenario that corticostriatal signaling regulates cystine-glutamate exchange, 
a phenomenon that could not be parsed out in a 1mm tissue punch from the nucleus 
accumbens core. Future experiments should investigate D1-like receptor stimulation in 
the prefrontal cortex and its contribution to cystine-glutamate exchange in the nucleus 
accumbens core. This idea is significant due to the fact that we showed regulation of 
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system xc- by the cortical derived neuropeptide pituitary adenylyl cyclase activating 
polypeptide (PACAP). 
In addition to investigating regulation of xc- by D1-like dopamine receptors, we 
also looked into regulation by D2-like receptors. We were unable to alter system xc- 
activity by stimulating D2-like dopamine receptors in vitro even though these receptors 
are Gi-linked and we were able to decrease cystine-glutamate exchange by inhibiting 
PKA activity in glioma culture. 
We also wanted to determine if nonspecific dopamine signaling regulates cystine-
glutamate exchange. Oxidative stress is capable of increasing system xc- activity (Allen et 
al., 2002, Dun et al., 2006, Lewerenz et al., 2006). Therefore, we considered the 
possibility that dopamine may regulate cystine-glutamate exchange by non-receptor 
mediated mechanisms such as oxidative stress through metabolism or auto-oxidation 
(Rabinovic and Hastings, 1998, LaVoie and Hastings, 1999). However, dopamine alone 
lacked an effect on cystine transport ex vivo. Taking into account that dopamine can be 
inactivated through metabolism or uptake, we also tested apomorphine because it is a 
nonspecific dopamine receptor agonist that is not susceptible to normal metabolism. We 
did not find altered cystine-glutamate exchange in the presence of apomorphine. Further, 
there exists D1-D2 dopamine receptor heterodimers that are Gq-linked (Rashid et al., 
2007), and binding of both the D1 and D2 receptor subunit is necessary for the 
downstream Ca
2+
 response. In support of our design, apomorphine is capable of binding 
to both receptor subtypes, suggesting that the heterodimer does not regulate cystine-
glutamate exchange 
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We then decided to investigate a pituitary adenylyl cyclase activating polypeptide 
(PACAP) as a potential regulator of cystine-glutamate exchange. PACAP is likely co-
released with glutamate based on the facts that it colocalizes with vesicular glutamate 
transporter 2 (VGLUT2) (Engelund et al., 2010) and that PACAP is produced in regions 
with glutamate projecting neurons such as the cortex (Mikkelsen et al., 1994, Figiel and 
Engele, 2000). As well, PACAP signaling regulates glutamate homeostasis by increasing 
glial glutamate transporter expression through a PKC-dependent mechanism (Figiel and 
Engele, 2000). We found that PACAP did indeed regulate system xc- activity in mixed 
cortical cultures and tissue punches from the nucleus accumbens core, an effect 
dependent on PKC activity. More importantly, we found that cystine-glutamate exchange 
in the nucleus accumbens core of animals withdrawn from cocaine self-administration 
did not exhibit regulation of cystine-glutamate exchange by PACAP. These findings 
suggest that cystine-glutamate exchange is dysregulated by altered PACAP signaling in 
animals withdrawn from chronic cocaine. 
As mentioned previously, PACAP mediates glutamate homeostasis by tonic 
regulation of GLT-1 function (Figiel and Engele, 2000). Interestingly, GLT-1 function 
has been previously shown diminished in the nucleus accumbens core of animals 
withdrawn from cocaine self-administration (Knackstedt et al., 2010). In the mentioned 
study, treatment with the -lactam antibiotic, ceftriaxone restored GLT-1 and system xc- 
in cocaine-withdrawn animals, suggesting that expression of GLT-1 and cystine-
glutamate exchange are linked. Because PACAP tonically regulates GLT-1 function, we 
hypothesized that it also tonically regulates cystine-glutamate exchange. We found that 
long-term blockade of PACAP signaling in mixed cortical cultures that endogenously 
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produce PACAP resulted in a decreased in system xc- activity. We then looked to 
determine if long-term PACAP signaling regulates cystine-glutamate exchange 
particularly on astrocytes. When treating glial cultures with PACAP for 48 hours, we 
measured an increase in the maximal capacity of cystine-glutamate exchange. 
Pituitary adenylyl cyclase activating polypeptide (PACAP) and its contribution to altered 
neurotransmission 
PACAP is a novel neuropeptide likely co-released with synaptic glutamate in the 
nucleus accumbens core due to the fact that PACAP mRNA is found in regions that 
produce PACAP (Mikkelsen et al., 1994), is colabeled with vesicular glutamate 
transporter 2 (VGLUT2) (Engelund et al., 2010), and PAC1 receptors are found in the 
nucleus accumbens (Hannibal, 2002). This is significant because we found that PACAP 
regulates cystine-glutamate exchange in mixed cortical culture in a PKC-dependent 
manner. Given that cystine-glutamate exchange is diminished in the nucleus accumbens 
core in animals withdrawn from cocaine self-administration, we looked to determine if 
PACAP regulates system xc- activity in the nucleus accumbens core. We found that 
PACAP does regulate cystine-glutamate in the nucleus accumbens core. Interestingly, we 
found that PACAP regulation of cystine-glutamate exchange is diminished in animals 
withdrawn from cocaine self-administration. 
Hypofrontality is a phenomenon described by decreased basal activity of the 
frontal cortical regions of the brain during a disorder such as cocaine addiction (Sun and 
Rebec, 2006) and schizophrenia (Jacquy et al., 1976, Buchsbaum and Wu, 1987). 
Interestingly, system xc- is diminished in both disorders (Baker et al., 2003, Baker et al., 
2008). As mentioned previously, PACAP derives from cortical regions and is likely co-
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released with synaptic glutamate. Therefore, if PACAP signaling is diminished due to 
hypofrontality, one may expect this is a major contributor to the decrease found in 
cystine-glutamate exchange (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008, 
Knackstedt et al., 2010, Moussawi et al., 2011b) and GLT-1 (Knackstedt et al., 2010) in 
cocaine-withdrawn animals. Investigators may also benefit from investigation of PACAP 
signaling in the neuropathology of schizophrenia. 
PAC1 receptors are both Gs- and Gq-coupled (Holighaus et al., 2011). However, 
we found that PACAP regulation of cystine-glutamate exchange is a PKC-dependent 
effect, implicating a Gq-coupled mechanism. In addition, we were unable to regulate 
system xc- activity by a Gs-coupled receptor such as D1-like dopamine receptors. This is 
in line with previous findings that PACAP regulation of GLT-1 expression is dependent 
on PKC signaling. Another metabotropic receptor that is also coupled to Gq and is found 
on astrocytes is Group I metabotropic glutamate receptors, specifically mGluR5. If 
hypofrontality contributes to altered glutamate homeostasis due to diminished activation 
of PAC1 receptors, it is likely that diminished basal glutamate, both synaptic and through 
cystine-glutamate exchange, is insufficient to stimulate mGluR5. Therefore, future 
studies should investigate other Gq-coupled receptors, in particular mGluR5, and their 
role in altered glutamate homeostasis. 
System xc-: a novel convergence of corticostriatal and midbrain dopaminergic signaling 
Historically, investigators have suggested that corticostriatal pathways regulate 
extracellular dopamine by targeting presynaptic terminals of midbrain dopaminergic 
neurons directly (Stewart, 2000, Schmidt et al., 2005, Thomas et al., 2008). Our findings 
suggest that a novel method of regulating dopamine release may converge at cystine-
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glutamate exchange. Until now, not much is known as to the contribution of 
hypofrontality to the neuropathology of addiction. We find that the cortical-derived 
neuropeptide, PACAP regulates cystine-glutamate exchange both tonic and acutely. As 
well, cystine-glutamate exchange regulates dopamine release, which contributes to 
elevated reinstatement. Therefore, diminished corticostriatal signaling, in part through 
PACAP, may contribute to augmented dopamine release into the nucleus accumbens core 
and heightened relapse vulnerability. 
  
110 
 
BIBLIOGRAPHY 
 
 
Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change 
in hedonic set point. Science 282:298-300. 
Ahmed SH, Lin D, Koob GF, Parsons LH (2003) Escalation of cocaine self-
administration does not depend on altered cocaine-induced nucleus accumbens 
dopamine levels. Journal of neurochemistry 86:102-113. 
Allen JW, Shanker G, Tan KH, Aschner M (2002) The consequences of methylmercury 
exposure on interactive functions between astrocytes and neurons. Neurotoxicology 
23:755-759. 
Alleweireldt AT, Weber SM, Kirschner KF, Bullock BL, Neisewander JL (2002) 
Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of 
extinguished cocaine-seeking behavior in rats. Psychopharmacology 159:284-293. 
Amen SL, Piacentine LB, Ahmad ME, Li SJ, Mantsch JR, Risinger RC, Baker DA 
(2011) Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving 
in cocaine-dependent humans. Neuropsychopharmacology : official publication of 
the American College of Neuropsychopharmacology 36:871-878. 
Anderson SM, Bari AA, Pierce RC (2003) Administration of the D1-like dopamine 
receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates 
cocaine priming-induced reinstatement of drug-seeking behavior in rats. 
Psychopharmacology 168:132-138. 
Aoyagi K, Takahashi M (2001) Pituitary adenylate cyclase-activating polypeptide 
enhances Ca(2+)-dependent neurotransmitter release from PC12 cells and cultured 
cerebellar granule cells without affecting intracellular Ca(2+) mobilization. 
Biochemical and biophysical research communications 286:646-651. 
Araque A, Li N, Doyle RT, Haydon PG (2000) SNARE protein-dependent glutamate 
release from astrocytes. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 20:666-673. 
Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C (1991) Tissue 
distribution of PACAP as determined by RIA: highly abundant in the rat brain and 
testes. Endocrinology 129:2787-2789. 
111 
 
Arnold JM, Roberts DC (1997) A critique of fixed and progressive ratio schedules used 
to examine the neural substrates of drug reinforcement. Pharmacology, 
biochemistry, and behavior 57:441-447. 
Bachtell RK, Whisler K, Karanian D, Self DW (2005) Effects of intra-nucleus 
accumbens shell administration of dopamine agonists and antagonists on cocaine-
taking and cocaine-seeking behaviors in the rat. Psychopharmacology 183:41-53. 
Baker DA, Madayag A, Kristiansen LV, Meador-Woodruff JH, Haroutunian V, Raju I 
(2008) Contribution of cystine-glutamate antiporters to the psychotomimetic effects 
of phencyclidine. Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology 33:1760-1772. 
Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW (2003) 
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nature 
neuroscience 6:743-749. 
Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW (2002) The origin and neuronal 
function of in vivo nonsynaptic glutamate. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 22:9134-9141. 
Balster RL, Bigelow GE (2003) Guidelines and methodological reviews concerning drug 
abuse liability assessment. Drug and alcohol dependence 70:S13-40. 
Bannai S (1986) Exchange of cystine and glutamate across plasma membrane of human 
fibroblasts. The Journal of biological chemistry 261:2256-2263. 
Basarsky TA, Feighan D, MacVicar BA (1999) Glutamate release through volume-
activated channels during spreading depression. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 19:6439-6445. 
Baskys A, Malenka RC (1991) Agonists at metabotropic glutamate receptors 
presynaptically inhibit EPSCs in neonatal rat hippocampus. The Journal of 
physiology 444:687-701. 
Baylis GC, Moore BO (1994) Hippocampal lesions impair spatial response selection in 
the primate. Experimental brain research Experimentelle Hirnforschung 
Experimentation cerebrale 98:110-118. 
112 
 
Baylis GC, Moore BO (1996) Hippocampal lesions cause forgetting in a spatial response 
task. The European journal of neuroscience 8:853-860. 
Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of 
dopamine receptors. Pharmacological reviews 63:182-217. 
Ben-Shahar O, Keeley P, Cook M, Brake W, Joyce M, Nyffeler M, Heston R, Ettenberg 
A (2007) Changes in levels of D1, D2, or NMDA receptors during withdrawal from 
brief or extended daily access to IV cocaine. Brain research 1131:220-228. 
Berendse HW, Galis-de Graaf Y, Groenewegen HJ (1992) Topographical organization 
and relationship with ventral striatal compartments of prefrontal corticostriatal 
projections in the rat. The Journal of comparative neurology 316:314-347. 
Berendse HW, Groenewegen HJ (1990) Organization of the thalamostriatal projections in 
the rat, with special emphasis on the ventral striatum. The Journal of comparative 
neurology 299:187-228. 
Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW, Jr., Miller SW, McGinty JF 
(2007) A BDNF infusion into the medial prefrontal cortex suppresses cocaine 
seeking in rats. The European journal of neuroscience 26:757-766. 
Berglind WJ, Whitfield TW, Jr., LaLumiere RT, Kalivas PW, McGinty JF (2009) A 
single intra-PFC infusion of BDNF prevents cocaine-induced alterations in 
extracellular glutamate within the nucleus accumbens. The Journal of neuroscience 
: the official journal of the Society for Neuroscience 29:3715-3719. 
Botia B, Jolivel V, Burel D, Le Joncour V, Roy V, Naassila M, Benard M, Fournier A, 
Vaudry H, Vaudry D (2011) Neuroprotective effects of PACAP against ethanol-
induced toxicity in the developing rat cerebellum. Neurotoxicity research 19:423-
434. 
Bradberry CW, Roth RH (1989) Cocaine increases extracellular dopamine in rat nucleus 
accumbens and ventral tegmental area as shown by in vivo microdialysis. 
Neuroscience letters 103:97-102. 
Bradley SR, Standaert DG, Levey AI, Conn PJ (1999) Distribution of group III mGluRs 
in rat basal ganglia with subtype-specific antibodies. Annals of the New York 
Academy of Sciences 868:531-534. 
113 
 
Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman 
JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE 
(1997) Acute effects of cocaine on human brain activity and emotion. Neuron 
19:591-611. 
Brito VI, Rozanski VE, Beyer C, Kuppers E (2009) Dopamine regulates the expression of 
the glutamate transporter GLT1 but not GLAST in developing striatal astrocytes. 
Journal of molecular neuroscience : MN 39:372-379. 
Brog JS, Salyapongse A, Deutch AY, Zahm DS (1993) The patterns of afferent 
innervation of the core and shell in the "accumbens" part of the rat ventral striatum: 
immunohistochemical detection of retrogradely transported fluoro-gold. The 
Journal of comparative neurology 338:255-278. 
Buchsbaum MS, Wu JC (1987) Hypofrontality in schizophrenia as assessed by PET. The 
American journal of psychiatry 144:122-123. 
Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, 
Borrelli E (2002) Role of dopamine D2-like receptors in cocaine self-
administration: studies with D2 receptor mutant mice and novel D2 receptor 
antagonists. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 22:2977-2988. 
Carlezon WA, Jr., Devine DP, Wise RA (1995) Habit-forming actions of nomifensine in 
nucleus accumbens. Psychopharmacology 122:194-197. 
Cerruti C, Pilotte NS, Uhl G, Kuhar MJ (1994) Reduction in dopamine transporter 
mRNA after cessation of repeated cocaine administration. Brain research Molecular 
brain research 22:132-138. 
Choi DW, Maulucci-Gedde M, Kriegstein AR (1987) Glutamate neurotoxicity in cortical 
cell culture. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 7:357-368. 
Churchill L, Kalivas PW (1994) A topographically organized gamma-aminobutyric acid 
projection from the ventral pallidum to the nucleus accumbens in the rat. The 
Journal of comparative neurology 345:579-595. 
Clark R, Schuster CR, Brady JV (1961) Instrumental conditioning of jugular self-infusion 
in the rhesus monkey. Science 133:1829-1830. 
114 
 
Cochilla AJ, Alford S (1998) Metabotropic glutamate receptor-mediated control of 
neurotransmitter release. Neuron 20:1007-1016. 
Cornish JL, Duffy P, Kalivas PW (1999) A role for nucleus accumbens glutamate 
transmission in the relapse to cocaine-seeking behavior. Neuroscience 93:1359-
1367. 
Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens 
mediates relapse in cocaine addiction. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 20:RC89. 
Crippa D, Schenk U, Francolini M, Rosa P, Verderio C, Zonta M, Pozzan T, Matteoli M, 
Carmignoto G (2006) Synaptobrevin2-expressing vesicles in rat astrocytes: insights 
into molecular characterization, dynamics and exocytosis. The Journal of 
physiology 570:567-582. 
D'Ascenzo M, Fellin T, Terunuma M, Revilla-Sanchez R, Meaney DF, Auberson YP, 
Moss SJ, Haydon PG (2007) mGluR5 stimulates gliotransmission in the nucleus 
accumbens. Proceedings of the National Academy of Sciences of the United States 
of America 104:1995-2000. 
Dackis CA (2004) Recent advances in the pharmacotherapy of cocaine dependence. 
Current psychiatry reports 6:323-331. 
Danbolt NC (2001) Glutamate uptake. Progress in neurobiology 65:1-105. 
Das M, Vihlen CS, Legradi G (2007) Hypothalamic and brainstem sources of pituitary 
adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic 
paraventricular nucleus in the rat. The Journal of comparative neurology 500:761-
776. 
De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ (1998) 
Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following 
long-term extinction is associated with expression of behavioural sensitization. The 
European journal of neuroscience 10:3565-3571. 
De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ (1999) Dopaminergic 
mechanisms mediating the incentive to seek cocaine and heroin following long-
term withdrawal of IV drug self-administration. Psychopharmacology 143:254-260. 
115 
 
Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M (2010) Interaction of 
glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats 
and mice. Pharmacology, biochemistry, and behavior 97:293-300. 
Dean O, Giorlando F, Berk M (2011) N-acetylcysteine in psychiatry: current therapeutic 
evidence and potential mechanisms of action. Journal of psychiatry & neuroscience 
: JPN 36:78-86. 
Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M (2009) A 
role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? 
Animal models and relevance to clinical practice. Current medicinal chemistry 
16:2965-2976. 
Deguil J, Chavant F, Lafay-Chebassier C, Perault-Pochat MC, Fauconneau B, Pain S 
(2010) Neuroprotective effect of PACAP on translational control alteration and 
cognitive decline in MPTP parkinsonian mice. Neurotoxicity research 17:142-155. 
Deguil J, Jailloux D, Page G, Fauconneau B, Houeto JL, Philippe M, Muller JM, Pain S 
(2007) Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide 
(PACAP) in MPP+-induced alteration of translational control in Neuro-2a 
neuroblastoma cells. Journal of neuroscience research 85:2017-2025. 
Di Ciano P, Robbins TW, Everitt BJ (2008) Differential effects of nucleus accumbens 
core, shell, or dorsal striatal inactivations on the persistence, reacquisition, or 
reinstatement of responding for a drug-paired conditioned reinforcer. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 33:1413-1425. 
Dugan LL, Bruno VM, Amagasu SM, Giffard RG (1995) Glia modulate the response of 
murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
15:4545-4555. 
Dumont NL, Andersen SL, Thompson AP, Teicher MH (2004) Transient dopamine 
synthesis modulation in prefrontal cortex: in vitro studies. Brain research 
Developmental brain research 150:163-166. 
Dun Y, Mysona B, Van Ells T, Amarnath L, Ola MS, Ganapathy V, Smith SB (2006) 
Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and 
regulation by nitric oxide and oxidative stress. Cell and tissue research 324:189-
202. 
116 
 
Endo K, Nakamachi T, Seki T, Kagami N, Wada Y, Nakamura K, Kishimoto K, Hori M, 
Tsuchikawa D, Shinntani N, Hashimoto H, Baba A, Koide R, Shioda S (2011) 
Neuroprotective effect of PACAP against NMDA-induced retinal damage in the 
mouse. Journal of molecular neuroscience : MN 43:22-29. 
Engelund A, Fahrenkrug J, Harrison A, Hannibal J (2010) Vesicular glutamate 
transporter 2 (VGLUT2) is co-stored with PACAP in projections from the rat 
melanopsin-containing retinal ganglion cells. Cell and tissue research 340:243-255. 
Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after 
prolonged extinction and a drug-free period. Psychopharmacology 128:408-412. 
Figiel M, Engele J (2000) Pituitary adenylate cyclase-activating polypeptide (PACAP), a 
neuron-derived peptide regulating glial glutamate transport and metabolism. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
20:3596-3605. 
Floresco SB, Todd CL, Grace AA (2001) Glutamatergic afferents from the hippocampus 
to the nucleus accumbens regulate activity of ventral tegmental area dopamine 
neurons. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 21:4915-4922. 
Floresco SB, West AR, Ash B, Moore H, Grace AA (2003) Afferent modulation of 
dopamine neuron firing differentially regulates tonic and phasic dopamine 
transmission. Nature neuroscience 6:968-973. 
Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ (2007) System x(c)- activity and 
astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. 
The Journal of neuroscience : the official journal of the Society for Neuroscience 
27:10094-10105. 
Fuchs RA, Branham RK, See RE (2006) Different neural substrates mediate cocaine 
seeking after abstinence versus extinction training: a critical role for the dorsolateral 
caudate-putamen. The Journal of neuroscience : the official journal of the Society 
for Neuroscience 26:3584-3588. 
Fujii H, Ishihama T, Ago Y, Shintani N, Kakuda M, Hashimoto H, Baba A, Matsuda T 
(2007) Methamphetamine-induced hyperactivity and behavioral sensitization in 
PACAP deficient mice. Peptides 28:1674-1679. 
117 
 
Gomes AR, Cunha P, Nuriya M, Faro CJ, Huganir RL, Pires EV, Carvalho AL, Duarte 
CB (2004) Metabotropic glutamate and dopamine receptors co-regulate AMPA 
receptor activity through PKA in cultured chick retinal neurones: effect on GluR4 
phosphorylation and surface expression. Journal of neurochemistry 90:673-682. 
Goto Y, Grace AA (2005) Dopaminergic modulation of limbic and cortical drive of 
nucleus accumbens in goal-directed behavior. Nature neuroscience 8:805-812. 
Grimaldi M, Cavallaro S (1999) Functional and molecular diversity of PACAP/VIP 
receptors in cortical neurons and type I astrocytes. The European journal of 
neuroscience 11:2767-2772. 
Groenewegen HJ, Berendse HW, Haber SN (1993) Organization of the output of the 
ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience 
57:113-142. 
Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH (1990) The anatomical 
relationship of the prefrontal cortex with the striatopallidal system, the thalamus 
and the amygdala: evidence for a parallel organization. Progress in brain research 
85:95-116; discussion 116-118. 
Groenewegen HJ, Vermeulen-Van der Zee E, te Kortschot A, Witter MP (1987) 
Organization of the projections from the subiculum to the ventral striatum in the rat. 
A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. 
Neuroscience 23:103-120. 
Gubellini P, Saulle E, Centonze D, Costa C, Tropepi D, Bernardi G, Conquet F, Calabresi 
P (2003) Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 
Neuropharmacology 44:8-16. 
Guo N, Guo W, Kralikova M, Jiang M, Schieren I, Narendran R, Slifstein M, Abi-
Dargham A, Laruelle M, Javitch JA, Rayport S (2010) Impact of D2 receptor 
internalization on binding affinity of neuroimaging radiotracers. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 35:806-817. 
Hannibal J (2002) Pituitary adenylate cyclase-activating peptide in the rat central nervous 
system: an immunohistochemical and in situ hybridization study. The Journal of 
comparative neurology 453:389-417. 
118 
 
Hannibal J, Mikkelsen JD, Clausen H, Holst JJ, Wulff BS, Fahrenkrug J (1995a) Gene 
expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat 
hypothalamus. Regulatory peptides 55:133-148. 
Hannibal J, Mikkelsen JD, Fahrenkrug J, Larsen PJ (1995b) Pituitary adenylate cyclase-
activating peptide gene expression in corticotropin-releasing factor-containing 
parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by 
colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. 
Endocrinology 136:4116-4124. 
Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, Sakaue M, 
Miyazaki J, Niwa H, Tashiro F, Yamamoto K, Koga K, Tomimoto S, Kunugi A, 
Suetake S, Baba A (2001) Altered psychomotor behaviors in mice lacking pituitary 
adenylate cyclase-activating polypeptide (PACAP). Proceedings of the National 
Academy of Sciences of the United States of America 98:13355-13360. 
Hepp R, Perraut M, Chasserot-Golaz S, Galli T, Aunis D, Langley K, Grant NJ (1999) 
Cultured glial cells express the SNAP-25 analogue SNAP-23. Glia 27:181-187. 
Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, Godukhin OV, Chen Y, 
Espinoza S, Pettersson E, Loidl CF, Lubec G, Andersson K, Nylander I, Terenius L, 
Ungerstedt U (1996) On the origin of extracellular glutamate levels monitored in 
the basal ganglia of the rat by in vivo microdialysis. Journal of neurochemistry 
66:1726-1735. 
Holighaus Y, Mustafa T, Eiden LE (2011) PAC1hop, null and hip receptors mediate 
differential signaling through cyclic AMP and calcium leading to splice variant-
specific gene induction in neural cells. Peptides 32:1647-1655. 
Hyman SE, Malenka RC (2001) Addiction and the brain: the neurobiology of compulsion 
and its persistence. Nature reviews Neuroscience 2:695-703. 
Ikemoto S (2007) Dopamine reward circuitry: two projection systems from the ventral 
midbrain to the nucleus accumbens-olfactory tubercle complex. Brain research 
reviews 56:27-78. 
Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ (2000) Dissociation in conditioned 
dopamine release in the nucleus accumbens core and shell in response to cocaine 
cues and during cocaine-seeking behavior in rats. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 20:7489-7495. 
119 
 
Itzhak Y, Martin JL (2002) Cocaine-induced conditioned place preference in mice: 
induction, extinction and reinstatement by related psychostimulants. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 26:130-134. 
Jabaudon D, Shimamoto K, Yasuda-Kamatani Y, Scanziani M, Gahwiler BH, Gerber U 
(1999) Inhibition of uptake unmasks rapid extracellular turnover of glutamate of 
nonvesicular origin. Proceedings of the National Academy of Sciences of the 
United States of America 96:8733-8738. 
Jackman NA, Uliasz TF, Hewett JA, Hewett SJ (2010) Regulation of system x(c)(-
)activity and expression in astrocytes by interleukin-1beta: implications for hypoxic 
neuronal injury. Glia 58:1806-1815. 
Jacquy J, Wilmotte J, Piraux A, Noel G (1976) Cerebral blood flow patterns studied by 
rheoencephalography in schizophrenia. Neuropsychobiology 2:94-103. 
Jeftinija SD, Jeftinija KV, Stefanovic G (1997) Cultured astrocytes express proteins 
involved in vesicular glutamate release. Brain research 750:41-47. 
Johanson CE (1990) The evaluation of the abuse liability of drugs. Drug safety : an 
international journal of medical toxicology and drug experience 5 Suppl 1:46-57. 
Jourdain P, Bergersen LH, Bhaukaurally K, Bezzi P, Santello M, Domercq M, Matute C, 
Tonello F, Gundersen V, Volterra A (2007) Glutamate exocytosis from astrocytes 
controls synaptic strength. Nature neuroscience 10:331-339. 
Kalivas PW, McFarland K (2003) Brain circuitry and the reinstatement of cocaine-
seeking behavior. Psychopharmacology 168:44-56. 
Kalivas PW, Volkow N, Seamans J (2005) Unmanageable motivation in addiction: a 
pathology in prefrontal-accumbens glutamate transmission. Neuron 45:647-650. 
Kau KS, Madayag A, Mantsch JR, Grier MD, Abdulhameed O, Baker DA (2008) 
Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes 
cocaine-induced drug seeking. Neuroscience 155:530-537. 
120 
 
Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurones: 
chemical, physiological and morphological characterization. Trends in 
neurosciences 18:527-535. 
Kelley AE, Domesick VB (1982) The distribution of the projection from the hippocampal 
formation to the nucleus accumbens in the rat: an anterograde- and retrograde-
horseradish peroxidase study. Neuroscience 7:2321-2335. 
Kelley AE, Domesick VB, Nauta WJ (1982) The amygdalostriatal projection in the rat--
an anatomical study by anterograde and retrograde tracing methods. Neuroscience 
7:615-630. 
Kelley AE, Stinus L (1984) The distribution of the projection from the parataenial 
nucleus of the thalamus to the nucleus accumbens in the rat: an autoradiographic 
study. Experimental brain research Experimentelle Hirnforschung Experimentation 
cerebrale 54:499-512. 
Kerner JA, Standaert DG, Penney JB, Jr., Young AB, Landwehrmeyer GB (1997) 
Expression of group one metabotropic glutamate receptor subunit mRNAs in 
neurochemically identified neurons in the rat neostriatum, neocortex, and 
hippocampus. Brain research Molecular brain research 48:259-269. 
Kita H, Kitai ST (1990) Amygdaloid projections to the frontal cortex and the striatum in 
the rat. The Journal of comparative neurology 298:40-49. 
Knackstedt LA, Melendez RI, Kalivas PW (2010) Ceftriaxone restores glutamate 
homeostasis and prevents relapse to cocaine seeking. Biological psychiatry 67:81-
84. 
Koob GF, Le HT, Creese I (1987) The D1 dopamine receptor antagonist SCH 23390 
increases cocaine self-administration in the rat. Neuroscience letters 79:315-320. 
Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 24:97-129. 
Kosinski CM, Risso Bradley S, Conn PJ, Levey AI, Landwehrmeyer GB, Penney JB, Jr., 
Young AB, Standaert DG (1999) Localization of metabotropic glutamate receptor 7 
mRNA and mGluR7a protein in the rat basal ganglia. The Journal of comparative 
neurology 415:266-284. 
121 
 
Koves K, Arimura A, Gorcs TG, Somogyvari-Vigh A (1991) Comparative distribution of 
immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive 
intestinal polypeptide in rat forebrain. Neuroendocrinology 54:159-169. 
Kranich O, Dringen R, Sandberg M, Hamprecht B (1998) Utilization of cysteine and 
cysteine precursors for the synthesis of glutathione in astroglial cultures: preference 
for cystine. Glia 22:11-18. 
Lack CM, Jones SR, Roberts DC (2008) Increased breakpoints on a progressive ratio 
schedule reinforced by IV cocaine are associated with reduced locomotor activation 
and reduced dopamine efflux in nucleus accumbens shell in rats. 
Psychopharmacology 195:517-525. 
Lam HC, Takahashi K, Ghatei MA, Kanse SM, Polak JM, Bloom SR (1990) Binding 
sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in 
the rat brain and lung. European journal of biochemistry / FEBS 193:725-729. 
LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification 
associated with the striatal neurotoxicity of methamphetamine: evidence against a 
role for extracellular dopamine. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 19:1484-1491. 
Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush AI, 
Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cuenod M, Buclin T, 
Do KQ (2008) Glutathione precursor, N-acetyl-cysteine, improves mismatch 
negativity in schizophrenia patients. Neuropsychopharmacology : official 
publication of the American College of Neuropsychopharmacology 33:2187-2199. 
Levy LM, Warr O, Attwell D (1998) Stoichiometry of the glial glutamate transporter 
GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low 
endogenous Na+-dependent glutamate uptake. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 18:9620-9628. 
Lewerenz J, Klein M, Methner A (2006) Cooperative action of glutamate transporters and 
cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity. 
Journal of neurochemistry 98:916-925. 
Li A, Guo H, Luo X, Sheng J, Yang S, Yin Y, Zhou J (2006) Apomorphine-induced 
activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures 
and promotes survival of dopaminergic neurons. The FASEB journal : official 
122 
 
publication of the Federation of American Societies for Experimental Biology 
20:1263-1265. 
Liu X, Resch J, Rush T, Lobner D (2011) Functional upregulation of system xc- by 
fibroblast growth factor-2. Neuropharmacology. 
Liu X, Rush T, Zapata J, Lobner D (2009) beta-N-methylamino-l-alanine induces 
oxidative stress and glutamate release through action on system Xc(-). Experimental 
neurology 217:429-433. 
Lobner D (2000) Comparison of the LDH and MTT assays for quantifying cell death: 
validity for neuronal apoptosis? Journal of neuroscience methods 96:147-152. 
Lobner D, Lipton P (1993) Intracellular calcium levels and calcium fluxes in the CA1 
region of the rat hippocampal slice during in vitro ischemia: relationship to 
electrophysiological cell damage. The Journal of neuroscience : the official journal 
of the Society for Neuroscience 13:4861-4871. 
Lovinger DM, McCool BA (1995) Metabotropic glutamate receptor-mediated 
presynaptic depression at corticostriatal synapses involves mGLuR2 or 3. Journal of 
neurophysiology 73:1076-1083. 
Lu L, Zhang B, Liu Z, Zhang Z (2002) Reactivation of cocaine conditioned place 
preference induced by stress is reversed by cholecystokinin-B receptors antagonist 
in rats. Brain research 954:132-140. 
Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R (2006) 
Characterization of novel splice variants of the PAC1 receptor in human 
neuroblastoma cells: consequences for signaling by VIP and PACAP. Molecular 
and cellular neurosciences 31:193-209. 
Malarkey EB, Parpura V (2008) Mechanisms of glutamate release from astrocytes. 
Neurochemistry international 52:142-154. 
Manzoni O, Michel JM, Bockaert J (1997) Metabotropic glutamate receptors in the rat 
nucleus accumbens. The European journal of neuroscience 9:1514-1523. 
123 
 
Marino MJ, Awad H, Poisik O, Wittmann M, Conn PJ (2002) Localization and 
physiological roles of metabotropic glutamate receptors in the direct and indirect 
pathways of the basal ganglia. Amino acids 23:185-191. 
McDonald AJ (1991) Topographical organization of amygdaloid projections to the 
caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain. 
Neuroscience 44:15-33. 
McFarland K, Kalivas PW (2001) The circuitry mediating cocaine-induced reinstatement 
of drug-seeking behavior. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 21:8655-8663. 
McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core 
of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking 
behavior. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 23:3531-3537. 
Meister A (1985) Methods for the selective modification of glutathione metabolism and 
study of glutathione transport. Methods in enzymology 113:571-585. 
Melendez RI, Vuthiganon J, Kalivas PW (2005) Regulation of extracellular glutamate in 
the prefrontal cortex: focus on the cystine glutamate exchanger and group I 
metabotropic glutamate receptors. The Journal of pharmacology and experimental 
therapeutics 314:139-147. 
Meredith GE (1999) The synaptic framework for chemical signaling in nucleus 
accumbens. Annals of the New York Academy of Sciences 877:140-156. 
Mikkelsen JD, Hannibal J, Larsen PJ, Fahrenkrug J (1994) Pituitary adenylate cyclase 
activating peptide (PACAP) mRNA in the rat neocortex. Neuroscience letters 
171:121-124. 
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: 
from structure to function. Physiological reviews 78:189-225. 
Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH 
(1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates 
adenylate cyclase in pituitary cells. Biochemical and biophysical research 
communications 164:567-574. 
124 
 
Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A 
(1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of 
the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). 
Biochemical and biophysical research communications 170:643-648. 
Moldeus P, Ormstad K, Reed DJ (1981) Turnover of cellular glutathione in isolated rat-
kidney cells. Role of cystine and methionine. European journal of biochemistry / 
FEBS 116:13-16. 
Montana V, Ni Y, Sunjara V, Hua X, Parpura V (2004) Vesicular glutamate transporter-
dependent glutamate release from astrocytes. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 24:2633-2642. 
Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK (2005) 
Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic 
inhibition of excitatory transmission and vulnerability to cocaine seeking. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
25:6389-6393. 
Moran MM, Melendez R, Baker D, Kalivas PW, Seamans JK (2003) Cystine/glutamate 
antiporter regulation of vesicular glutamate release. Annals of the New York 
Academy of Sciences 1003:445-447. 
Moussawi K, Riegel A, Nair S, Kalivas PW (2011a) Extracellular glutamate: functional 
compartments operate in different concentration ranges. Frontiers in systems 
neuroscience 5:94. 
Moussawi K, Zhou W, Shen H, Reichel CM, See RE, Carr DB, Kalivas PW (2011b) 
Reversing cocaine-induced synaptic potentiation provides enduring protection from 
relapse. Proceedings of the National Academy of Sciences of the United States of 
America 108:385-390. 
Murase T, Kondo K, Arima H, Iwasaki Y, Ito M, Miura Y, Oiso Y (1995) The expression 
of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in rat brain: 
possible role of endogenous PACAP in vasopressin release. Neuroscience letters 
185:103-106. 
Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in 
a neuronal cell line involves inhibition of cystine transport leading to oxidative 
stress. Neuron 2:1547-1558. 
125 
 
Murphy TH, Schnaar RL, Coyle JT (1990) Immature cortical neurons are uniquely 
sensitive to glutamate toxicity by inhibition of cystine uptake. The FASEB journal : 
official publication of the Federation of American Societies for Experimental 
Biology 4:1624-1633. 
Mustafa T, Grimaldi M, Eiden LE (2007) The hop cassette of the PAC1 receptor confers 
coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating 
polypeptide-evoked neurosecretion. The Journal of biological chemistry 282:8079-
8091. 
Nakanishi S (1994) The molecular diversity of glutamate receptors. Progress in clinical 
and biological research 390:85-98. 
O'Brien CP, Childress AR, Ehrman R, Robbins SJ (1998) Conditioning factors in drug 
abuse: can they explain compulsion? J Psychopharmacol 12:15-22. 
O'Brien CP, Childress AR, McLellan AT, Ehrman R (1992) Classical conditioning in 
drug-dependent humans. Annals of the New York Academy of Sciences 654:400-
415. 
Onoue S, Endo K, Ohshima K, Yajima T, Kashimoto K (2002) The neuropeptide PACAP 
attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 23:1471-
1478. 
Owe SG, Marcaggi P, Attwell D (2006) The ionic stoichiometry of the GLAST glutamate 
transporter in salamander retinal glia. The Journal of physiology 577:591-599. 
Panlilio LV, Goldberg SR (2007) Self-administration of drugs in animals and humans as 
a model and an investigative tool. Addiction 102:1863-1870. 
Park MK, Kang YJ, Ha YM, Jeong JJ, Kim HJ, Seo HG, Lee JH, Chang KC (2009) EP2 
receptor activation by prostaglandin E2 leads to induction of HO-1 via PKA and 
PI3K pathways in C6 cells. Biochemical and biophysical research communications 
379:1043-1047. 
Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC (2002) 
Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking 
behavior by increasing AMPA receptor-mediated glutamate transmission in the 
nucleus accumbens. The Journal of neuroscience : the official journal of the Society 
for Neuroscience 22:2916-2925. 
126 
 
Parker LA, McDonald RV (2000) Reinstatement of both a conditioned place preference 
and a conditioned place aversion with drug primes. Pharmacology, biochemistry, 
and behavior 66:559-561. 
Parpura V, Fang Y, Basarsky T, Jahn R, Haydon PG (1995) Expression of synaptobrevin 
II, cellubrevin and syntaxin but not SNAP-25 in cultured astrocytes. FEBS letters 
377:489-492. 
Pasti L, Zonta M, Pozzan T, Vicini S, Carmignoto G (2001) Cytosolic calcium 
oscillations in astrocytes may regulate exocytotic release of glutamate. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 21:477-484. 
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Sydney ; Orlando: 
Academic Press. 
Pfeffer CK, Stein V, Keating DJ, Maier H, Rinke I, Rudhard Y, Hentschke M, Rune GM, 
Jentsch TJ, Hubner CA (2009) NKCC1-dependent GABAergic excitation drives 
synaptic network maturation during early hippocampal development. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 29:3419-3430. 
Pierce RC, Bell K, Duffy P, Kalivas PW (1996) Repeated cocaine augments excitatory 
amino acid transmission in the nucleus accumbens only in rats having developed 
behavioral sensitization. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 16:1550-1560. 
Pierce RC, Vanderschuren LJ (2010) Kicking the habit: the neural basis of ingrained 
behaviors in cocaine addiction. Neuroscience and biobehavioral reviews 35:212-
219. 
Pileblad E, Magnusson T (1992) Increase in rat brain glutathione following 
intracerebroventricular administration of gamma-glutamylcysteine. Biochemical 
pharmacology 44:895-903. 
Pisani A, Bonsi P, Centonze D, Bernardi G, Calabresi P (2001a) Functional coexpression 
of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons. 
Neuropharmacology 40:460-463. 
Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi 
P (2001b) Metabotropic glutamate receptor 5 mediates the potentiation of N-
127 
 
methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience 
106:579-587. 
Rabinovic AD, Hastings TG (1998) Role of endogenous glutathione in the oxidation of 
dopamine. Journal of neurochemistry 71:2071-2078. 
Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George 
SR (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology 
are coupled to rapid activation of Gq/11 in the striatum. Proceedings of the National 
Academy of Sciences of the United States of America 104:654-659. 
Reid MS, Berger SP (1996) Evidence for sensitization of cocaine-induced nucleus 
accumbens glutamate release. Neuroreport 7:1325-1329. 
Reynolds SM, Zahm DS (2005) Specificity in the projections of prefrontal and insular 
cortex to ventral striatopallidum and the extended amygdala. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 25:11757-11767. 
Robbins TW, Everitt BJ, Nutt DJ (2008) Introduction. The neurobiology of drug 
addiction: new vistas. Philosophical transactions of the Royal Society of London 
Series B, Biological sciences 363:3109-3111. 
Rodd-Henricks ZA, McKinzie DL, Li TK, Murphy JM, McBride WJ (2002) Cocaine is 
self-administered into the shell but not the core of the nucleus accumbens of Wistar 
rats. The Journal of pharmacology and experimental therapeutics 303:1216-1226. 
Romieu P, Meunier J, Garcia D, Zozime N, Martin-Fardon R, Bowen WD, Maurice T 
(2004) The sigma1 (sigma1) receptor activation is a key step for the reactivation of 
cocaine conditioned place preference by drug priming. Psychopharmacology 
175:154-162. 
Rush T, Liu X, Nowakowski AB, Petering DH, Lobner D (2012) Glutathione-mediated 
neuroprotection against methylmercury neurotoxicity in cortical culture is 
dependent on MRP1. Neurotoxicology. 
Russo LC, Goni CN, Castro LM, Asega AF, Camargo AC, Trujillo CA, Ulrich H, 
Glucksman MJ, Scavone C, Ferro ES (2009) Interaction with calmodulin is 
important for the secretion of thimet oligopeptidase following stimulation. The 
FEBS journal 276:4358-4371. 
128 
 
Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA (2003) Manipulation of dopamine d1-
like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-
induced reinstatement of conditioned place preference behavior. Neuroscience 
119:497-505. 
Schmidt HD, Anderson SM, Famous KR, Kumaresan V, Pierce RC (2005) Anatomy and 
pharmacology of cocaine priming-induced reinstatement of drug seeking. European 
journal of pharmacology 526:65-76. 
Schmidt HD, Anderson SM, Pierce RC (2006) Stimulation of D1-like or D2 dopamine 
receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-
seeking behaviour in the rat. The European journal of neuroscience 23:219-228. 
Schmidt HD, Pierce RC (2006) Cooperative activation of D1-like and D2-like dopamine 
receptors in the nucleus accumbens shell is required for the reinstatement of 
cocaine-seeking behavior in the rat. Neuroscience 142:451-461. 
Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glutamate 
receptors in the central nervous system. The Journal of pharmacology and 
experimental therapeutics 299:12-20. 
Schwartz JP, Wilson DJ (1992) Preparation and characterization of type 1 astrocytes 
cultured from adult rat cortex, cerebellum, and striatum. Glia 5:75-80. 
See RE (2002) Neural substrates of conditioned-cued relapse to drug-seeking behavior. 
Pharmacology, biochemistry, and behavior 71:517-529. 
Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking 
in rats: a review. Brain research Brain research reviews 33:13-33. 
Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine 
seeking: a review. Pharmacological reviews 54:1-42. 
Shih AY, Erb H, Murphy TH (2007) Dopamine activates Nrf2-regulated neuroprotective 
pathways in astrocytes and meningeal cells. Journal of neurochemistry 101:109-
119. 
Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH 
(2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-
129 
 
expressing glia potently protects neurons from oxidative stress. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 23:3394-3406. 
Shih AY, Murphy TH (2001) xCt cystine transporter expression in HEK293 cells: 
pharmacology and localization. Biochemical and biophysical research 
communications 282:1132-1137. 
Skoglosa Y, Takei N, Lindholm D (1999) Distribution of pituitary adenylate cyclase 
activating polypeptide mRNA in the developing rat brain. Brain research Molecular 
brain research 65:1-13. 
Smith JA, Mo Q, Guo H, Kunko PM, Robinson SE (1995) Cocaine increases 
extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain 
research 683:264-269. 
Song XJ, Wang ZB, Gan Q, Walters ET (2006) cAMP and cGMP contribute to sensory 
neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia 
compression. Journal of neurophysiology 95:479-492. 
Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) 
Pharmacological and environmental determinants of relapse to cocaine-seeking 
behavior. Pharmacology, biochemistry, and behavior 64:327-336. 
Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stress-induced 
relapse to drug-taking. Journal of psychiatry & neuroscience : JPN 25:125-136. 
Strange RW, Murphy LM, Karlsson BG, Reinhammar B, Hasnain SS (1996) Effect of pH 
and ligand binding on the structure of the Cu site of the Met121Glu mutant of 
azurin from Pseudomonas aeruginosa. Biochemistry 35:16391-16398. 
Sun W, Rebec GV (2003) Lidocaine inactivation of ventral subiculum attenuates cocaine-
seeking behavior in rats. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 23:10258-10264. 
Sun W, Rebec GV (2006) Repeated cocaine self-administration alters processing of 
cocaine-related information in rat prefrontal cortex. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 26:8004-8008. 
130 
 
Sundler F, Ekblad E, Hannibal J, Moller K, Zhang YZ, Mulder H, Elsas T, Grunditz T, 
Danielsen N, Fahrenkrug J, Uddman R (1996) Pituitary adenylate cyclase-activating 
peptide in sensory and autonomic ganglia: localization and regulation. Annals of the 
New York Academy of Sciences 805:410-426; discussion 427-418. 
Suto N, Ecke LE, Wise RA (2009) Control of within-binge cocaine-seeking by dopamine 
and glutamate in the core of nucleus accumbens. Psychopharmacology 205:431-
439. 
Sutton MA, Karanian DA, Self DW (2000) Factors that determine a propensity for 
cocaine-seeking behavior during abstinence in rats. Neuropsychopharmacology : 
official publication of the American College of Neuropsychopharmacology 22:626-
641. 
Tanaka K, Shibuya I, Nagamoto T, Yamashita H, Kanno T (1996) Pituitary adenylate 
cyclase-activating polypeptide causes rapid Ca2+ release from intracellular stores 
and long lasting Ca2+ influx mediated by Na+ influx-dependent membrane 
depolarization in bovine adrenal chromaffin cells. Endocrinology 137:956-966. 
Tang XC, Kalivas PW (2003) Bidirectional modulation of cystine/glutamate exchanger 
activity in cultured cortical astrocytes. Annals of the New York Academy of 
Sciences 1003:472-475. 
Tarazi FI, Baldessarini RJ (2000) Comparative postnatal development of dopamine D(1), 
D(2) and D(4) receptors in rat forebrain. International journal of developmental 
neuroscience : the official journal of the International Society for Developmental 
Neuroscience 18:29-37. 
Testa CM, Friberg IK, Weiss SW, Standaert DG (1998) Immunohistochemical 
localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat 
basal ganglia. The Journal of comparative neurology 390:5-19. 
Thomas MJ, Kalivas PW, Shaham Y (2008) Neuroplasticity in the mesolimbic dopamine 
system and cocaine addiction. British journal of pharmacology 154:327-342. 
Timmerman W, Westerink BH (1997) Brain microdialysis of GABA and glutamate: what 
does it signify? Synapse 27:242-261. 
Torregrossa MM, Kalivas PW (2008) Microdialysis and the neurochemistry of addiction. 
Pharmacology, biochemistry, and behavior 90:261-272. 
131 
 
Torregrossa MM, Tang XC, Kalivas PW (2008) The glutamatergic projection from the 
prefrontal cortex to the nucleus accumbens core is required for cocaine-induced 
decreases in ventral pallidal GABA. Neuroscience letters 438:142-145. 
Totterdell S, Meredith GE (1997) Topographical organization of projections from the 
entorhinal cortex to the striatum of the rat. Neuroscience 78:715-729. 
Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) 
paradigm: update of the last decade. Addiction biology 12:227-462. 
Van Bockstaele EJ, Pickel VM (1995) GABA-containing neurons in the ventral 
tegmental area project to the nucleus accumbens in rat brain. Brain research 
682:215-221. 
Volkow ND, Fowler JS (2000) Addiction, a disease of compulsion and drive: 
involvement of the orbitofrontal cortex. Cereb Cortex 10:318-325. 
Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding 
YS, Pappas N (1999) Association of methylphenidate-induced craving with changes 
in right striato-orbitofrontal metabolism in cocaine abusers: implications in 
addiction. The American journal of psychiatry 156:19-26. 
Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Ding YS, Hitzemann R, Swanson 
JM, Kalivas P (2005) Activation of orbital and medial prefrontal cortex by 
methylphenidate in cocaine-addicted subjects but not in controls: relevance to 
addiction. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 25:3932-3939. 
Voorn P, Jorritsma-Byham B, Van Dijk C, Buijs RM (1986) The dopaminergic 
innervation of the ventral striatum in the rat: a light- and electron-microscopical 
study with antibodies against dopamine. The Journal of comparative neurology 
251:84-99. 
Waniewski RA, Martin DL (1984) Characterization of L-glutamic acid transport by 
glioma cells in culture: evidence for sodium-independent, chloride-dependent high 
affinity influx. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 4:2237-2246. 
132 
 
Warr O, Takahashi M, Attwell D (1999) Modulation of extracellular glutamate 
concentration in rat brain slices by cystine-glutamate exchange. The Journal of 
physiology 514 ( Pt 3):783-793. 
Weeks JR (1962) Experimental morphine addiction: method for automatic intravenous 
injections in unrestrained rats. Science 138:143-144. 
Wenzel A, Fritschy JM, Mohler H, Benke D (1997) NMDA receptor heterogeneity 
during postnatal development of the rat brain: differential expression of the NR2A, 
NR2B, and NR2C subunit proteins. Journal of neurochemistry 68:469-478. 
Westerink BH (1995) Brain microdialysis and its application for the study of animal 
behaviour. Behavioural brain research 70:103-124. 
Williamson JM, Meister A (1981) Stimulation of hepatic glutathione formation by 
administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. 
Proceedings of the National Academy of Sciences of the United States of America 
78:936-939. 
Wise RA (1984) Neural mechanisms of the reinforcing action of cocaine. NIDA research 
monograph 50:15-33. 
Wolf ME, Sun X, Mangiavacchi S, Chao SZ (2004) Psychomotor stimulants and 
neuronal plasticity. Neuropharmacology 47 Suppl 1:61-79. 
Wu M, Hrycyshyn AW, Brudzynski SM (1996) Subpallidal outputs to the nucleus 
accumbens and the ventral tegmental area: anatomical and electrophysiological 
studies. Brain research 740:151-161. 
Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V 
(1998) Identity of the organic cation transporter OCT3 as the extraneuronal 
monoamine transporter (uptake2) and evidence for the expression of the transporter 
in the brain. The Journal of biological chemistry 273:32776-32786. 
Xi ZX, Baker DA, Shen H, Carson DS, Kalivas PW (2002a) Group II metabotropic 
glutamate receptors modulate extracellular glutamate in the nucleus accumbens. 
The Journal of pharmacology and experimental therapeutics 300:162-171. 
133 
 
Xi ZX, Ramamoorthy S, Baker DA, Shen H, Samuvel DJ, Kalivas PW (2002b) 
Modulation of group II metabotropic glutamate receptor signaling by chronic 
cocaine. The Journal of pharmacology and experimental therapeutics 303:608-615. 
Xia Y, Goebel DJ, Kapatos G, Bannon MJ (1992) Quantitation of rat dopamine 
transporter mRNA: effects of cocaine treatment and withdrawal. Journal of 
neurochemistry 59:1179-1182. 
Ye ZC, Rothstein JD, Sontheimer H (1999) Compromised glutamate transport in human 
glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters 
and enhanced activity of cystine-glutamate exchange. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 19:10767-10777. 
Ye ZC, Wyeth MS, Baltan-Tekkok S, Ransom BR (2003) Functional hemichannels in 
astrocytes: a novel mechanism of glutamate release. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 23:3588-3596. 
Zerangue N, Kavanaugh MP (1996) Flux coupling in a neuronal glutamate transporter. 
Nature 383:634-637. 
Zhang J, Ravichandran KS, Garrison JC (2010) A key role for the phosphorylation of 
Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the 
Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1). The Journal of 
biological chemistry 285:34839-34849. 
Zhang J, Walk SF, Ravichandran KS, Garrison JC (2009) Regulation of the Src 
homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-
dependent protein kinase. The Journal of biological chemistry 284:20070-20078. 
 
 
